UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended
June 30, 20202021
or
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from _____ to _____
Commission File Number: 001-38272
EVOQUA WATER TECHNOLOGIES CORP.
(Exact name of registrant as specified in its charter)
 
Delaware46-4132761
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer Identification No.)
210 Sixth Avenue15222
Pittsburgh,Pennsylvania
(Address of principal executive offices)(Zip code)Code)
(724) 724) 772-0044
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareAQUANew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes    No 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of


this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes     No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”,filer,” “accelerated filer”,filer,” “smaller reporting company”company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
AcceleratedNon-accelerated filer
Non-accelerated filer 
(Do not check if a
smaller reporting company)
Smaller reporting company

Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes     No 
There were 117,199,388120,232,936 shares of the registrant’s common stock, par value $0.01 per share, outstanding as of July 31, 2020.30, 2021.






EVOQUA WATER TECHNOLOGIES CORP.
TABLE OF CONTENTS







CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q (this “Report”) contains forward‑looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). You can generally identify forward‑looking statements by our use of forward‑looking terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “projection,” “seek,” “should,” “will” or “would”“would,” or the negative thereof, or other variations thereon or comparable terminology. In particular, statements about the markets in which we operate, including growth of our various markets, our expectations, beliefs, plans, strategies, objectives, prospects, assumptions, or future events or performance, statements regarding our restructuring actions and expected restructuring charges and cost savings for fiscal 20202021 and beyond, statements regarding our cash requirements, working capital needs and expected capital expenditures, and statements related to the COVID-19 pandemic and its ongoing impact on our business contained in this Report are forward‑looking statements.
We have based these forward‑looking statements on our current expectations, assumptions, estimates and projections. While we believe these expectations, assumptions, estimates and projections are reasonable, such forward‑looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond our control. These and other important factors, including those discussed in Part I, Item 1A. “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended September 30, 2019,2020, as filed with the Securities and Exchange Commission (“SEC”) on November 25, 2019, Part II, Item 1A. “Risk Factors” of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, as filed with the SEC on May 6,20, 2020, and Part I, Item 2. “Management’s Discussion and Analysis of Financial Condition and Results of Operation” of this Report may cause our actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward‑looking statements or could affect our share price. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward‑looking statements include:include, among other things:
general global economic and business conditions, including the impacts of the COVID-19 pandemic and recent disruptions in global oil markets;supply chains;
our ability to compete successfully in our markets;
our ability to continue to develop or acquire new products, services and solutions and adapt our business to meet the demands of our customers, comply with changes to government regulations and achieve market acceptance with acceptable margins;
our ability to implement our growth strategy, including acquisitions, and our ability to identify suitable acquisition targets;
our ability to operate or integrate any acquired businesses, assets or product lines profitably or otherwise successfully implement our growth strategy;
our ability to achieve the expected benefits of our restructuring actions, including restructuring our business into two segments;
material and other cost inflation and our ability to mitigate the impact of inflation by increasing selling prices and improving our productivity efficiencies;
our ability to execute projects in a timely manner, consistent with our customers’ demands;on budget and on schedule;
our ability to accurately predict the timing of contract awards;
delays in enactment or repeals of environmental laws and regulations;
the potential for us to become subject to claims relating to handling, storage, release or disposal of hazardous materials;
risks associated with product defects and unanticipated or improper use of our products;
the potential for us to incur liabilities to customers as a result of warranty claims or failure to meet performance guarantees;

our ability to meet our customers’ safety standards or the potential for adverse publicity affecting our reputation as a result of incidents such as workplace accidents, mechanical failures, spills, uncontrolled discharges, damage to customer or third‑party property or the transmission of contaminants or diseases;
our ability to continue to develop or acquire new products, services and solutions and adapt our business to meet the demands of our customers, comply with changes to government regulations and achieve market acceptance with acceptable margins;
our ability to implement our growth strategy, including acquisitions, and our ability to identify suitable acquisition targets;
our ability to operate or integrate any acquired businesses, assets or product lines profitably or otherwise successfully implement our growth strategy;
our ability to achieve the expected benefits of our restructuring actions;
material and other cost inflation and our ability to mitigate the impact of inflation by increasing selling prices and/or improving our productivity efficiencies;
our ability to accurately predict the timing of contract awards;
delays in enactment or repeals of environmental laws and regulations;
the potential for us to become subject to claims relating to handling, storage, release or disposal of hazardous materials;
1


our ability to retain our senior management and other key personnel and to attract key talent in increasingly competitive labor markets;
our increasing dependence on the continuous and reliable operation of our information technology systems;
risks associated with product defects and unanticipated or improper use of our products;
litigation, regulatory or enforcement actions and reputational risk as a result of the nature of our business or our participation in large‑scale projects;
seasonality of sales and weather conditions;
risks related to government customers, including potential challenges to our government contracts or our eligibility to serve government customers;
the potential for our contracts with federal, state and local governments to be terminated or adversely modified prior to completion;
risks related to foreign, federal, state and local environmental, health and safety laws and regulations and the costs associated therewith;
risks associated with international sales and operations, including our operations in the People’s Republic of China;
our ability to adequately protect our intellectual property from third‑party infringement;
our increasing dependence on the continuous and reliable operation of our information technology systems;
risks related to our substantial indebtedness;
our need for a significant amount of cash, which depends on many factors beyond our control; and
risks related to AEA Investors LP’s (along with certain of its affiliates, collectively, “AEA”) ownership interest in us; and
other risks and uncertainties, including those listed under Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended September 30, 2019,2020, as filed with the SEC on November 25, 2019, Part II, Item 1A. “Risk Factors” of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, as filed with the SEC on May 6,20, 2020, and in other filings we may make from time to time with the SEC.
Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward‑looking statements. The forward‑looking statements contained in this Report are not guarantees of future performance and our actual results of operations, financial condition and liquidity, and the development of the industry in which we operate, may differ materially from the forward‑looking statements contained in this Report. In addition, even if our results of operations, financial condition and liquidity, and events in the industry in which we operate, are consistent with the forward‑looking statements contained in this Report, they may not be predictive of results or developments in future periods.
Any forward‑looking statement that we make in this Report speaks only as of the date of such statement. Except as required by law, we do not undertake any obligation to update or revise, or to publicly announce any update or revision to, any of the forward‑looking statements, whether as a result of new information, future events or otherwise, after the date of this Report.

2


Part I - Financial Information

Item 1. Consolidated Financial Statements

INDEX TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

3


Evoqua Water Technologies Corp.
Consolidated Balance Sheets
(In thousands)
(Unaudited)  (Unaudited)
June 30,
2020
 September 30,
2019
June 30,
2021
September 30,
2020
ASSETS   ASSETS
Current assets$642,722
 $637,293
Current assets$664,060 $695,712 
Cash and cash equivalents142,737
 109,881
Cash and cash equivalents141,524 193,001 
Receivables, net242,898
 257,585
Receivables, net246,619 260,479 
Inventories, net159,446
 137,164
Inventories, net161,228 142,379 
Contract assets77,590
 73,467
Contract assets69,343 80,759 
Prepaid and other current assets20,051
 21,940
Prepaid and other current assets43,444 18,715 
Assets held for sale
 37,256
Income tax receivableIncome tax receivable1,902 379 
Property, plant, and equipment, net356,424
 333,584
Property, plant, and equipment, net372,399 364,461 
Goodwill393,427
 392,890
Goodwill409,756 397,205 
Intangible assets, net316,299
 314,767
Intangible assets, net297,674 309,967 
Deferred income taxes, net of valuation allowance4,170
 2,790
Deferred income taxes, net of valuation allowance1,710 3,639 
Operating lease right-of-use assets, net39,427
 
Operating lease right-of-use assets, net47,307 45,965 
Other non‑current assets25,427
 25,715
Other non‑current assets50,252 27,509 
Non-current assets held for sale
 30,809
Total assets$1,777,896
 $1,737,848
Total assets$1,843,158 $1,844,458 
LIABILITIES AND EQUITY   LIABILITIES AND EQUITY
Current liabilities$335,292
 $322,221
Current liabilities$370,703 $349,555 
Accounts payable154,322
 144,247
Accounts payable144,426 153,890 
Current portion of debt14,611
 13,418
Current portion of debt, net of deferred financing fees and discountsCurrent portion of debt, net of deferred financing fees and discounts11,474 14,339 
Contract liabilities30,841
 39,051
Contract liabilities36,915 26,259 
Product warranties5,246
 4,922
Product warranties8,063 6,115 
Accrued expenses and other liabilities124,016
 101,839
Accrued expenses and other liabilities165,127 143,389 
Income tax payable6,256
 4,536
Income tax payable4,698 5,563 
Liabilities held for sale
 14,208
Non‑current liabilities995,274
 1,049,805
Non‑current liabilities$927,276 $1,012,840 
Long-term debt855,359
 951,599
Long-term debt, net of deferred financing fees and discountsLong-term debt, net of deferred financing fees and discounts778,170 861,695 
Product warranties1,600
 2,332
Product warranties2,629 1,724 
Obligation under operating leases31,008
 
Obligation under operating leases38,541 37,796 
Other non‑current liabilities93,909
 78,661
Other non‑current liabilities95,924 98,456 
Deferred income taxes13,398
 13,548
Deferred income taxes12,012 13,169 
Non-current liabilities held for sale
 3,665
Total liabilities1,330,566
 1,372,026
Total liabilities$1,297,979 $1,362,395 
Commitments and Contingent Liabilities (Note 20)


 


Commitments and Contingent Liabilities (Note 19)Commitments and Contingent Liabilities (Note 19)00
Shareholders’ equity   Shareholders’ equity
Common stock, par value $0.01: authorized 1,000,000 shares; issued 119,392 shares, outstanding 117,197 at June 30, 2020; issued 116,008, outstanding 114,344 shares at September 30, 20191,187
 1,154
Treasury stock: 2,195 shares at June 30, 2020 and 1,664 shares at September 30, 2019(2,837) (2,837)
Common stock, par value $0.01: authorized 1,000,000 shares; issued 121,837 shares, outstanding 120,173 at June 30, 2021; issued 119,486 shares, outstanding 117,291 at September 30, 2020Common stock, par value $0.01: authorized 1,000,000 shares; issued 121,837 shares, outstanding 120,173 at June 30, 2021; issued 119,486 shares, outstanding 117,291 at September 30, 2020$1,219 $1,189 
Treasury stock: 1,664 shares at June 30, 2021 and 2,195 shares at September 30, 2020Treasury stock: 1,664 shares at June 30, 2021 and 2,195 shares at September 30, 2020(2,837)(2,837)
Additional paid-in capital578,842
 552,422
Additional paid-in capital573,892 564,928 
Retained deficit(93,972) (174,976)Retained deficit(38,040)(62,664)
Accumulated other comprehensive loss, net of tax(38,019) (13,004)
Accumulated other comprehensive income (loss), net of taxAccumulated other comprehensive income (loss), net of tax9,342 (20,472)
Total Evoqua Water Technologies Corp. equity445,201
 362,759
Total Evoqua Water Technologies Corp. equity$543,576 $480,144 
Non-controlling interest2,129
 3,063
Non-controlling interest1,603 1,919 
Total shareholders’ equity447,330
 365,822
Total shareholders’ equity$545,179 $482,063 
Total liabilities and shareholders’ equity$1,777,896
 $1,737,848
Total liabilities and shareholders’ equity$1,843,158 $1,844,458 
See accompanying notes to these Unaudited Consolidated Financial Statements
4


Evoqua Water Technologies Corp.
Unaudited Consolidated Statements of Operations
(In thousands, except per share data)
Three Months Ended
June 30,
 Nine Months Ended
June 30,
Three Months Ended
June 30,
Nine Months Ended
June 30,
2020 2019 2020 20192021202020212020
Revenue from product sales$207,575
 $210,363
 $610,104
 $597,319
Revenue from product sales$218,427 $207,575 $600,908 $610,104 
Revenue from services140,252
 149,980
 435,491
 434,654
Revenue from services151,254 140,252 437,530 435,491 
Revenue from product sales and services347,827
 360,343
 1,045,595
 1,031,973
Revenue from product sales and services$369,681 $347,827 $1,038,438 $1,045,595 
Cost of product sales(143,457) (148,417) (428,069) (438,869)Cost of product sales(152,591)(143,457)(428,173)(428,069)
Cost of services(94,136) (100,632) (290,371) (297,469)Cost of services(100,061)(94,136)(291,972)(290,371)
Cost of product sales and services(237,593) (249,049) (718,440) (736,338)Cost of product sales and services$(252,652)$(237,593)$(720,145)$(718,440)
Gross profit110,234
 111,294
 327,155
 295,635
Gross profit$117,029 $110,234 $318,293 $327,155 
General and administrative expense(44,867) (49,525) (152,767) (152,571)General and administrative expense(50,837)(44,867)(146,048)(152,767)
Sales and marketing expense(29,855) (31,959) (101,845) (103,546)Sales and marketing expense(35,871)(29,855)(103,629)(101,845)
Research and development expense(2,782) (3,281) (9,655) (11,384)Research and development expense(3,413)(2,782)(9,929)(9,655)
Total operating expenses(77,504) (84,765) (264,267) (267,501)Total operating expenses$(90,121)$(77,504)$(259,606)$(264,267)
Other operating income621
 746
 61,859
 4,625
Other operating income1,662 621 2,653 61,859 
Other operating expense(285) (184) (834) (559)Other operating expense(260)(285)(618)(834)
Income before interest expense and income taxes33,066
 27,091
 123,913
 32,200
Income before interest expense and income taxes$28,310 $33,066 $60,722 $123,913 
Interest expense(10,485) (14,842) (37,320) (43,759)Interest expense(11,224)(10,485)(28,292)(37,320)
Income (loss) before income taxes22,581
 12,249
 86,593
 (11,559)
Income tax (expense) benefit(740) (7,959) (3,336) 1,134
Net income (loss)21,841
 4,290
 83,257
 (10,425)
Income before income taxesIncome before income taxes$17,086 $22,581 $32,430 $86,593 
Income tax expenseIncome tax expense(3,887)(740)(7,672)(3,336)
Net incomeNet income$13,199 $21,841 $24,758 $83,257 
Net income attributable to non‑controlling interest457
 155
 916
 786
Net income attributable to non‑controlling interest44 457 134 916 
Net income (loss) attributable to Evoqua Water Technologies Corp.$21,384
 $4,135
 $82,341
 $(11,211)
Basic income (loss) per common share$0.18
 $0.04
 $0.71
 $(0.10)
Diluted income (loss) per common share$0.18
 $0.03
 $0.68
 $(0.10)
Net income attributable to Evoqua Water Technologies Corp.Net income attributable to Evoqua Water Technologies Corp.$13,155 $21,384 $24,624 $82,341 
Basic income per common shareBasic income per common share$0.11 $0.18 $0.21 $0.71 
Diluted income per common shareDiluted income per common share$0.11 $0.18 $0.20 $0.68 
See accompanying notes to these Unaudited Consolidated Financial Statements

5


Evoqua Water Technologies Corp.
Unaudited Consolidated Statements of Comprehensive Income (Loss)
(In thousands)
Three Months Ended
June 30,
Nine Months Ended
June 30,
Three Months Ended
June 30,
 Nine Months Ended
June 30,
2021202020212020
2020 2019 2020 2019
Net income (loss)$21,841
 $4,290
 $83,257
 $(10,425)
Other comprehensive (loss) income       
Net incomeNet income$13,199 $21,841 $24,758 $83,257 
Other comprehensive income (loss)Other comprehensive income (loss)
Foreign currency translation adjustments1,366
 (526) (22,196) 737
Foreign currency translation adjustments591 1,366 22,605 (5,301)
Unrealized derivative loss on cash flow hedges, net of tax(3,314) (161) (3,525) (215)
Unrealized derivative (loss) gain on cash flow hedges, net of taxUnrealized derivative (loss) gain on cash flow hedges, net of tax(3,524)(3,314)6,569 (3,525)
Change in pension liability, net of tax235
 95
 706
 288
Change in pension liability, net of tax266 235 640 706 
Total other comprehensive (loss) income(1,713) (592) (25,015) 810
Total other comprehensive (loss) income$(2,667)$(1,713)$29,814 $(8,120)
Less: Comprehensive income attributable to non‑controlling interest(457) (155) (916) (786)Less: Comprehensive income attributable to non‑controlling interest(44)(457)(134)(916)
Comprehensive income (loss) attributable to Evoqua Water Technologies Corp.$19,671
 $3,543
 $57,326
 $(10,401)
Comprehensive income attributable to Evoqua Water Technologies Corp.Comprehensive income attributable to Evoqua Water Technologies Corp.$10,488 $19,671 $54,438 $74,221 
See accompanying notes to these Unaudited Consolidated Financial Statements

6


Evoqua Water Technologies Corp.
Unaudited Consolidated Statements of Changes in Equity
(In thousands)
Common StockTreasury StockAdditional
Paid‑in
Capital
Retained
Deficit
Accumulated
Other Comprehensive (Loss) Income
Non‑controlling
Interest
Total
SharesCostSharesCost
Balance at September 30, 2020119,486 $1,189 2,195 $(2,837)$564,928 $(62,664)$(20,472)$1,919 $482,063 
Equity based compensation expense— — — — 3,019 — — — $3,019 
Issuance of common stock, net1,264 13 — 14,250 — — — $14,263 
Dividends paid to non-controlling interest— — — — — — — (250)$(250)
Net income— — — — — 6,433 — 44 $6,477 
Other comprehensive loss— — — — — — (3,611)— $(3,611)
Balance at December 31, 2020120,750 $1,202 2,196 $(2,837)$582,197 $(56,231)$(24,083)$1,713 $501,961 
Equity based compensation expense— — — — 3,214 — — — $3,214 
Issuance of common stock, net692 13 (532)— (21,377)— — — $(21,364)
Dividends paid to non-controlling interest— — — — — — — (100)$(100)
Net income— — — — — 5,036 — 46 $5,082 
Other comprehensive income— — — — — — 36,092 — $36,092 
Balance at March 31, 2021121,442 $1,215 1,664 $(2,837)$564,034 $(51,195)$12,009 $1,659 $524,885 
Equity based compensation expense— — — — 4,228 — — — $4,228 
Issuance of common stock, net395 — 5,630 — — — $5,634 
Dividends paid to non-controlling interest— — — — — — — (100)$(100)
Net income— — — — — 13,155 — 44 $13,199 
Other comprehensive loss— — — — — — (2,667)— $(2,667)
Balance at June 30, 2021121,837 $1,219 1,664 $(2,837)$573,892 $(38,040)$9,342 $1,603 $545,179 
7


 Three Months Ended June 30, 2020
 Common Stock Treasury Stock Additional
Paid‑in
Capital
 Retained
Deficit
 Accumulated
Other Comprehensive Loss
 Non‑controlling
Interest
 Total
 Shares Cost Shares Cost     
Balance at March 31, 2020119,070
 $1,185
 2,194
 $(2,837) $573,745
 $(115,356) $(36,306) $2,072
 $422,503
Cumulative effect of adoption of new accounting standards
 
 
 
 
 
 
 
 
Equity based compensation expense
 
 
 
 2,520
 
 
 
 2,520
Issuance of common stock
 2
 
 
 2,577
 
 
 
 2,579
Shares withheld related to net share settlement (including tax withholdings)322
 
 1
 
 
 
 
 
 
Dividends paid to non-controlling interest
 
 
 
 
 
 
 (400) (400)
Net income
 
 
 
 
 21,384
 
 457
 21,841
Other comprehensive loss
 
 
 
 
 
 (1,713) 
 (1,713)
Balance at June 30, 2020119,392
 $1,187
 2,195
 $(2,837) $578,842
 $(93,972) $(38,019) $2,129
 $447,330
 Three Months Ended June 30, 2019
 Common Stock Treasury Stock Additional
Paid‑in
Capital
 Retained
Deficit
 Accumulated
Other Comprehensive Loss
 Non‑controlling
Interest
 Total
 Shares Cost Shares Cost     
Balance at March 31, 2019115,691
 $1,151
 1,518
 $(2,837) $542,104
 $(180,618) $(7,615) $3,192
 $355,377
Equity based compensation expense
 
 
 
 4,978
 
 
 
 4,978
Issuance of common stock46
 
 
 
 
 
 
 
 
Shares withheld related to net share settlement (including tax withholdings)231
 3
 138
 
 (315) 
 
 
 (312)
Dividends paid to non-controlling interest
 
 
 
 
 
 
 (150) (150)
Net income
 
 
 
 
 4,135
 
 155
 4,290
Other comprehensive income
 
 
 
 
 
 (592) 
 (592)
Balance at June 30, 2019115,968
 $1,154
 1,656
 $(2,837) $546,767
 $(176,483) $(8,207) $3,197
 $363,591



 Nine Months Ended June 30, 2020
 Common Stock Treasury Stock Additional
Paid‑in
Capital
 Retained
Deficit
 Accumulated
Other Comprehensive Loss
 Non‑controlling
Interest
 Total
 Shares Cost Shares Cost     
Balance at September 30, 2019116,008
 $1,154
 1,664
 $(2,837) $552,422
 $(174,976) $(13,004) $3,063
 $365,822
Cumulative effect of adoption of new accounting standards
 
 
 
 
 (1,337) 
 
 (1,337)
Equity based compensation expense
 
 
 
 8,504
 
 
 
 8,504
Issuance of common stock150
 33
 
 
 17,916
 
 
 
 17,949
Shares withheld related to net share settlement (including tax withholdings)3,234
 
 531
 
 
 
 
 
 
Dividends paid to non-controlling interest
 
 
 
 
 
 
 (1,850) (1,850)
Net income
 
 
 
 
 82,341
 
 916
 83,257
Other comprehensive loss
 
 
 
 
 
 (25,015) 
 (25,015)
Balance at June 30, 2020119,392
 $1,187
 2,195
 $(2,837) $578,842
 $(93,972) $(38,019) $2,129
 $447,330
 Nine Months Ended June 30, 2019
 Common Stock Treasury Stock Additional
Paid‑in
Capital
 Retained
Deficit
 Accumulated
Other Comprehensive Loss
 Non‑controlling
Interest
 Total
 Shares Cost Shares Cost     
Balance at September 30, 2018115,016
 $1,145
 1,087
 $(2,837) $533,435
 $(163,871) $(9,017) $3,161
 $362,016
Cumulative effect of adoption of new accounting standards
 
 
 
 
 (1,401) 
 
 (1,401)
Equity based compensation expense
 
 
 
 14,248
 
 
 
 14,248
Issuance of common stock108
 
 
 
 341
 
 
 
 341
Shares withheld related to net share settlement (including tax withholdings)844
 9
 569
 
 (1,257) 
 
 
 (1,248)
Dividends paid to non-controlling interest
 
 
 
 
 
 
 (750) (750)
Net (loss) income
 
 
 
 
 (11,211) 
 786
 (10,425)
Other comprehensive income
 
 
 
 
 
 810
 
 810
Balance at June 30, 2019115,968
 $1,154
 1,656
 $(2,837) $546,767
 $(176,483) $(8,207) $3,197
 $363,591
Common StockTreasury StockAdditional
Paid‑in
Capital
Retained
Deficit
Accumulated
Other Comprehensive (Loss) Income
Non‑controlling
Interest
Total
SharesCostSharesCost
Balance at September 30, 2019116,008 $1,154 1,664 $(2,837)$552,422 $(174,976)$(13,004)$3,063 $365,822 
Cumulative effect of adoption of new accounting standards— — — — — (2,023)— — $(2,023)
Equity based compensation expense— — — — 3,680 — — — $3,680 
Issuance of common stock, net1,645 16 419 — 4,030 — — — $4,046 
Dividends paid to non-controlling interest— — — — — — — (1,250)$(1,250)
Divestiture of Memcor product line— — — — (16,895)— — — $(16,895)
Net income— — — — — 53,145 — 361 $53,506 
Other comprehensive income— — — — — — 8,244 — $8,244 
Balance at December 31, 2019117,653 $1,170 2,083 $(2,837)$543,237 $(123,854)$(4,760)$2,174 $415,130 
Cumulative effect of adoption of new accounting standards— — — — — 686 — — $686 
Equity based compensation expense— — — — 2,304 — — — $2,304 
Issuance of common stock, net1,417 15 111 — 11,309 — — — $11,324 
Dividends paid to non-controlling interest— — — — — — — (200)$(200)
Net income— — — — — 7,812 — 98 $7,910 
Other comprehensive loss— — — — — — (14,651)— $(14,651)
Balance at March 31, 2020119,070 $1,185 2,194 $(2,837)$556,850 $(115,356)$(19,411)$2,072 $422,503 
Equity based compensation expense— — — — 2,520 — — — $2,520 
Issuance of common stock, net322 — 2,577 — — — $2,579 
Dividends paid to non-controlling interest— — — — — — — (400)$(400)
Net income— — — — — 21,384 — 457 $21,841 
Other comprehensive loss— — — — — — (1,713)— $(1,713)
Balance at June 30, 2020119,392 $1,187 2,195 $(2,837)$561,947 $(93,972)$(21,124)$2,129 $447,330 
See accompanying notes to these Unaudited Consolidated Financial Statements

8


Evoqua Water Technologies Corp.
Unaudited Consolidated Statements of Changes in Cash Flows
(In thousands)
Nine Months Ended
June 30,
Nine Months Ended
June 30,
2020 201920212020
Operating activities   Operating activities
Net income (loss)$83,257
 $(10,425)
Reconciliation of net income (loss) to cash flows provided by operating activities:   
Net incomeNet income$24,758 $83,257 
Reconciliation of net income to cash flows provided by operating activities:Reconciliation of net income to cash flows provided by operating activities:
Depreciation and amortization80,056
 71,397
Depreciation and amortization83,707 80,056 
Amortization of debt related costs (includes $1,795 and $0 write off of deferred financing fees)3,504
 1,916
Amortization of deferred financing fees (includes $1,333 and $1,795 write off of deferred financing fees)Amortization of deferred financing fees (includes $1,333 and $1,795 write off of deferred financing fees)2,814 3,504 
Deferred income taxes(1,422) (4,115)Deferred income taxes994 (1,422)
Share-based compensation8,504
 14,248
Share-based compensation10,461 8,504 
Loss (gain) on sale of property, plant and equipment767
 (588)
Gain on sale of business(68,051) 
Foreign currency exchange losses on intercompany loans and other non-cash items(2,438) 4,002
Loss on sale of property, plant and equipmentLoss on sale of property, plant and equipment2,456 767 
Loss (gain) on sale of businessLoss (gain) on sale of business193 (68,051)
Foreign currency exchange gains on intercompany loans and other non-cash itemsForeign currency exchange gains on intercompany loans and other non-cash items(4,628)(2,438)
Changes in assets and liabilities   Changes in assets and liabilities
Accounts receivable8,685
 7,495
Accounts receivable18,931 8,685 
Inventories(25,523) (17,664)Inventories(18,261)(25,523)
Contract assets(1,486) (6,912)Contract assets12,059 (1,486)
Prepaids and other current assets1,359
 7,260
Prepaids and other current assets(21,869)1,359 
Accounts payable8,938
 (2,819)Accounts payable(10,587)8,938 
Accrued expenses and other liabilities(19,919) (19,578)Accrued expenses and other liabilities23,065 (1,738)
Contract liabilities(7,893) 13,051
Contract liabilities9,337 (7,893)
Income taxes1,620
 (6,786)Income taxes(2,489)1,620 
Other non‑current assets and liabilities12,528
 3,875
Other non‑current assets and liabilities(28,083)12,528 
Net cash provided by operating activities82,486
 54,357
Net cash provided by operating activities102,858 100,667 
Investing activities   Investing activities
Purchase of property, plant and equipment(65,924) (63,948)Purchase of property, plant and equipment(54,147)(65,924)
Purchase of intangibles(708) (4,775)Purchase of intangibles(1,206)(708)
Proceeds from sale of property, plant and equipment379
 2,860
Proceeds from sale of property, plant and equipment1,108 379 
Proceeds from sale of business, net of cash of $12,117118,894
 
Acquisitions, net of cash received of $0 and $2,073(10,884) (2,811)
Net cash provided by (used in) investing activities41,757
 (68,674)
Proceeds from sale of business, net of cash of $0 and $12,117Proceeds from sale of business, net of cash of $0 and $12,117897 118,894 
AcquisitionsAcquisitions(21,059)(10,884)
Net cash (used in) provided by investing activitiesNet cash (used in) provided by investing activities(74,407)41,757 
Financing activities   Financing activities
Issuance of debt, net of deferred issuance costs12,859
 15,965
Issuance of debt, net of deferred issuance costs747,877 12,859 
Borrowings under credit facility2,597
 230,000
Borrowings under credit facility2,597 
Repayment of debt(113,572) (238,908)Repayment of debt(837,082)(113,572)
Repayment of finance lease obligation(9,988) (9,273)Repayment of finance lease obligation(10,173)(9,988)
Payment of earn-out related to previous acquisitions(175) (461)Payment of earn-out related to previous acquisitions(175)
Proceeds from issuance of common stock17,949
 341
Proceeds from issuance of common stock18,096 9,596 
Taxes paid related to net share settlements of share-based compensation awards
 (1,248)Taxes paid related to net share settlements of share-based compensation awards(1,315)(9,828)
Cash paid for interest rate cap
 (2,235)
Distribution to non‑controlling interest(1,850) (750)Distribution to non‑controlling interest(450)(1,850)
Net cash used in financing activities(92,180) (6,569)Net cash used in financing activities(83,047)(110,361)
Effect of exchange rate changes on cash793
 (357)Effect of exchange rate changes on cash3,119 793 
Change in cash and cash equivalents32,856
 (21,243)Change in cash and cash equivalents(51,477)32,856 
Cash and cash equivalents   Cash and cash equivalents
Beginning of period109,881
 82,365
Beginning of period193,001 109,881 
End of period$142,737
 $61,122
End of period$141,524 $142,737 
See accompanying notes to these Unaudited Consolidated Financial Statements
9


Evoqua Water Technologies Corp.
Unaudited Supplemental Disclosure of Cash Flow Information
(In thousands)
Nine Months Ended
June 30,
Nine Months Ended
June 30,
2020 201920212020
Supplemental disclosure of cash flow information   Supplemental disclosure of cash flow information
Cash paid for taxes$3,865
 $8,731
Cash paid for taxes$7,536 $3,865 
Cash paid for interest$31,200
 $39,409
Cash paid for interest$20,643 $31,200 
Non‑cash investing and financing activities   Non‑cash investing and financing activities
Finance lease transactions$8,401
 $11,788
Finance lease transactions$12,300 $8,401 
Operating lease transactions12,085
 
Operating lease transactions$11,699 $12,085 
Option and Purchase Right7,167
 
Purchase RightPurchase Right$$7,167 
See accompanying notes to these Unaudited Consolidated Financial Statements
10


Evoqua Water Technologies Corp.
Notes to Unaudited Consolidated Financial Statements
(In thousands)thousands, except per share data)
1. Description of the Company and Basis of Presentation
Background
Evoqua Water Technologies Corp. (referred to herein as the “Company” or “EWT”) is a holding company and does not conduct any business operations of its own. The Company was incorporated on October 7, 2013. On January 15, 2014, Evoqua Water Technologies Corp.,the Company acquired, through its wholly owned entities,subsidiaries, EWT Holdings II Corp. (“EWT II”) and EWT Holdings III Corp. (a/k/a Evoqua Water Technologies)(“EWT III”), all of the outstanding shares of Siemens Water Technologies, a group of legal entity businessesentities formerly owned by Siemens AG (“Siemens”). The stock purchase closed on January 15, 2014 and was effective January 16, 2014 (the “Acquisition”). The stock purchase price, net of cash received, was approximately $730,577. On November 6, 2017, the Company completed its initial public offering (“IPO”), pursuant to which an aggregate of 27,777 shares of common stock were sold, of which 8,333 were sold by the Company and 19,444 were sold by the selling shareholders, with a par value of $0.01 per share. After underwriting discounts and commissions and other expenses, the Company received net proceeds from the IPO of approximately $137,605. The Company used a portion of these proceeds to repay $104,936 of indebtedness (including accrued and unpaid interest) under EWT III’s senior secured first lien term loan facility and the remainder for general corporate purposes. The Company did not receive any proceeds from the sale of shares by the selling shareholders. On November 7, 2017, the selling shareholders sold an additional 4,167 shares of common stock as a result of the exercise in full by the underwriters of an option to purchase additional shares..
On March 19, 2018,December 4, 2020, the Company completed a secondary public offering, pursuant to which 17,50012,000 shares of common stock were sold by certain selling shareholders. On March 21, 2018, the selling shareholders sold an additional 2,625 shares of common stock as a result of the exercise in full by the underwriters of an option to purchase additional shares. On March 10, 2020,February 11, 2021, the Company completed an additional secondary public offering, pursuant to which 13,00016,383 shares of common stock were sold by certain selling shareholders. Upon completion of these offerings, AEA Investors LP disposed of all of their shares of the Company’s common stock. The Company did not receive any proceeds from the sale of shares by the selling shareholders in either of these secondary public offerings.
The Business
EWT provides a wide range of product brands and advanced water and wastewater treatment systems and technologies, as well as mobile and emergency water supply solutions and service contract options through its branch network. Headquartered in Pittsburgh, Pennsylvania, EWT is a multi‑nationalmultinational corporation with operations in the United States (“U.S.”), Canada, the United Kingdom (“UK”), the Netherlands, Germany, Australia, the People’s Republic of China, Singapore, the Republic of Korea and India.
The Company is organizationally structured into 2 reportable operating segments for the purpose of making operational decisions and assessing financial performance: (i) Integrated Solutions and Services and (ii) Applied Product Technologies.
Basis of Presentation
The accompanying Unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the U.S. (“GAAP”). All intercompany transactions have been eliminated. Unless otherwise specified, all dollar and share amounts in these notes are referred to in thousands.
The interim Unaudited Consolidated Financial Statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such SEC rules. We believe that the disclosures made are adequate to make the information presented not misleading. In our opinion, all adjustments considered necessary for a fair presentation of the financial statements have been included, and all adjustments are of a normal and recurring nature. We consistently applied the accounting policies described in our Annual Report on Form 10-K for the fiscal year ended September 30, 2019,2020, as filed with the SEC on November 25, 2019 and as amended on December 4, 201920, 2020 (“20192020 Annual Report”), in preparing these Unaudited Consolidated Financial Statements, with the exception of accounting standard updates described in Note 2, “Summary of Significant“Recent Accounting Policies.Pronouncements.” These Unaudited Consolidated Financial Statements should be read in

conjunction with the audited financial statements and the notes included in our 20192020 Annual Report. Certain prior period amounts have been reclassified to conform to the current period presentation.
11


2. SummaryCorrection of SignificantImmaterial Errors
During the quarter ended March 31, 2021, the Company identified errors related to the reporting of tax remittances associated with certain equity awards, resulting in a classification error of $18,669 between additional paid in capital and accumulated other comprehensive loss. Management recorded the correction to additional paid in capital and accumulated other comprehensive balances during the quarter ended March 31, 2021. Management considered both the quantitative and qualitative factors within the provisions of SEC Staff Accounting Policies
FiscalBulletin No. 99, Materiality, and Staff Accounting Bulletin No. 108, Considering the Effects of Prior Year
Misstatements when Quantifying Misstatements in Current Year Financial Statements. Based on evaluation of the errors, management has concluded that the prior period errors were immaterial to the previously issued financial statements. As a result of that classification error, management also identified a second, related immaterial classification error for the understatement of net cash provided by operating cash flows of $18,669 and an overstatement of net cash provided by financing activities of $18,669 for the period from October 1, 2019 to September 30, 2020. The Company’s fiscal year ends on September 30.
Use of Estimates
TheCompany has elected to voluntarily correct the identified immaterial classification error in the prior period Unaudited Consolidated Financial Statements have been prepared in conformity with GAAP and require management to make estimates and assumptions. These assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Unaudited Consolidated Financial Statements and the reported amounts of revenue and expenses during the reporting period. Estimates are revised as additional information becomes available. Actual results could differ from these estimates.
Cash and Cash Equivalents
Cash and cash equivalents are liquid investments with an original maturity of three or fewer months when purchased.
Accounts Receivable
Receivables are primarily comprised of uncollected amounts owed to us from transactions with customers and are presented net of allowances for doubtful accounts. Allowances are estimated based on historical write‑offs and the economic status of customers. The Company considers a receivable delinquent if it is unpaid after the term of the related invoice has expired. Write‑offs are recorded at the time all collection efforts have been exhausted.
Inventories
Inventories are stated at the lower of cost or market, where cost is generally determined on the basis of an average or first‑in, first‑out (“FIFO”) method. Production costs comprise direct material and labor and applicable manufacturing overheads, including depreciation charges. The Company regularly reviews inventory quantities on hand and writes off excess or obsolete inventory based on estimated forecasts of product demand and production requirements. Manufacturing operations recognize cost of product sales using standard costing rates with overhead absorption which generally approximates actual cost.
Property, Plant, and Equipment
Property, plant, and equipment is valued at cost less accumulated depreciation. Depreciation expense is recognized using the straight‑line method. Useful lives are reviewed annually and, if expectations differ from previous estimates, adjusted accordingly. Estimated useful lives for major classes of depreciable assets are as follows:
Asset ClassEstimated Useful Life
Machinery and equipment3 to 20 years
Buildings and improvements10 to 40 years

Leasehold improvements are depreciated over the shorter of their estimated useful life or the term of the lease. Costs related to maintenance and repairs that do not extend the assets’ useful life are expensed as incurred.

Acquisitions
Acquisitions are recorded using the purchase method of accounting. The purchase price of acquisitions is allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair value at the acquisition date. The excess of the acquisition price over those estimated fair values is recorded as goodwill. Changes to the acquisition date preliminary fair values priorCash Flows to the expiration of the measurement period, a period not to exceed 12 months from date of acquisition, are recorded as an adjustment to the associated goodwill. Contingent consideration resulting from acquisitions is recorded at its estimated fair value on the acquisition date. These obligations are revalued during each subsequent reporting period and changes in the fair value of the contingent consideration obligations can result from adjustments in the probability of achieving future development steps, sales targets and profitability and are recorded in General and administrative expensesenhance comparability. In doing so, balances in the Unaudited Consolidated Statements of Operations. Acquisition-related expensesChanges to Cash Flows included in this Form 10-Q have been adjusted to reflect the voluntary immaterial classification error correction of $18,182 between financing and restructuring costs,operating in the prior period. Future filings that include prior periods will be corrected, as needed, when filed.
The correction of the above classification errors did not have any effect on the Unaudited Consolidated Statements of Operations in any of the periods previously presented.
2. Recent Accounting Pronouncements
Accounting Pronouncements Not Yet Adopted
In March 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”), which was amended by the subsequent issuance in January 2021 of ASU 2021-01, Reference Rate Reform (Topic 848): Scope (“ASU 2021-01”). ASU 2020-04 became effective immediately and expires on December 21, 2022. ASU 2020-04 allows eligible contracts that are modified to be accounted for as a continuation of those contracts, permits companies to preserve their hedging accounting during the transition period and enables companies to make a one-time election to transfer or sell held-to-maturity debt securities that are affected by rate reform. ASU 2021-01 provides optional expedients and exceptions for contracts, hedging relationships and other transactions that reference the London Inter-Bank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform, if any,certain criteria are recognized separately frommet. The Company is currently assessing the business combinationimpact of the adoption of ASU 2020-04 and are expensedASU 2021-01 on the Company’s Unaudited Consolidated Financial Statements and related disclosures.
12


Accounting Pronouncements Recently Adopted
The Company adopted ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments on October 1, 2020 (“ASU 2016-13”). ASU 2016-13 requires entities to use a new forward-looking “expected loss” model that reflects expected credit losses, including credit losses related to trade receivables, and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, which generally will result in the earlier recognition of allowances for losses. The Company adopted ASU 2016-13 using a modified retrospective approach and determined that there was no cumulative-effect adjustment to its beginning Retained deficit on the Consolidated Balance Sheets. The adoption of this standard did not have a material impact on the Company’s Unaudited Consolidated Financial Statements. See Note 7, “Accounts Receivable” for further details and related disclosures.
The following accounting pronouncements were adopted by the Company on October 1, 2020, and the adoptions did not have a material impact on the Company’s Unaudited Consolidated Financial Statements or disclosures:
Accounting Standards Updates
ASU 2020-03, Codification Improvements to Financial Instruments
ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments—Credit Losses
ASU 2018-18, Collaborative Arrangements (Topic 808) Clarifying the Interaction between Topic 808 and Topic 606
ASU 2018-13, Fair Value Measurement (Subtopic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement
3. Variable Interest Entities
Treated Water Outsourcing (“TWO”) is a joint venture between the Company and Nalco Water, an Ecolab company, in which the Company holds a 50% partnership interest. The Company is obligated to absorb all risk of loss up to 100% of the joint venture partner’s equity. As such, the Company fully consolidates TWO as incurred.a variable interest entity (“VIE”) under ASC Topic No. 810, Consolidation. The Company has not provided, and is not contractually required to provide, additional financial support to this entity, and the Company does not have the ability to use the assets of TWO to settle obligations of the Company’s other subsidiaries.
GoodwillThe following provides a summary of TWO’s balance sheet as of June 30, 2021 and Other Intangible AssetsSeptember 30, 2020, and summarized financial information for the three and nine months ended June 30, 2021 and 2020.
Goodwill represents purchase consideration paid
June 30,
2021
September 30,
2020
Current assets (includes cash of $1,580 and $2,088)$3,529 $4,016 
Property, plant and equipment963 1,145 
Goodwill2,206 2,206 
Total liabilities(1,287)(1,324)
Three Months Ended
June 30,
Nine Months Ended
June 30,
2021202020212020
Total revenue$843 $1,328 $2,511 $5,180 
Total operating expenses(748)(803)(2,217)(3,847)
Income from operations$95 $525 $294 $1,333 
On October 1, 2019, the Company acquired a 60% investment position in San Diego-based Frontier Water Systems, LLC (“Frontier”). The Frontier acquisition is a business combination that exceeds the valueVIE because it has insufficient equity to finance its activities due to key assets being assigned to the net assets of acquired businesses. Other intangible assets consist of customer‑related intangibles, proprietary technology, software, trademarks and other intangible assets.Company upon acquisition.  The Company amortizes intangible assets with definite useful lives on a straight‑line basis over their respective estimated economic lives which range from 1 to 26 years.
The Company reviews goodwill to determine potential impairment annually duringis the fourth quarterprimary beneficiary of the fiscal year, or more frequently if events and circumstances indicate that the asset might be impaired. Impairment testing for goodwill is performed at a reporting unit level. The quantitative impairment testing utilizes both a market (guideline public company) and income (discounted cash flows) method for determining fair value. In estimating the fair value of the reporting unit,Frontier because the Company utilized a discounted cash flow (“DCF”) valuation technique, which incorporates judgments and estimates of future cash flows, future revenue and gross profit growth rates, terminal value amount, capital expenditures and applicable weighted‑average cost of capital usedhas the power to discount these estimated cash flows. The estimates and projections used indirect the estimate of fair value are consistent with the current budget and long‑range plans, including anticipated change in market conditions, industry trend, growth rates and planned capital expenditures, among other considerations.activities that most significantly affect Frontier’s economic performance.
Impairment of Long‑Lived Assets
13


Long‑lived assets, such as property, plant, and equipment, and purchased intangibles subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability of the asset or asset group is measured by comparison of its carrying amount to undiscounted future net cash flows the asset or asset group is expected to generate. If the carrying amount of an asset or asset group is not recoverable, the Company recognizes an impairment loss based on the excess of the carrying amount of the asset or asset group over its respective fair value which is generally determined as the present value of estimated future cash flows or as the appraised value.
Assets Held for Sale
Assets and liabilities (the “disposal group”) are classified as held for sale when all of the following criteria are met: (i) the Company commits to a plan to sell the disposal group; (ii) it is unlikely the disposal plan will be significantly modified or discontinued; (iii) the disposal group is available for immediate sale in its present condition; (iv) actions required to complete the sale of the disposal group have been initiated; (v) the sale of the asset is probable and the completed sale is expected to occur within one year; and (vi) the disposal group is actively being marketed for sale at a price that is reasonable given its current market value. Upon classification as held for sale, such assets are no longer depreciated or depleted, and a measurement for impairment is performed to determine if there is any excess of carrying value over fair value less costs to sell. Subsequent changes to estimated fair value less the cost to sell will impact the measurement of assets held for sale if the fair value is determined to be less than the carrying value of the assets.
Debt Issuance Costs and Debt Discounts
Debt issuance costs are capitalized and amortized over the contractual term of the underlying debt using the straight line method which approximates the effective interest method. Debt discounts and lender arrangement fees deducted from the proceeds have been included as a component of the carrying value of debt and are being amortized to interest expense using the effective interest method.

In the first quarter of 2019,addition, the Company entered into an agreement to purchase the remaining 40%interest rate capin Frontier on or prior to mitigate risks associated withMarch 30, 2024. This agreement (a) gave holders of the remaining 40% interest in Frontier (the “Minority Owners”) the right to sell to Evoqua up to approximately 10% of the outstanding equity in Frontier at a predetermined price, which right was exercisable by the Minority Owners between January 1, 2021 and February 28, 2021 (the “Option”), and (b) obligates the Company to purchase and the Minority Owners to sell all of the Minority Owners’ remaining interest in Frontier at the fair market value at the time of sale on or prior to March 30, 2024 (the “Purchase Right”). The Purchase Right may be exercised early by the Minority Owners. The agreement to purchase the remaining interest was determined to be financing due to the mandatory Purchase Right, as per ASC Topic 480, Distinguishing Liabilities From Equity, and as such, the Company recognized a liability for the remaining 40% interest. The Minority Owners exercised the Option, and on April 8, 2021, the Company completed the purchase of an additional 8% of the outstanding equity in Frontier for approximately $1,490. As a result, the Company’s variable rate debt. Theownership position in Frontier increased to 68%.
Additionally, the Company paid $2,235fully consolidates Frontier as a premiumVIE under ASC Topic No. 810, Consolidation.
The following provides a summary of Frontier’s balance sheet as of June 30, 2021 and September 30, 2020, and summarized financial information for the interest rate cap, which was being amortized to interest expense over its term of three years. The Company terminated the interest rate cap during the third quarter of 2020, and as a result wrote off the remaining unamortized premium of $1,118 to interest expense. No additional fees were incurred. The Company recorded $124 and $187 of premium amortization to interest expense during the threenine months ended June 30, 20202021 and 2019, respectively2020.
June 30,
2021
September 30,
2020
Current assets (includes cash of $2,947 and $1,675)$10,034 $4,024 
Property, plant and equipment2,974 3,159 
Goodwill1,798 1,798 
Intangible assets, net8,678 9,918 
Total liabilities(9,039)(3,692)
Three Months Ended
June 30,
Nine Months Ended
June 30,
2021202020212020
Total revenue$4,945 $1,411 $7,793 $4,134 
Total operating expenses(4,448)(2,003)(8,587)(6,304)
Income (loss) from operations$497 $(592)$(794)$(2,170)
4. Acquisitions and $496Divestitures
Acquisitions support the Company’s strategy of delivering a broad solutions portfolio with robust technology across multiple geographies and $435 duringend markets. The Company continues to evaluate potential strategic acquisitions of businesses, assets and product lines and believes that capex-like, tuck-in acquisitions present a key opportunity within its overall growth strategy.
14


On April 1, 2021, the Company acquired the assets of Water Consulting Specialists, Inc. (“WCSI”) for $12,025 cash paid at closing. In addition, the Company recorded a liability of $761 associated with an earn-out related to the WCSI acquisition, which is included in Accrued expenses and other liabilities on the Consolidated Balance Sheets. WCSI is a leader in the design, manufacturing, and service of industrial high-purity water treatment systems. The acquisition strengthens the Company’s portfolio of high-purity water treatment systems and provides the opportunity to further expand its digitally enabled solutions and services in key industrial markets. WCSI is a part of the Integrated Solutions and Services segment. During the nine months ended June 30, 20202021, the Company incurred approximately $117 in acquisition costs, which are included in General and 2019, respectively. See Note 11, “Derivative Financial Instruments”administrative expense on the Unaudited Consolidated Statements of Operations.
The Company has not finalized the valuations of the acquired assets, assumed liabilities, and identifiable intangible assets, including goodwill. The preliminary opening balance sheet for further details.WCSI is summarized as follows:
In January
Current assets$1,813 
Property, plant and equipment221 
Goodwill4,361 
Intangible assets, net7,336 
Other non-current assets86 
Total assets acquired13,817 
Liabilities assumed(1,792)
Net assets acquired$12,025 
On December 17, 2020, the Company utilized $100,000acquired the industrial water business of Ultrapure & Industrial Services, LLC (“Ultrapure”) for $8,743 cash paid at closing. On April 1, 2021, the proceeds from the sale of the Memcor product line to repay a portion of the Company’s First Lien Term Loans. AsCompany paid an additional $290 as a result of net working capital adjustments. Ultrapure, based out of Texas, provides customers across multiple end markets with a variety of water treatment products and services, including service deionization, reverse osmosis, UV, and ozonation. Ultrapure will strengthen the prepayment,Company’s service capabilities in the Company wrote off $1,795Houston and Dallas markets and is a part of deferred financing fees during the three months ended March 31, 2020.
In February 2020, the Company entered into Amendment No. 7 to the Credit Agreement,Integrated Solutions and as a result incurred $760 of fees which were recorded as deferred financing fees on the Consolidated Balance Sheets.
Amortization of debt issuance costs and discounts included in interest expense were $277 and $498 for the three months ended June 30, 2020 and 2019, respectively and $1,213 and $1,481 forServices segment. During the nine months ended June 30, 20202021, the Company incurred approximately $230 in acquisition costs, which are included in General and 2019, respectively.administrative expense on the Unaudited Consolidated Statements of Operations.
The Company has not finalized the valuations of the acquired assets, assumed liabilities and identifiable intangible assets, including goodwill. The preliminary opening balance sheet for Ultrapure is summarized as follows:
Current assets$2,366 
Property, plant and equipment963 
Goodwill2,836 
Intangible assets, net3,751 
Other non-current assets21 
Total assets acquired9,937 
Liabilities assumed(904)
Net assets acquired$9,033 
On March 1, 2021, the Company completed the divestiture of the Lange containment system, geomembrane and geosynthetic liner product line (the “Lange Product Line”) for $897 in cash at closing. The Lange Product Line was a part of the Integrated Solutions and Services segment. During the nine months ended June 30, 2021, the Company recognized a loss of $193 on the divestiture.
15


5. Revenue
Revenue RecognitionAccounting Pronouncements Recently Adopted
The Company adopted Accounting Standards Update (“ASU”) No. 2014-09,ASU 2016-13, Revenue from Contracts with CustomersFinancial Instruments—Credit Losses (Topic 606) 326): Measurement of Credit Losses on Financial Instrumentson October 1, 2018, and recognizes sales of products and services based on the five-step analysis of transactions as provided in Topic 606 which2020 (“ASU 2016-13”). ASU 2016-13 requires an entityentities to recognize revenue to depict the transfer of promised goods or services to customers in an amountuse a new forward-looking “expected loss” model that reflects expected credit losses, including credit losses related to trade receivables, and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, which generally will result in the consideration to which the entity expects to be entitled in exchangeearlier recognition of allowances for such goods or services.
For sales of aftermarket parts or products with a low level of customization and engineering time, the Company recognizes revenues at the time risks and rewards of ownership pass, which is generally when products are shipped or delivered to the customer as the Company has no obligation for installation. Sales of short‑term service arrangements are recognized as the services are performed, and sales of long‑term service arrangements are typically recognized on a straight‑line basis over the life of the agreement.
For certain arrangements where there is significant customization to the product, the Company recognizes revenue either over time or at a point in time. These products include large capital water treatment projects, systems and solutions for municipal and industrial applications. The nature of the contracts is generally fixed price with milestone billings.losses. The Company recognizes revenue over time if the product hasadopted ASU 2016-13 using a modified retrospective approach and determined that there was no alternative use and the Company has an enforceable rightcumulative-effect adjustment to payment for the performance completed to date, including a normal profit margin, in the event of termination for convenience. If these two criteria are not met, revenues from these contracts will not be recognized until construction is complete. Contract revenues and cost estimates are reviewed and revised quarterly at a minimum and the cumulative effect of such adjustments are recognized in current operations. The amount of such adjustments has not been material. See Note 4, “Revenue” for further details.
Product Warranties
Accruals for estimated expenses related to warranties are made at the time products are sold and are recorded as a component of Cost of product sales in the Unaudited Consolidated Statements of Operations. The estimated warranty obligation is based on product warranty terms offered to customers, ongoing product failure rates, material usage and service delivery costs expected to be incurred in correcting a product failure, as well as specific obligations for known failures and other currently available evidence. The Company assesses the adequacy of the recorded warranty liabilities on a regular basis and adjusts amounts as necessary.
Leases
The Company accounts for leases in accordance with ASC Topic No. 842, Leases, adopted as of October 1, 2019 (Topic 842). Please see the “Accounting Pronouncements Recently Adopted” section below for information regarding this adoption. See Note 19, “Leases” for further details.

Lessee Accounting
The Company leases office space, buildings, vehicles, forklifts, computers, copiers and other assets under non-cancellable operating and finance leases. The Company determines whether an arrangement is or contains a lease at the inception of the arrangement based on the terms and conditions in the contract. A contract contains a lease if there is an identified asset and the Company has the right to control the asset. If the arrangement contains a lease, the Company recognizes a right-of-use (“ROU”) asset and an operating lease liability as of the lease commencement date. Operating lease assets and finance lease assets are included in Operating lease right-of-use assets, net and Property, plant, and equipment, net, respectively,its beginning Retained deficit on the Consolidated Balance Sheets. The corresponding operating lease liabilities are included in Accrued expenses and other liabilities and Obligation under operating leasesadoption of this standard did not have a material impact on the Company’s Unaudited Consolidated Balance Sheets. Financial Statements. See Note 7, “Accounts Receivable” for further details and related disclosures.
The corresponding finance lease liabilities are included in Accrued expensesfollowing accounting pronouncements were adopted by the Company on October 1, 2020, and other liabilities and Other non‑current liabilitiesthe adoptions did not have a material impact on the Consolidated Balance Sheets.
Lessor Accounting
The Company generates revenue through the lease of its water treatment equipment and systems to customers. In certain instances, the Company enters into a contract with a customer but must construct the underlying asset prior to its lease. At the time of contract inception, the Company determines if an arrangement is or contains a lease. These contracts generally contain both lease and non-lease components, including installation, maintenance and monitoring services of the Company-owned equipment, in addition to sale of certain constructed assets. In situations where arrangements contain multiple elements, contract consideration is allocated based on relative standalone selling price. Lease components associated to underlying assets that have an alternative use are classified as operating leases with revenue recognized over time throughout the lease term, whereas lease components associated to underlying assets that have no alternative use and the Company has an enforceable right to payment for the performance completed to date, including a normal profit margin, in the event of termination for convenience are classified as sales-type leases, with point in time revenue recognition at the on-set of the lease. In order for a component to be separate, the Customer would be able to benefit from the right of use of the component separately or with other resources readily available to the Customer and the right of the use is not highly dependent or highly interrelated with the other rights to use the other underlying assets or components.
Shipping and Handling Cost
Shipping and handling costs are included as a component of Cost of product sales.
Derivative Financial Instruments
The Company’s risk-management strategy uses derivative financial instruments to manage interest rate risk and foreign currency exchange rate risk. The Company’s objective in using interest rate derivatives is to add stability to interest expense and manage its exposure to interest rate movements. To accomplish this objective, in the third quarter of 2020, the Company entered into an interest rate swap which has been designated as a cash flow hedge. The Company uses foreign currency derivative contracts in order to manage the effect of exchange rate fluctuations on forecasted sales and purchases that are denominated in foreign currencies. To mitigate the impact of foreign exchange rate risk, the Company entered into a series of forward contracts designated as cash flow hedges. The Company does not enter into derivatives for trading or speculative purposes. The Company accounts for derivatives and hedging activities in accordance with ASC Topic No. 815, Derivatives and Hedging (ASC 815). The Company recognizes all derivatives on the balance sheet at fair value. Changes in the fair values of derivatives that are not designated as hedges are recognized in earnings. If the derivative is designated and qualifies as a hedge, depending on the nature of the hedge, changes in the fair value of the derivatives are either offset against the change in the hedged assets or liabilities through earnings or recognized in Accumulated other comprehensive income (loss), net of tax (“AOCI”) until the hedged item is recognized in earnings.
Income Taxes
The Company recognizes deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are provided against deferred tax assets when it is deemed more likely than not that some portion or all of the deferred tax asset will not be realized within a reasonable time period. We assess tax positions using a two‑step process. A tax position is recognized

if it meets a more‑likely‑than‑not threshold and is measured at the largest amount of benefit that is greater than 50% percent of being realized. Uncertain tax positions are reviewed each balance sheet date.
Foreign Currency Translation and Transactions
The functional currency for the international subsidiaries is the local currency. Assets and liabilities are translated into U.S. dollars using current rates of exchange, with the resulting translation adjustments recorded in AOCI within shareholders’ equity. Revenues and expenses are translated at the weighted‑average exchange rate for the period, with the resulting translation adjustments recorded in the Unaudited Consolidated Financial Statements of Operations.or disclosures:
Foreign currency translation (gains) losses, mainly related to intercompany loans, which aggregated $(3,833) and $(772) for the three months ended June 30, 2020 and 2019, respectively, and $(2,662) and $4,636 for the nine months ended June 30, 2020 and 2019, respectively, are primarily included in General and administrative expenses in the Unaudited Consolidated Statements of Operations.
Accounting Standards Updates
ASU 2020-03, Codification Improvements to Financial Instruments
ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments—Credit Losses
ASU 2018-18, Collaborative Arrangements (Topic 808) Clarifying the Interaction between Topic 808 and Topic 606
ASU 2018-13, Fair Value Measurement (Subtopic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement
Research and Development Costs
Research and development costs are expensed as incurred. The Company recorded $2,782 and $3,281 for the three months ended June 30, 2020 and 2019, respectively, and $9,655 and $11,384 for the nine months ended June 30, 2020 and 2019, respectively.
Equity‑based Compensation
The Company measures the cost of awards of equity instruments to employees based on the grant‑date fair value of the award. The grant‑date fair value of a non-qualified stock option is determined using the Black‑Scholes model. The fair value of restricted stock unit awards is determined using the closing price of the Company’s common stock on the date of grant. Compensation costs resulting from equity-based payment transactions are recognized primarily within General and administrative expenses, at fair value over the requisite vesting period on a straight-line basis.
Earnings (Loss) Per Share
Basic earnings (loss) per common share is computed based on the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per common share is computed based on the weighted-average number of shares of common stock, plus the effect of diluted common shares outstanding during the period using the treasury stock method. Diluted potential common shares include outstanding stock options.
Retirement Benefits
The Company applies ASC Topic No. 715, Compensation—Retirement Benefits, which requires the recognition in pension obligations and AOCI of actuarial gains or losses, prior service costs or credits and transition assets or obligations that have previously been deferred. The determination of retirement benefit pension obligations and associated costs requires the use of actuarial computations to estimate participant plan benefits to which the employees will be entitled. The significant assumptions primarily relate to discount rates, expected long‑term rates of return on plan assets, rate of future compensation increases, mortality, years of service, and other factors. The Company develops each assumption using relevant experience in conjunction with market‑related data for each individual country in which such plans exist. All actuarial assumptions are reviewed annually with third‑party consultants and adjusted as necessary. For the recognition of net periodic post-retirement cost, the calculation of the expected return on plan assets is generally derived by applying the expected long‑term rate of return on the market‑related value of plan assets. The fair value of plan assets is determined based on actual market prices or estimated fair value at the measurement date.
3. Variable Interest Entities
Treated Water Outsourcing (“TWO”) is a joint venture between the Company and Nalco Water, an Ecolab company, in which the Company holds a 50% partnership interest. The Company is obligated to absorb all risk of loss up to 100% of the joint venture partner’s equity. As such, the Company fully consolidates TWO as a variable interest entity (“VIE”) under ASC Topic No. 810, Consolidation. The Company has not provided, and is not contractually required to provide, additional financial support to this entity, which it is not contractually required to provide, and the Company does not have the ability to use the assets of TWO to settle obligations of the Company’s other subsidiaries.

The following provides a summary of TWO’s balance sheet as of June 30, 20202021 and September 30, 2019,2020, and summarized financial information for the three and nine months ended June 30, 20202021 and 2019.2020.
June 30,
2021
September 30,
2020
Current assets (includes cash of $1,580 and $2,088)$3,529 $4,016 
Property, plant and equipment963 1,145 
Goodwill2,206 2,206 
Total liabilities(1,287)(1,324)
 
June 30, 2020
 September 30,
2019
Current assets (includes cash of $2,505 and $3,903)$4,548
 $6,324
Property, plant and equipment1,109
 2,186
Goodwill2,206
 2,206
Other non-current assets3
 3
Total liabilities(1,402) (2,388)
 Three Months Ended
June 30,
 Nine Months Ended
June 30,
 2020 2019 2020 2019
Total revenues$1,328
 $2,573
 $5,180
 $8,951
Total operating expenses(803) (2,231) (3,847) (7,267)
Income from operations$525
 $342
 $1,333
 $1,684

Three Months Ended
June 30,
Nine Months Ended
June 30,
2021202020212020
Total revenue$843 $1,328 $2,511 $5,180 
Total operating expenses(748)(803)(2,217)(3,847)
Income from operations$95 $525 $294 $1,333 
On October 1, 2019, the Company acquired a 60% investment position in San Diego-based Frontier Water Systems, LLC (“Frontier”). The Frontier acquisition is a VIE because it has insufficient equity to finance its activities due to key assets being assigned to the Company upon acquisition.  The Company is the primary beneficiary of Frontier because the Company has the power to direct the activities that most significantly affect Frontier’s economic performance.
13


In addition, the Company entered into an agreement to purchase the remaining As40% interest in Frontier on or prior to March 30, 2024. This agreement (a) gave holders of the remaining 40% interest in Frontier (the “Minority Owners”) the right to sell to Evoqua up to approximately 10% of the outstanding equity in Frontier at a predetermined price, which right was exercisable by the Minority Owners between January 1, 2021 and February 28, 2021 (the “Option”), and (b) obligates the Company to purchase and the Minority Owners to sell all of the Minority Owners’ remaining interest in Frontier at the fair market value at the time of sale on or prior to March 30, 2024 (the “Purchase Right”). The Purchase Right may be exercised early by the Minority Owners. The agreement to purchase the remaining interest was determined to be financing due to the mandatory Purchase Right, as per ASC Topic 480, Distinguishing Liabilities From Equity, and as such, the Company recognized a liability for the remaining 40% interest. The Minority Owners exercised the Option, and on April 8, 2021, the Company completed the purchase of an additional 8% of the outstanding equity in Frontier for approximately $1,490. As a result, the Company’s ownership position in Frontier increased to 68%.
Additionally, the Company fully consolidates Frontier as a VIE under ASC Topic No. 810, Consolidation. See Note 3, “Acquisitions and Divestitures” for further discussion of the Frontier acquisition.
The following provides a summary of Frontier’s balance sheet as of June 30, 2021 and September 30, 2020, and summarized financial information for the three and nine months ended June 30, 2020.2021 and 2020.
June 30,
2021
September 30,
2020
Current assets (includes cash of $2,947 and $1,675)$10,034 $4,024 
Property, plant and equipment2,974 3,159 
Goodwill1,798 1,798 
Intangible assets, net8,678 9,918 
Total liabilities(9,039)(3,692)
Three Months Ended
June 30,
Nine Months Ended
June 30,
2021202020212020
Total revenue$4,945 $1,411 $7,793 $4,134 
Total operating expenses(4,448)(2,003)(8,587)(6,304)
Income (loss) from operations$497 $(592)$(794)$(2,170)
4. Acquisitions and Divestitures
Acquisitions support the Company’s strategy of delivering a broad solutions portfolio with robust technology across multiple geographies and end markets. The Company continues to evaluate potential strategic acquisitions of businesses, assets and product lines and believes that capex-like, tuck-in acquisitions present a key opportunity within its overall growth strategy.
14
 
June 30, 2020
Current assets (includes cash of $2,611)$4,106
Property, plant and equipment3,251
Goodwill2,582
Other non-current assets
Total liabilities(3,457)

 Three Months Ended
June 30,
 Nine Months Ended
June 30,
 2020 2020
Total revenues$1,411
 $4,134
Total operating expenses(1,498) (5,047)
Loss from operations$(87) $(913)

Recent Accounting Pronouncements
On April 1, 2021, the Company acquired the assets of Water Consulting Specialists, Inc. (“WCSI”) for $12,025 cash paid at closing. In March 2020,addition, the Financial Accounting Standards Board (“FASB”) issued ASU 2020-04, Reference Rate Reform (Topic 848): FacilitationCompany recorded a liability of $761 associated with an earn-out related to the Effects of Reference Rate Reform on Financial ReportingWCSI acquisition, which provides optional expedients and exceptions for contracts, hedging relationshipsis included in Accrued expenses and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform, if certain criteria are met. ASU 2020-04 is effective immediately

and expires on December 21, 2022. The ASU allows eligible contracts that are modified to be accounted for as a continuation of those contracts, permits companies to preserve their hedging accounting during the transition period and enables companies to make a one-time election to transfer or sell held-to-maturity debt securities that are affected by rate reform. The Company is currently assessing the impact of adoptionliabilities on the Company’s Unaudited Consolidated Financial StatementsBalance Sheets. WCSI is a leader in the design, manufacturing, and related disclosures.
In March 2020, the FASB issued ASU 2020-03, Codification Improvements to Financial Instruments, which includes several amendments to clarify, conform or improve the Codification and make it easier to apply by eliminating inconsistencies and providing clarifications.service of industrial high-purity water treatment systems. The ASU includes seven different issues that describe the areas of improvement and the related amendments, which have various effective dates. The Company is currently assessing the impact of adoption onacquisition strengthens the Company’s Unaudited Consolidated Financial Statementsportfolio of high-purity water treatment systems and related disclosures.
In November 2018,provides the FASB issued ASU 2018-19, Codification Improvementsopportunity to Topic 326, Financial Instruments—Credit Losses which clarifies that receivables from operating leases are accounted for using the lease guidancefurther expand its digitally enabled solutions and not as financial instruments. ASU 2018-19 will be effective for the Company for the quarter ending December 31, 2020, with early adoption permitted. The Companyservices in key industrial markets. WCSI is currently assessing the impact of adoption on the Company’s Unaudited Consolidated Financial Statements.
In November 2018, the FASB issued ASU 2018-18, Collaborative Arrangements (Topic 808) Clarifying the Interaction between Topic 808 and Topic 606, which clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue under Topic 606 when the collaborative arrangement participant is a customer in the context of a unit of account. In addition, unit-of-account guidance in Topic 808 was aligned with the guidance in Topic 606 (that is, a distinct good or service) when an entity is assessing whether the collaborative arrangement or a part of the arrangementIntegrated Solutions and Services segment. During the nine months ended June 30, 2021, the Company incurred approximately $117 in acquisition costs, which are included in General and administrative expense on the Unaudited Consolidated Statements of Operations.
The Company has not finalized the valuations of the acquired assets, assumed liabilities, and identifiable intangible assets, including goodwill. The preliminary opening balance sheet for WCSI is withinsummarized as follows:
Current assets$1,813 
Property, plant and equipment221 
Goodwill4,361 
Intangible assets, net7,336 
Other non-current assets86 
Total assets acquired13,817 
Liabilities assumed(1,792)
Net assets acquired$12,025 
On December 17, 2020, the scopeCompany acquired the industrial water business of Topic 606. ASU 2018-18 should be applied retrospectively toUltrapure & Industrial Services, LLC (“Ultrapure”) for $8,743 cash paid at closing. On April 1, 2021, the dateCompany paid an additional $290 as a result of initial adoptionnet working capital adjustments. Ultrapure, based out of Topic 606Texas, provides customers across multiple end markets with a variety of water treatment products and services, including service deionization, reverse osmosis, UV, and ozonation. Ultrapure will strengthen the Company’s service capabilities in the Houston and Dallas markets and is effective fora part of the Integrated Solutions and Services segment. During the nine months ended June 30, 2021, the Company forincurred approximately $230 in acquisition costs, which are included in General and administrative expense on the quarter ending December 31, 2020, with early adoption permitted. Unaudited Consolidated Statements of Operations.
The Company has not finalized the valuations of the acquired assets, assumed liabilities and identifiable intangible assets, including goodwill. The preliminary opening balance sheet for Ultrapure is currently assessingsummarized as follows:
Current assets$2,366 
Property, plant and equipment963 
Goodwill2,836 
Intangible assets, net3,751 
Other non-current assets21 
Total assets acquired9,937 
Liabilities assumed(904)
Net assets acquired$9,033 
On March 1, 2021, the impactCompany completed the divestiture of adoptionthe Lange containment system, geomembrane and geosynthetic liner product line (the “Lange Product Line”) for $897 in cash at closing. The Lange Product Line was a part of the Integrated Solutions and Services segment. During the nine months ended June 30, 2021, the Company recognized a loss of $193 on the Company’s Unaudited Consolidated Financial Statements.divestiture.
15


In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Subtopic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement, which modifies the disclosure requirements on fair value measurements. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. ASU 2018-14 will be effective for the Company for the quarter ending December 31, 2020, with early adoption permitted. The Company is currently assessing the impact of adoption on the Company’s disclosures.
In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, amended in November 2019 (ASU 2019-11 and 2019-10), which requires entities to use a new forward-looking “expected loss” model that reflects expected credit losses, including credit losses related to trade receivables, and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates which generally will result in the earlier recognition of allowances for losses. ASU 2016-13 will be effective for the Company for the quarter ending December 31, 2020. The Company is not expecting this ASU to have a significant impact on the Company’s Unaudited Consolidated Financial Statements given our current practices and history.5. Revenue
Accounting Pronouncements Recently Adopted
The Company adopted ASU 2019-12,2016-13, Income TaxesFinancial Instruments—Credit Losses (Topic 740)326): Simplifying the Accounting for Income TaxesMeasurement of Credit Losses on Financial Instruments, as of on October 1, 2019,2020 (“ASU 2016-13”). ASU 2016-13 requires entities to use a new forward-looking “expected loss” model that reflects expected credit losses, including credit losses related to trade receivables, and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, which simplifiesgenerally will result in the accountingearlier recognition of allowances for income taxes by removing certain exceptionslosses. The Company adopted ASU 2016-13 using a modified retrospective approach and by clarifying and amending existing guidance in orderdetermined that there was no cumulative-effect adjustment to improve consistent applicationits beginning Retained deficit on the Consolidated Balance Sheets. The adoption of and simplify GAAP for other areas of Topic 740. This adoptionthis standard did not have anhave a material impact on the Company’s Unaudited Consolidated Financial Statements. See Note 7, “Accounts Receivable” for further details and related disclosures.
The following accounting pronouncements were adopted by the Company adopted ASU 2018‑07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, as ofon October 1, 2019. ASU 2018-07 expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. This adoption did not have an impact on the Company’s Unaudited Consolidated Financial Statements.

The Company adopted ASU 2017‑12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities, as of October 1, 2019. ASU 2017-12 expands and refines hedge accounting for both nonfinancial and financial risk components and aligns the recognition and presentation of the effects of the hedging instrument2020, and the hedged item in the financial statements and also made certain targeted improvements to simplify the application of hedge accounting guidance and ease the administrative burden of hedge documentation requirements and assessing hedge effectiveness. This adoptionadoptions did not have a material impact on the Company’s Unaudited Consolidated Financial Statements.Statements or disclosures:
Accounting Standards Updates
ASU 2020-03, Codification Improvements to Financial Instruments
ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments—Credit Losses
ASU 2018-18, Collaborative Arrangements (Topic 808) Clarifying the Interaction between Topic 808 and Topic 606
ASU 2018-13, Fair Value Measurement (Subtopic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement
3. Variable Interest Entities
Treated Water Outsourcing (“TWO”) is a joint venture between the Company and Nalco Water, an Ecolab company, in which the Company holds a 50% partnership interest. The Company adopted ASU 2016-02, Leases (Topic 842), including associated ASUs relatedis obligated to Topic 842,asabsorb all risk of October 1, 2019. ASU No. 2016-02 requires recognitionloss up to 100% of operating leases as lease assets and liabilities on the balance sheet, and disclosure of key information about leasing arrangements. Amendments to the standard were issued by the FASB in January, July and December 2018, and March 2019 including certain practical expedients, an amendment that provides an additional and optional transition method to adopt the standard at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption and certain narrow-scope improvements for lessors. The Company adopted this standard using a modified retrospective approach, applying the new standard to all leases existing at the date of initial adoption andjoint venture partner’s equity. As such, the Company elected to apply the transition requirements at the October 1, 2019 effective date rather than the beginning of the earliest comparative period presented. Asfully consolidates TWO as a result, the Company recorded a cumulative effect adjustment in the period of adoption, and prior periods were not restated and continue to be reported in accordance with historic accountingvariable interest entity (“VIE”) under ASC Topic No. 840. In addition,810, Consolidation. The Company has not provided, and is not contractually required to provide, additional financial support to this entity, and the Company has elected the package of practical expedients permitted under the transition guidance which does not require reassessmenthave the ability to use the assets of prior conclusions relatedTWO to contracts containingsettle obligations of the Company’s other subsidiaries.
The following provides a lease, lease classification and initial direct lease costs. As an accounting policy election, the Company elected to exclude short-term leases (termsummary of 12 months or less) from theTWO’s balance sheet and accounts for non-lease and lease components separately for all asset classes. The following table summarizes the impact of adoption to the Consolidated Balance Sheet as of October 1, 2019:June 30, 2021 and September 30, 2020, and summarized financial information for the three and nine months ended June 30, 2021 and 2020.
 As Reported September 30, 2019 Impact of Adoption of ASU 2016-02 Updated October 1, 2019
Assets     
Prepaid and other current assets$21,940
 $(73) $21,867
Total current assets637,293
 (73) 637,220
Property, plant and equipment, net333,584
 2,812
 336,396
Operating lease right-of-use assets, net
 42,073
 42,073
Total Assets1,737,848
 44,812
 1,782,660
Liabilities     
Accrued expenses and other liabilities101,839
 13,596
 115,435
Total current liabilities322,221
 13,596
 335,817
Obligation under operating leases
 29,308
 29,308
Other non-current liabilities78,661
 3,245
 81,906
Total non-current liabilities1,049,805
 32,553
 1,082,358
Total liabilities1,372,026
 46,149
 1,418,175
Shareholders' equity     
Retained deficit(174,976) (1,337) (176,313)
Total Evoqua Water Technologies Corp. equity362,759
 (1,337) 361,422
Total shareholder's equity365,822
 (1,337) 364,485
Total liabilities and shareholders' equity$1,737,848
 $44,812
 $1,782,660

June 30,
2021
September 30,
2020
Current assets (includes cash of $1,580 and $2,088)$3,529 $4,016 
Property, plant and equipment963 1,145 
Goodwill2,206 2,206 
Total liabilities(1,287)(1,324)

3. Acquisitions and Divestitures
Acquisitions
Acquisitions support the Company’s strategy of delivering a broad solutions portfolio with robust technology across multiple geographies and end markets. The Company continues to evaluate potential strategic acquisitions of businesses, assets and product lines and believes that capex-like, tuck-in acquisitions present a key opportunity within its overall growth strategy.
Three Months Ended
June 30,
Nine Months Ended
June 30,
2021202020212020
Total revenue$843 $1,328 $2,511 $5,180 
Total operating expenses(748)(803)(2,217)(3,847)
Income from operations$95 $525 $294 $1,333 
On October 1, 2019, the Company acquired a 60% investment position in San Diego-based Frontier Water Systems, LLC (“Frontier”) for $11,160 cash paid at closing. During the third quarter of 2020, as. The Frontier acquisition is a result of net working capital adjustments,VIE because it has insufficient equity to finance its activities due to key assets being assigned to the Company received $275 in cash fromupon acquisition.  The Company is the sellersprimary beneficiary of Frontier reducing the purchase price to $10,885. Frontier is a pioneer in the development of patented, engineered equipment packages for high-rate treatment and removal of selenium, nitrate and other metals from complex water systems. During the nine months ended June 30, 2020,because the Company incurred approximately $424 in acquisition costs, which are included in General and administrative expenses. Frontier is part ofhas the Integrated Solutions and Services segment.power to direct the activities that most significantly affect Frontier’s economic performance.
13

The
In addition, the Company has entered into an agreement to purchase the remaining 40% interest in Frontier on or prior to March 30, 2024. This agreement (a) givesgave holders of the remaining 40% interest in Frontier (the “Minority Owners”) the right to sell to Evoqua up to approximately 10% of the outstanding equity in Frontier at a predetermined price, which right may be exercisedwas exercisable by the Minority Owners between January 1, 2021 and February 28, 2021 (the “Option”), and (b) obligates the Company to purchase and the Minority Owners to sell all of the Minority Owners’ remaining interest in Frontier at the fair market value at the time of sale on or prior to March 30, 2024 (the “Purchase Right”). The Purchase Right may be exercised early by the Minority Owners. The agreement to purchase the remaining interest was determined to be financing due to the mandatory Purchase Right, as per ASC Topic 480, Distinguishing Liabilities From Equity, and as such, the Company has recognized a liability for the remaining 40% interest.The Minority Owners exercised the Option, and on April 8, 2021, the Company completed the purchase of an additional 8% of the outstanding equity in Frontier for approximately $1,490. As a result, the Company’s ownership position in Frontier increased to 68%.
Additionally, the Company fully consolidates Frontier as a VIE under ASC Topic No. 810, Consolidation.
The valuefollowing provides a summary of Frontier’s balance sheet as of June 30, 2021 and September 30, 2020, and summarized financial information for the Option was determinedthree and nine months ended June 30, 2021 and 2020.
June 30,
2021
September 30,
2020
Current assets (includes cash of $2,947 and $1,675)$10,034 $4,024 
Property, plant and equipment2,974 3,159 
Goodwill1,798 1,798 
Intangible assets, net8,678 9,918 
Total liabilities(9,039)(3,692)
Three Months Ended
June 30,
Nine Months Ended
June 30,
2021202020212020
Total revenue$4,945 $1,411 $7,793 $4,134 
Total operating expenses(4,448)(2,003)(8,587)(6,304)
Income (loss) from operations$497 $(592)$(794)$(2,170)
4. Acquisitions and Divestitures
Acquisitions support the Company’s strategy of delivering a broad solutions portfolio with robust technology across multiple geographies and end markets. The Company continues to be $506 usingevaluate potential strategic acquisitions of businesses, assets and product lines and believes that capex-like, tuck-in acquisitions present a Black Scholes model, andkey opportunity within its overall growth strategy.
14


On April 1, 2021, the Company acquired the assets of Water Consulting Specialists, Inc. (“WCSI”) for $12,025 cash paid at closing. In addition, the Company recorded a liability of $761 associated with an earn-out related to the WCSI acquisition, which is included withinin Accrued expenses and other liabilities on the Consolidated Balance Sheets.
WCSI is a leader in the design, manufacturing, and service of industrial high-purity water treatment systems. The valueacquisition strengthens the Company’s portfolio of high-purity water treatment systems and provides the opportunity to further expand its digitally enabled solutions and services in key industrial markets. WCSI is a part of the Purchase Right was determined to be $6,661,Integrated Solutions and isServices segment. During the nine months ended June 30, 2021, the Company incurred approximately $117 in acquisition costs, which are included within Other non‑current liabilitiesin General and administrative expense on the Unaudited Consolidated Balance Sheets, based upon the enterprise valueStatements of Frontier upon the acquisition date as per ASC Topic 480, Distinguishing Liabilities From Equity. Pursuant to ASC Topic 480, the Company determined that this should be recorded as a liability and should be recognized at the fair value at the time of inception, adjusted for any consideration or unstated rights or privileges. The liability will be subsequently measured at an amount that would be paid on the reporting date with any change in value from the previous reporting date recognized as interest cost.Operations.
The accounting for the acquisition has not yet been completed because the Company has not finalized the deferred tax accounting related tovaluations of the purchase price allocation.acquired assets, assumed liabilities, and identifiable intangible assets, including goodwill. The preliminary opening balance sheet for FrontierWCSI is summarized as follows:
Current assets$3,186
Property, plant and equipment2,963
Goodwill1,798
Intangible assets11,571
Total assets acquired19,518
Liabilities related to Option and Purchase Right(7,167)
Other liabilities assumed(1,466)
Net assets acquired$10,885

Divestitures
Current assets$1,813 
Property, plant and equipment221 
Goodwill4,361 
Intangible assets, net7,336 
Other non-current assets86 
Total assets acquired13,817 
Liabilities assumed(1,792)
Net assets acquired$12,025 
On December 31, 2019,17, 2020, the Company completedacquired the saleindustrial water business of Ultrapure & Industrial Services, LLC (“Ultrapure”) for $8,743 cash paid at closing. On April 1, 2021, the Memcor product line to DuPont de Nemours, Inc. (“DuPont”). The aggregate purchase priceCompany paid by DuPont in the Transaction was $110,000 in cash, subject to certain adjustments. Following adjustments for cash and net working capital, gross proceeds paid by DuPont were $131,011. The Company recognized a $49,000 net pre-tax benefit on the sale of the Memcor product line, net of $8,300 of discretionary

compensation payments to employees in connection with the transaction and $1,000 in transaction costs incurred in the three months ended December 31, 2019. Asan additional $290 as a result of net working capital adjustments,adjustments. Ultrapure, based out of Texas, provides customers across multiple end markets with a variety of water treatment products and services, including service deionization, reverse osmosis, UV, and ozonation. Ultrapure will strengthen the Company’s service capabilities in the Houston and Dallas markets and is a part of the Integrated Solutions and Services segment. During the nine months ended June 30, 2021, the Company incurred approximately $230 in acquisition costs, which are included in General and administrative expense on the Unaudited Consolidated Statements of Operations.
The Company has not finalized the valuations of the acquired assets, assumed liabilities and identifiable intangible assets, including goodwill. The preliminary opening balance sheet for Ultrapure is summarized as follows:
Current assets$2,366 
Property, plant and equipment963 
Goodwill2,836 
Intangible assets, net3,751 
Other non-current assets21 
Total assets acquired9,937 
Liabilities assumed(904)
Net assets acquired$9,033 
On March 1, 2021, the Company completed the divestiture of the Lange containment system, geomembrane and geosynthetic liner product line (the “Lange Product Line”) for $897 in cash at closing. The Lange Product Line was a part of the Integrated Solutions and Services segment. During the nine months ended June 30, 2021, the Company recognized an additional $9,000 net pre-tax benefit ina loss of $193 on the three months ended March 31, 2020. The Company utilized $100,000 of the proceeds from the transaction to repay a portion of the Company’s First Lien Term Loans in January 2020.divestiture.
15
4.


5. Revenue
Revenue Recognition
The Company recognizes sales of products and services based on the five-step analysis of transactions as provided in ASU 2014-09, Revenue from Contracts with Customers (Topic 606) (“Topic 606.606”). For all contracts with customers, the Company first identifies the contract which usually is established when the customer’s purchase order is accepted or acknowledged. Next, the Company identifies the performance obligations in the contract. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer. The Company then determines the transaction price in the arrangement and allocates the transaction price to each performance obligation identified in the contract. The Company’s allocation of the transaction price to the performance obligations areis based on the relative standalone selling prices for the goods and services contained in a particular performance obligation. The transaction price is adjusted for the Company’s estimate of variable consideration, which may include discounts if the Company would fail to meet certain performance requirements, volume discounts or early payment discounts. To estimate variable consideration, the Company utilizes historical experience and known terms. Variable consideration in contracts for the three and nine months ended June 30, 20202021 was insignificant.
For sales of aftermarket parts or products with a low level of customization and engineering time, the Company recognizes revenuesrevenue at the time risks and rewards of ownership pass, which is generally when products are shipped or delivered to the customer as the Company has no obligation for installation. The Company considers shipping and handling services to be fulfillment activities and as such they do not represent separate performance obligations for revenue recognition. Sales of service arrangements are recognized as the services are performed.
For certain arrangements where there is significant customization to the product and for long-term construction-type sales contracts, revenue may be recognized over time. In these instances, revenue is recognized using a measure of progress that applies an input method based on costs incurred in relation to total estimated costs. These arrangements include large capital water treatment projects, and systems and solutions for municipal and industrial applications. The nature of the contracts is generally fixed price with milestone billings. In order for revenue to be recognized over a period of time, the product must have no alternative use and the Company must have an enforceable right to payment for the performance completed to date, including a normal profit margin, in the event of termination for convenience. If these two criteria are not met, revenuesrevenue from these contracts will not be recognized until construction is complete. Contract revenuesrevenue and cost estimates are reviewed and revised quarterly at a minimum and the cumulative effect of such adjustments are recognized in current operations. The amount of such adjustments has not been material.
The Company has made accounting policy elections to exclude all taxes by governmental authorities from the measurement of the transaction price and that long-term construction-type sales contracts, or those contracts for products with significant customization that the total contract price is less than $100, will be recorded at the point in time when the construction is complete.
Performance Obligations

The Company elects to apply the practical expedient to exclude from this disclosure revenue related to performance obligations if the product has an alternative use and the Company does not have an enforceable right to payment for the performance completed to date, including a normal profit margin, in the event of termination for convenience. The Company maintains a backlog of confirmed orders, ofwhich totaled approximately $163,517$250,887 at June 30, 2020.2021. This backlog represents the aggregate amount of the transaction price allocated to performance obligations that were unsatisfied or partially unsatisfied as of the end of the reporting period. The Company estimates that the majority of these performance obligations will be satisfied within the next twelve to twenty-four months.

The recording of assets recognized from the costs to obtain and fulfill customer contracts primarily relaterelates to the deferral of sales commissions. The Company’s costs incurred to obtain or fulfill a contract with a customer are classified

16


as non-current assets and amortized to expense over the period of benefit of the related revenue. These costs are recorded within Cost of product sales and services. The amount of contract costs was insignificant at June 30, 2020.2021.
The Company offers standard warranties that generally do not represent a separate performance obligation. In certain instances, a warranty is obtained separately from the original equipment sale or the warranty provides incremental services and as such is treated as a separate performance obligation.
Disaggregation of Revenue
In accordance with Topic 606, the Company disaggregates revenue from contracts with customers into source of revenue, reportable operating segment and geographical regions. The Company determined that disaggregating revenue into these categories meets the disclosure objective in Topic 606, which is to depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors.
Information regarding the source of revenues:revenue:
Three Months Ended
June 30,
Nine Months Ended
June 30,
2021202020212020
Revenue from contracts with customers recognized under Topic 606$320,218 $310,525 $903,325 $934,121 
Other (1)49,463 37,302 135,113 111,474 
Total$369,681 $347,827 $1,038,438 $1,045,595 
 Three Months Ended
June 30,
 Nine Months Ended
June 30,
 2020 2019 2020 2019
Revenue from contracts with customers recognized under Topic 606$310,525
 $325,009
 $934,121
 $934,111
Other (1)37,302
 35,334
 111,474
 97,862
Total$347,827
 $360,343
 $1,045,595
 $1,031,973
(1)     Other revenue relates to revenue recognized pursuant to ASU 2016-02, Leases (Topic 842), primarily attributable to long term rentals.
(1)Other revenue relates to revenue recognized from Topic 842 (previously Topic 840), Leases, mainly attributable to long term rentals.
Information regarding revenuesrevenue disaggregated by source of revenue and segment is as follows:

Three Months Ended June 30,Three Months Ended June 30,
2020 201920212020
Integrated Solutions and Services Applied Product Technologies Total Integrated Solutions and Services Applied Product Technologies TotalIntegrated Solutions and ServicesApplied Product TechnologiesTotalIntegrated Solutions and ServicesApplied Product TechnologiesTotal
Revenue from capital projects$64,692
 $85,654
 $150,346
 $52,132
 $83,390
 $135,522
Revenue from capital projects$63,336 $92,692 $156,028 $64,692 $85,654 $150,346 
Revenue from aftermarket29,143
 28,086
 57,229
 29,968
 44,873
 74,841
Revenue from aftermarket31,852 30,547 62,399 29,143 28,086 57,229 
Revenue from service134,876
 5,376
 140,252
 143,329
 6,651
 149,980
Revenue from service144,499 6,755 151,254 134,876 5,376 140,252 
Total$228,711
 $119,116
 $347,827
 $225,429
 $134,914
 $360,343
Total$239,687 $129,994 $369,681 $228,711 $119,116 $347,827 

Nine Months Ended June 30,
20212020
Integrated Solutions and ServicesApplied Product TechnologiesTotalIntegrated Solutions and ServicesApplied Product TechnologiesTotal
Revenue from capital projects$166,055 $259,877 $425,932 $185,404 $235,794 $421,198 
Revenue from aftermarket91,499 83,477 174,976 90,717 98,189 188,906 
Revenue from service420,984 16,546 437,530 418,613 16,878 435,491 
Total$678,538 $359,900 $1,038,438 $694,734 $350,861 $1,045,595 
17

 Nine Months Ended June 30,
 2020 2019
 Integrated Solutions and Services Applied Product Technologies Total Integrated Solutions and Services Applied Product Technologies Total
Revenue from capital projects$185,404
 $235,794
 $421,198
 $152,772
 $230,887
 $383,659
Revenue from aftermarket90,717
 98,189
 188,906
 93,238
 120,422
 213,660
Revenue from service418,613
 16,878
 435,491
 416,781
 17,873
 434,654
Total$694,734
 $350,861
 $1,045,595
 $662,791
 $369,182
 $1,031,973


Information regarding revenuesrevenue disaggregated by geographic area is as follows:
 Three Months Ended
June 30,
 Nine Months Ended
June 30,
 2020 2019 2020 2019
United States$285,077
 $284,737
 $853,067
 $823,923
Europe23,413
 26,677
 79,906
 71,235
Asia19,806
 23,007
 51,268
 62,411
Canada16,536
 20,873
 50,418
 58,836
Australia2,995
 5,049
 10,936
 15,568
Total$347,827
 $360,343
 $1,045,595
 $1,031,973

Three Months Ended
June 30,
Nine Months Ended
June 30,
2021202020212020
United States$291,113 $285,077 $829,925 $853,067 
Asia31,987 19,806 81,568 51,268 
Europe28,749 23,413 81,561 79,906 
Canada14,210 16,536 36,025 50,418 
Australia3,622 2,995 9,359 10,936 
Total$369,681 $347,827 $1,038,438 $1,045,595 
Contract Balances
The Company performs its obligations under a contract with a customer by transferring products and/or services in exchange for consideration from the customer. The Company receives payments from customers based on a billing schedule as established in its contracts.
Contract assets relate to costs incurred to perform in advance of scheduled billings. Contract liabilities relate to payments received in advance of performance under the contracts. Change in contract assets and liabilities are due to the Company’s performance under the contract.

The tables below provide a roll-forward of contract assets and contract liabilities balances for the periods presented:
Nine Months Ended
June 30,
Contract assets (a)20212020
Balance at beginning of period$80,759 $73,467 
Recognized in current period232,750 255,623 
Reclassified to accounts receivable(244,766)(253,199)
Amounts related to sale of the Memcor product line2,710 
Foreign currency600 (1,011)
Balance at end of period$69,343 $77,590 
(a)     Excludes receivable balances which are disclosed on the Consolidated Balance Sheets.
Nine Months Ended
June 30,
Contract Liabilities20212020
Balance at beginning of period$26,259 $39,051 
Recognized in current period245,049 241,468 
Amounts in beginning balance reclassified to revenue(18,496)(37,508)
Current period amounts reclassified to revenue(216,972)(210,985)
Amounts related to sale of the Memcor product line(700)
Foreign currency1,075 (485)
Balance at end of period$36,915 $30,841 
18
 Nine Months Ended
June 30,
Contract assets (a)2020 2019
Balance at beginning of period$73,467
 $69,147
Cumulative effect of adoption of new accounting standards
 (6,106)
Recognized in current period255,623
 225,341
Reclassified to accounts receivable(253,199) (218,433)
Amounts related to sale of the Memcor product line2,710
 
Foreign currency(1,011) 69
Balance at end of period$77,590
 $70,018
(a)Excludes receivable balances which are disclosed on the Consolidated Balance Sheets.

 Nine Months Ended
June 30,
Contract Liabilities2020 2019
Balance at beginning of period$39,051
 $17,652
Cumulative effect of adoption of new accounting standards

 1,773
Recognized in current period241,468
 214,444
Amounts in beginning balance reclassified to revenue(37,508) (20,127)
Current period amounts reclassified to revenue(210,985) (181,266)
Amounts related to sale of the Memcor product line(700) 
Foreign currency(485) (164)
Balance at end of period$30,841
 $32,312


5.6. Fair Value Measurements
As of June 30, 20202021 and September 30, 2019,2020, the fair values of cash and cash equivalents, accounts receivable, and accounts payable approximate carrying values due to the short maturity of these items.
The Company measures the fair value of pension plan assets and liabilities, deferred compensation plan assets and liabilities on a recurring basis pursuant to ASC Topic No. 820, Fair Value Measurement. ASC Topic No. 820 establishes a three‑tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include:
Level 1: Quoted prices for identical instruments in active markets.
Level 2: Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model‑derived valuations whose inputs are observable or whose significant value driver is observable.
Level 3: Unobservable inputs in which little or no market data is available, therefore requiring an entity to develop its own assumptions.
The following table presents the Company’s financial assets and liabilities at fair value. The fair values related to the pension plan assets are determined using net asset value (“NAV”) as a practical expedient, or by information categorized in the fair value hierarchy level based on the inputs used to determine fair value. The reported carrying amounts of deferred compensation plan assets and liabilities and debt approximate their fair values. The Company uses interest rates and other relevant information generated by market transactions involving similar instruments to fair value these assets and liabilities, therefore all are classified as Level 2 within the valuation hierarchy.

19


Net Asset ValueQuoted Market
Prices in Active
Markets (Level 1)
Significant Other
Observable Inputs
(Level 2)
Significant
Unobservable Inputs
(Level 3)
As of June 30, 2021
Assets:
Pension plan
Cash$— $448 $— $— 
Global Multi-Asset Fund15,303 — — — 
Government Securities2,557 — — — 
Liability Driven Investment5,930 — — — 
Guernsey Unit Trust2,381 — — — 
Global Absolute Return2,275 — — — 
Deferred compensation plan assets
Cash— 1,240 — — 
Mutual Funds— 17,964 — — 
Interest rate swaps— — 2,443 — 
Foreign currency forward contracts— — 59 — 
Liabilities:
Pension plan— — (48,524)— 
Deferred compensation plan liabilities— — (23,980)— 
Long‑term debt— — (799,922)— 
Interest rate swap— — (376)— 
Foreign currency forward contracts— — (120)— 
Commodity swaps(16)
Earn-outs related to acquisitions— — — (1,056)
Purchase Right— — — (6,249)
As of September 30, 2020
Assets:
Pension plan
Cash$— $15,061 $— $— 
Government Securities4,924 — — — 
Liability Driven Investment3,604 — — — 
Guernsey Unit Trust1,881 — — — 
Global Absolute Return2,060 — — — 
Deferred compensation plan assets
Trust Assets— 55 — — 
Insurance— — 19,804 — 
Foreign currency forward contracts— — 140 — 
Liabilities:
Pension plan— — (47,389)— 
Deferred compensation plan liabilities— — (21,439)— 
Long‑term debt— — (872,441)— 
Interest rate swap— — (4,669)— 
Foreign currency forward contracts— — (47)— 
Earn-outs related to acquisitions— — — (295)
Option and Purchase Right— — — (7,739)
 Net Asset Value Quoted Market
Prices in Active
Markets (Level 1)
 Significant Other
Observable Inputs
(Level 2)
 Significant
Unobservable Inputs
(Level 3)
As of June 30, 2020       
Assets:       
Pension plan       
Cash$
 $14,207
 $
 $
Government Securities2,846
 
 
 
Liability Driven Investment5,603
 
 
 
Guernsey Unit Trust1,000
 
 
 
Global Absolute Return1,935
 
 
 
Deferred compensation plan assets       
Trust Assets
 6
 
 
Insurance
 
 18,654
 
Foreign currency forward contracts
 
 305
 
Liabilities:       
Pension plan
 
 (43,981) 
Deferred compensation plan liabilities
 
 (19,960) 
Long‑term debt
 
 (854,885) 
Interest rate swap
 
 (3,258) 
Foreign currency forward contracts
 
 (411) 
Earn-outs related to acquisitions
 
 
 (91)
Option and Purchase Right
 
 
 (7,167)
        
As of September 30, 2019       
Assets:       
Pension plan       
Cash$
 $14,607
 $
 $
Government Securities4,703
 
 
 
Liability Driven Investment3,261
 
 
 
Guernsey Unit Trust997
 
 
 
Global Absolute Return1,957
 
 
 
Deferred compensation plan assets       
Trust Assets
 16
 
 
Insurance
 
 18,684
 
Interest rate cap
 
 19
 
Foreign currency forward contracts
 
 278
 
Liabilities:       
Pension plan
 
 (42,948) 
Deferred compensation plan liabilities
 
 (21,318) 
Long‑term debt
 
 (979,357) 
Foreign currency forward contracts
 
 (154) 
Earn-outs related to acquisitions
 
 
 (1,545)
20


The pension plan assets and liabilities and deferred compensation plan assets and liabilities are included in Other non‑current assets and Other non‑current liabilities at June 30, 20202021 and September 30, 2019.2020. The unrealized gain on mutual funds was $532 at June 30, 2021.
The Company records contingent consideration arrangements at fair value on a recurring basis, and the associated balances presented as of June 30, 20202021 and September 30, 20192020 are earn-outs related to acquisitions. The fair value of earn-outs related to acquisitions is based on significant unobservable inputs including the achievement of certain performance

metrics. Significant changes in these inputs would result in corresponding increases or decreases in the fair value of the earn-out each period until the related contingency has been resolved. Changes in the fair value of the contingent consideration obligations can result from adjustments in the probability of achieving future development steps, sales targets and profitability and are recorded in General and administrative expenses in the Unaudited Consolidated Statements of Operations.
A roll-forward During the three and nine months ended June 30, 2021, the Company recorded a liability of $761 associated with an earn-out related to the activityWCSI acquisition, which is included in Accrued expenses and other liabilities on the Consolidated Balance Sheets. There were no other changes in the Company’s fair value of earn-outs related to acquisitions. As of June 30, 2021 and September 30, 2020, earn-outs related to acquisitions is as follows:totaled $1,056 and are included in Accrued expenses and other liabilities on the Consolidated Balance Sheets.
 Current Portion (1) Long-term Portion (2) Total
Balance at September 30, 2019$611
 $934
 $1,545
Payments(187) 
 (187)
Fair value adjustment(333) (934) (1,267)
Balance at June 30, 2020$91
 $
 $91
(1)Included in Accrued expenses and other liabilities on the Consolidated Balance Sheets.
(2)Included in Other non‑current liabilities on the Consolidated Balance Sheets.
Pursuant to the acquisition of Frontier, the Company recorded a liability for the Option and Purchase Right
to purchase the remaining
40% interest. The fair value of thethese options is based upon significant unobservable inputs including future earnings and other market factors. Significant changes in these inputs would result in corresponding increases or decreases in the fair value of thethese options each period until the purchase of the remaining 40% interest has occurred. Changes in the fair value can result from earnings achieved over the passage of time and will be recorded in Interest expense in the Unaudited Consolidated Statements of Operations. There were no changes in the fair value of the Option and Purchase Right recorded during the three and nine months ended June 30, 2021. The Minority Owners exercised the Option, and on April 8, 2021 the Company completed the purchase of an additional 8% of the outstanding equity in Frontier for approximately $1,490. As of June 30, 2021 and September 30, 2020, $506 is included in Accrued expenses$6,249 and other liabilities related to the Option and $6,661$7,739, respectively, is included in Other non‑current liabilities related to the Purchase Right on the Consolidated Balance Sheets.
6.7. Accounts Receivable
All trade receivables are reported on the Consolidated Balance Sheets at the outstanding principal amount adjusted for any allowance for credit losses and any charge offs. The Company provides an allowance for credit losses to reduce trade receivables to their estimated net realizable value equal to the amount that is expected to be collected. This allowance is estimated based on historical collection experience, the aging of receivables, specific current and expected future macro-economic and market conditions, and assessments of the current creditworthiness and economic status of customers. The Company considers a receivable delinquent if it is unpaid after the term of the related invoice has expired. Write‑offs are recorded at the time all collection efforts have been exhausted. The Company reviews its allowance for credit losses on a quarterly basis.
Accounts receivable are summarized as follows:
June 30,
2021
September 30,
2020
Accounts receivable$250,608 $264,536 
Allowance for credit losses(3,989)(4,057)
Receivables, net$246,619 $260,479 
 June 30,
2020
 September 30,
2019
Accounts receivable$247,478
 $262,491
Allowance for doubtful accounts(4,580) (4,906)
Receivables, net$242,898
 $257,585
The movement in the allowance for credit losses was as follows for the nine months ended June 30, 2021:
Balance at September 30, 2020$(4,057)
Charged to costs and expenses(460)
Write-offs562 
Foreign currency and other(34)
Balance at June 30, 2021$(3,989)
21


7.8. Inventories
The major classes of Inventories, net are as follows:
 June 30,
2020
 September 30,
2019
Raw materials and supplies$86,604
 $75,223
Work in progress19,544
 14,741
Finished goods and products held for resale62,380
 58,223
Costs of unbilled projects4,553
 2,347
Reserves for excess and obsolete(13,635) (13,370)
Inventories, net$159,446
 $137,164

June 30,
2021
September 30,
2020
Raw materials and supplies$85,671 $78,319 
Work in progress19,489 15,654 
Finished goods and products held for resale63,493 56,435 
Costs of unbilled projects3,789 3,438 
Reserves for excess and obsolete(11,214)(11,467)
Inventories, net$161,228 $142,379 

8.9. Property, Plant, and Equipment
Property, plant, and equipment consists of the following:
 June 30,
2020
 September 30,
2019
Machinery and equipment$341,606
 $316,390
Rental equipment201,379
 172,534
Land and buildings69,313
 64,165
Construction in process54,975
 40,599
 667,273
 593,688
Less: accumulated depreciation(310,849) (260,104)
 $356,424
 $333,584

June 30,
2021
September 30,
2020
Machinery and equipment$386,458 $357,650 
Rental equipment238,953 221,953 
Land and buildings70,591 70,245 
Construction in process53,975 48,325 
749,977 698,173 
Less: accumulated depreciation(377,578)(333,712)
$372,399 $364,461 
The Company entered into secured financing agreements that require providing a security interest in specified equipment. As of June 30, 20202021 and September 30, 2019,2020, the gross and net amounts of those assets are as follows:
 June 30,
2020
 September 30,
2019
 Gross Net Gross Net
Machinery and equipment$59,307
 $49,959
 $48,288
 $42,162
Construction in process3,724
 3,724
 2,531
 2,531
 $63,031
 $53,683
 $50,819
 $44,693

June 30,
2021
September 30,
2020
GrossNetGrossNet
Machinery and equipment$71,012 $55,956 $63,305 $52,620 
Construction in process22,760 22,760 8,098 8,098 
$93,772 $78,716 $71,403 $60,718 
Depreciation expense and maintenance and repairs expense for the three and nine months ended June 30, 20202021 and 20192020 were as follows:
Three Months Ended
June 30,
Nine Months Ended
June 30,
2021202020212020
Depreciation expense$19,170 $18,992 $56,450 $54,480 
Maintenance and repair expense4,603 4,601 14,565 15,915 
 Three Months Ended
June 30,
 Nine Months Ended
June 30,
 2020 2019 2020 2019
Depreciation expense$18,992
 $15,979
 $54,480
 $47,334
Maintenance and repair expense4,601
 6,144
 15,915
 18,192
22


9.10. Goodwill
Changes in the carrying amount of goodwill are as follows:
 Integrated Solutions and Services Applied Product Technologies Total
Balance at September 30, 2019$222,013
 $170,877
 $392,890
Business combinations and divestitures1,798
 (405) 1,393
Measurement period adjustment
 298
 298
Foreign currency translation(1,142) (12) (1,154)
Balance at June 30, 2020$222,669
 $170,758
 $393,427

Integrated Solutions and ServicesApplied Product TechnologiesTotal
Balance at September 30, 2020$224,381 $172,824 $397,205 
Business combinations and divestitures10,349 10,349 
Measurement period adjustment(3,194)(3,194)
Foreign currency translation3,232 2,164 5,396 
Balance at June 30, 2021$234,768 $174,988 $409,756 
As of June 30, 20202021 and September 30, 2019, $152,0242020, $159,620 and $151,880,$153,004, respectively, of goodwill was deductible for tax purposes.


10.11. Debt
Long‑term debt consists of the following:
June 30,
2021
September 30,
2020
2021 Term Loan, due April 1, 2028 (1)$475,000 $
2021 Revolving Credit Facility, due April 1, 2026 (1)95,000 
2014 Term Loan, due December 20, 2024 (1)819,276 
2014 Revolving Credit Facility (1)
Securitization Facility, due April 1, 2024148,151 
Equipment Financing, due September 30, 2023 to July 5, 2029, interest rates ranging from 3.13% to 8.07%83,255 63,918 
Notes Payable, due July 31, 2023455 611 
Mortgage (2)1,665 
Total debt801,861 885,470 
Less unamortized deferred financing fees(12,217)(9,436)
Total net debt789,644 876,034 
Less current portion(11,474)(14,339)
Total long‑term debt$778,170 $861,695 
 June 30,
2020
 September 30,
2019
First Lien Term Loan, due December 20, 2024$821,646
 $928,753
Revolving Credit Facility
 
Equipment Financing, due June 30, 2024 to July 5, 2029, interest rates ranging from 3.84% to 8.07%56,003
 45,960
Notes Payable, due July 31, 2023661
 807
Mortgage, due June 30, 20281,617
 1,635
Total debt879,927
 977,155
Less unamortized discount and lender fees(9,957) (12,138)
Total net debt869,970
 965,017
Less current portion(14,611) (13,418)
Total long‑term debt$855,359
 $951,599

(1)
On April 1, 2021, the Company paid off the outstanding balance of the 2014 Term Loan (as defined below) and entered into the 2021 Credit Agreement (as defined below).
Term Facilities and Revolving(2)In November 2020, the Company paid off the outstanding balance of the mortgage due June 30, 2028.
2014 Credit FacilityAgreement
On January 15, 2014, EWT Holdings III Corp. (“EWT III”), an indirect wholly-owned subsidiary of the Company, entered into a First Lien Credit Agreement (as modified, amended or supplemented from time to time, the “2014 Credit Agreement”) and a Second Lien Credit Agreement (the “Credit Agreements” or, after the prepayment and termination of the Second Lien Credit Agreement, the “First Lien Credit Agreement” or “Credit Agreement”) among EWT III, EWT Holdings II, Corp., the lenders party thereto and Credit Suisse AG as administrative agent and collateral agent.

In January 2020, The term loans outstanding under the Second Lien Credit Agreement were prepaid on October 28, 2016. The 2014 Credit Agreement also made available to the Company utilized $100,000a revolving credit facility (the “ 2014 Revolving Credit Facility”) of up to $125,000, with a letter of credit sublimit of up to $45,000. The term loan outstanding under the 2014 Credit Agreement (the “2014 Term Loan”) was scheduled to mature on December 20, 2024, and the 2014 Revolving Credit Facility was scheduled to mature on December 20, 2022. As described below, on April 1, 2021, we completed a refinancing of the proceeds fromoutstanding 2014 Term Loan and terminated the sale of the Memcor product line to repay a portion of the Company’s First Lien Term Loans. As a result of the prepayment, the Company wrote off $1,795 of deferred financing fees during the three months ended March 31, 2020. 2014 Credit Agreement.
23


2021 Credit Agreement
On February 18, 2020,April 1, 2021, EWT III entered into Amendment No. 7a Credit Agreement (the “Amendment”“2021 Credit Agreement”), among EWT III, as the borrower, EWT Holdings II, Corp., as parent guarantor, the subsidiary guarantorslenders from time to time party thereto, the financial institutions party thereto, and Credit Suisse AG,JPMorgan Chase Bank, N.A., as administrative agent and collateral agent, relating to theand ING Capital, LLC, as sustainability coordinator. The 2021 Credit Agreement. AsAgreement provides for a result of the Amendment, the Company incurred $760 of fees which were recorded as deferred financing fees on the Consolidated Balance Sheets. Prior to the Amendment, First Lien Term Loansmulti-currency senior secured revolving credit facility in an aggregate principal amount not to exceed the U.S. dollar equivalent of approximately $826,000$350,000 (the “Existing“2021 Revolving Credit Facility”) and a discounted senior secured term (the “2021 Term Loans”Loan”) werein the amount of $475,000 (together with the 2021 Revolving Credit Facility, the “Senior Facilities”). The 2021 Credit Agreement also provides for a letter of credit sub-facility not to exceed $60,000. The Senior Facilities are guaranteed by EWT II and certain existing and future direct or indirect wholly-owned domestic subsidiaries of EWT III (together with EWT III, collectively, the “Loan Parties”), and collateralized by a first lien on substantially all of the assets of the Loan Parties, with certain exceptions. In connection with entering into the 2021 Credit Agreement, on April 1, 2021, EWT III repaid all outstanding indebtedness under the Credit Agreement. Pursuant to the Amendment, the Existing Term Loans were refinanced with the proceeds of the refinancing term loans. Additionally, the Amendment amended the2014 Credit Agreement to, among other things:and terminated that facility.

(i)reduce the interest rate spread applicable to term loans based on LIBOR from (A) 2.75% to 2.50% per annum during any period during which EWT III maintains a public corporate family rating better than or equal to B1 from Moody’s and B+ from S&P, in each case with a stable outlook (a “Ratings Condition Period”), and (B) 3.00% to 2.75% per annum for any period other than a Ratings Condition Period;
(ii)reduce the interest rate spread applicable to term loans based on the Base Rate from (A) 1.75% to 1.50% per annum during any Ratings Condition Period and (B) 2.00% to 1.75% per annum during any period other than a Ratings Condition Period;
(iii)remove the 1.00% floor for term loans based on LIBOR and the 2.00% floor for term loans based on the Base Rate;
(iv)schedule existing indebtedness and investments, allowing EWT III and its subsidiaries to incur incremental indebtedness and make incremental investments under the applicable baskets;
(v)increase the generally permitted investments basket; and
(vi)extend the 1.00% prepayment premium for refinancing in connection with certain repricing transactions through August 18, 2020.

The Company makes quarterly principal payments of $2,369. At June 30, 2020, the interest rate on borrowings was 3.45%, comprised of 0.70% LIBOR plus the 2.75% spread.

Total deferred fees related to the First Lien Term Loan were $9,957 and $12,138, net of amortization, as of June 30, 2020 and September 30, 2019, respectively. These fees were included as a contra liability to debt on the Consolidated Balance Sheets.

The following summarizes the Company’s outstanding borrowings under the Revolver and outstanding letters of credit as of June 30, 2020 and September 30, 2019, respectively.
 June 30,
2020
 September 30,
2019
Borrowing availability under the Revolver$125,000
 $125,000
Outstanding borrowings under the Revolver
 
Outstanding letters of credit under the Revolver11,872
 12,956
Unused amounts under the Revolver$113,128
 $112,044
    
Additional letters of credit under a separate arrangement$51
 $204

The First Lien2021 Credit Agreement contains limitations on incremental borrowings, is subjectcustomary representations, warranties, affirmative covenants, and negative covenants, each substantially similar to those included in the 2014 Credit Agreement, including, among other things, a springing maximum first lien leverage ratios and allows for optional prepayments. Under certain circumstances, the Company may be requiredratio of 5.55 to remit excess cash flows as defined based upon exceeding certain leverage ratios.1.00. The Company did not exceed such ratiosthis ratio during the ninethree months ended June 30, 2020,2021, does not anticipate exceeding such ratiosthis ratio during the year ending September 30, 2020,2021, and therefore does not anticipate any additional repayments during the year ending September 30, 2021. In addition, the Company did not exceed this ratio as noted in the 2014 Credit Agreement during the six months ended March 31, 2021.
With respect to the 2021 Revolving Credit Facility, EWT III is required to pay a commitment fee based on the daily unused portion of the 2021 Revolving Credit Facility, as well as certain other fees to the agents and the arrangers under the Senior Facilities. Amounts outstanding under the Senior Facilities, at EWT III’s option, bear interest at either (i) a Base Rate determined in accordance with the terms of the 2021 Credit Agreement, (ii) with respect to any amounts denominated in U.S. dollars or Sterling, LIBOR, or replacement thereof, as determined in accordance with the terms of the 2021 Credit Agreement, or (iii) with respect to amounts denominated in Euros, the EURIBOR, or replacement thereof, as determined in accordance with the terms of the 2021 Credit Agreement. In the case of the 2021 Revolving Credit Facility, an applicable margin based on the consolidated total leverage of EWT III and its restricted subsidiaries, as calculated in accordance with the terms of the 2021 Credit Agreement, will be added to the interest rate elected by EWT III; provided that the interest rate may be adjusted if EWT III meets certain metrics for a sustainability price adjustment prior to December 31, 2021. In the case of the 2021 Term Loan, a fixed applicable margin, calculated in accordance with the terms of the 2021 Credit Agreement, will be added to the interest rate elected by EWT III.
On April 1, 2021, EWT III borrowed the full amount of $475,000 under the 2021 Term Loan and $105,000 under the 2021 Revolving Credit Facility. The 2021 Term Loan was issued at a discount of $2,375, which is recorded as a contra-liability to the carrying amount of debt issued, and is being amortized to interest expense using the effective interest method. The net proceeds of these borrowings under the Senior Facilities, together with the net proceeds of the Receivables Securitization Program (as defined below) and cash on hand, were used to repay all outstanding indebtedness, in an aggregate principal amount of approximately $814,538, under the 2014 Credit Agreement. The proceeds of the 2021 Revolving Credit Facility may also be used to finance or refinance the working capital and capital expenditures needs of EWT III and certain of its subsidiaries and for general corporate purposes.
The 2021 Term Loan matures on April 1, 2028 and requires quarterly principal payments of $1,188 starting in the fourth quarter of 2021. Subject to the terms of the 2021 Credit Agreement, to the extent not previously paid, any amount owed under the 2021 Revolving Credit Facility will become due and payable in full on April 1, 2026.
At June 30, 2021, the Company had (a) $475,000 outstanding under the 2021 Term Loan at an interest rate of 2.63%, comprised of 0.13% LIBOR plus the 2.50% spread, and (b) $95,000 outstanding under the 2021 Revolving Credit Facility at an interest rate of 2.38%, comprised of 0.13% LIBOR plus the 2.25% spread.
The following table summarizes the amount of the Company’s outstanding borrowings and outstanding letters of credit under the 2021 Revolving Credit Facility as of June 30, 2021, and under the 2014 Revolving Credit Facility as of September 30, 2020.
24


June 30,
2021
September 30,
2020
Borrowing availability$350,000 $125,000 
Outstanding borrowings95,000 
Outstanding letters of credit11,504 12,963 
Unused amounts$243,496 $112,037 
Additional letters of credit under a separate arrangement$$52 
Receivables Securitization Program
On April 1, 2021, Evoqua Finance LLC (“Evoqua Finance”), an indirect wholly-owned subsidiary of the Company, entered into an accounts receivable securitization program (the “Receivables Securitization Program”) consisting of, among other agreements, (i) a Receivables Financing Agreement (the “Receivables Financing Agreement”) among Evoqua Finance, as the borrower, the lenders from time to time party thereto (the “Receivables Financing Lenders”), PNC Bank, National Association (“PNC Bank”), as administrative agent, Evoqua Water Technologies LLC (“EWT LLC”), an indirect wholly-owned subsidiary of the Company, as initial servicer, and PNC Capital Markets LLC (“PNC Markets”), as structuring agent, pursuant to which the lenders have made available to Evoqua Finance a receivables finance facility (the “Securitization Facility”) in an amount up to $150,000 and (ii) a Sale and Contribution Agreement (the “Sale Agreement”) among Evoqua Finance, as purchaser, EWT LLC, as initial servicer and as an originator, and Neptune Benson, Inc., an indirectly wholly-owned subsidiary of the Company, as an originator (together with EWT LLC, the “Originators”). Under the Receivables Securitization Program, the Originators, pursuant to the Sale Agreement, are required to sell substantially all of their domestic trade receivables and certain related rights to payment and obligations of the Originators with respect to such receivables (the “Receivables”) to Evoqua Finance, which, in turn, will obtain loans secured by the Receivables from the Receivables Financing Lenders pursuant to the Receivables Financing Agreement. The Receivables underlying any borrowings will continue to be included in Accounts receivable, net, in the Consolidated Balance Sheets of the Company. On April 1, 2021, Evoqua Finance borrowed $142,200 under the Securitization Facility. During the third quarter of 2021, Evoqua Finance borrowed an additional amount under the Securitization Facility and had $148,151 outstanding at June 30, 2021 which includes $51 of accrued interest.
The Receivables Securitization Program contains certain customary representations, warranties, affirmative covenants, and negative covenants, subject to certain cure periods in some cases, including the eligibility of the Receivables being sold by the Originators and securing the loans made by the Receivables Financing Lenders, as well as customary reserve requirements, events of default, termination events, and servicer defaults. The Company was in compliance with all covenants during the three months ended June 30, 2021, does not anticipate becoming noncompliant during the year ending September 30, 2021, and therefore does not anticipate any additional repayments during the year ending September 30, 2021.
The Receivables Financing Lenders under the Receivables Securitization Program receive interest at LIBOR or LMIR as selected by Evoqua Finance. The Receivables Financing Agreement contains customary LIBOR benchmark replacement language. The interest rate on the Securitization Facility was 1.35% as of June 30, 2021, comprised of 0.10% LIBOR plus the 1.25% spread. The Receivables Securitization Program matures on April 1, 2024.
25


Equipment Financings
During the nine months ended June 30, 2021, the Company completed the following equipment financings:
Date EnteredDueInterest Rate at 6/30/2021Principal Amount
June 30, 2021June 30, 20283.85 %$1,348 
June 30, 2021
July 31, 2029(1)
4.75 %8,378 
June 30, 2021June 30, 20294.09 %1,653 
March 31, 2021March 31, 20283.85 %3,630 
March 31, 2021June 30, 20294.09 %2,559
December 31, 2020June 30, 20294.09 %3,899
December 30, 2020December 30, 20273.73 %3,905
$25,372 
(1)    Represents an advance received from the lender on a multiple draw term loan in which the Company is making interest only payments through August 1, 2022 based on a 1.00% LIBOR floor plus a 3.75% spread. The Company entered into an interest rate swap with an effective date of August 1, 2022 to mitigate risk associated with this variable rate equipment financing, see Note 12, “Derivative Financial Instruments” for further discussion.
Deferred Financing Fees and Discounts
Deferred financing fees and discounts related to the Company’s long-term debt were included as a contra liability to debt on the Consolidated Balance Sheets as follows:
June 30,
2021
September 30,
2020
Current portion of deferred financing fees and discounts (1)$(1,791)$(2,112)
Long-term portion of deferred financing fees and discounts (2)(10,426)(7,324)
Total deferred financing fees and discounts$(12,217)$(9,436)
(1)Included in Current portion of debt, net of deferred financing fees and discounts on the Consolidated Balance Sheets.
(2)Included in Long-term debt, net of deferred financing fees and discounts on the Consolidated Balance Sheets.
As a result of the refinancing on April 1, 2021, the Company wrote off approximately $1,333 of deferred financing fees related to the 2014 Term Loan. In addition, the Company incurred approximately $4,985 of fees, of which approximately $1,931 were recorded as deferred financing fees on the Consolidated Balance Sheets and approximately $3,054 were expensed. During the nine months ended June 30, 2021, the Company incurred approximately $822 of fees related to the Receivables Securitization Program and $467 of fees related to an equipment financing which were recorded as deferred financing fees on the Consolidated Balance Sheets.
Amortization of deferred financing fees and discounts included in interest expense were $437 and $277 for the three months ended June 30, 2021 and 2020, respectively and $1,481 and $1,213 for the nine months ended June 30, 2021 and 2020, respectively.
26


Repayment Schedule
Aggregate maturities of all long‑term debt, including current portion of long‑term debt and excluding finance lease obligations as of June 30, 2020,2021, are presented below:
Fiscal Year 
Remainder of 2020$3,638
202114,661
202214,915
202315,125
202415,051
Thereafter816,537
Total$879,927

Fiscal Year
Remainder of 2021$3,372 
202213,612 
202314,536 
2024161,158 
202514,579 
Thereafter594,604 
Total$801,861 
11.12. Derivative Financial Instruments
Interest Rate Risk Management
The Company is subject to market risk exposure arising from changes in interest rates on the senior secured credit facilities as well as variable rate equipment financings, which bear interest at rates that are indexed against LIBOR. The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to mitigate its exposure to rising interest rates.
To accomplish these objectives, on June 30, 2021, the Company entered into an interest rate swap duringwith an effective date of August 1, 2022 to mitigate risk associated with a variable rate equipment financing. The interest rate swap provides for a fixed rate of 5.25%, has a notional amount of $31,000 and a term of seven years. The interest rate swap has been designated as a cash flow hedge.
On May 22, 2020, the third quarter of fiscal 2020Company entered into an interest rate swap to mitigate risks associated with variable rate debt. The interest rate swap isbecame effective on June 30, 2020, has a term of five years to hedge the variability of interest payments on the first $500,000 of the Company’s senior secured debt and provides for a fixed ratefixes LIBOR on this portion of 0.5455%the senior secured debt at 0.55%. The interest rate swap has been designated as a cash flow hedge and unrealized gains or losses, net of income tax, are recorded as a component of AOCI on the Consolidated Balance Sheets. As interest payments are made, the realized gain or loss on the payments are recorded in Interest expense on the Unaudited Consolidated Statements of Operations.

In addition, in the third quarter of fiscal 2020, the Company terminated the interest rate cap it had entered effective November 28, 2018. The LIBOR interest rate cap covered a notional amount of $600,000 of the Company’s senior secured debt, was effective for a period of three years and had a strike rate of 3.5%. The premium paid for the interest rate cap was $2,235 and was being amortized to interest expense over its term of three years. As a result of the termination, this derivative was de-designated from hedge accounting and the Company wrote off the remaining unamortized premium of $1,118 to interest expense. No additional fees were incurred. At September 30, 2019, the unamortized premium was $1,614, of which $869 was included in Other non‑current assets and the remaining $745 was included in Prepaid and other current assets. The Company recorded $124 and $187 of premium amortization to interest expense during the three months ended June 30, 2020 and 2019, respectively, and $496 and $435 of premium amortization to interest expense during the nine months ended June 30, 2020 and 2019, respectively.hedge.
Foreign Currency Risk Management
The Company’s functional currency is the U.S. dollar. By operating internationally, the Company is subject to foreign currency risk from transactions denominated in currencies other than the U.S. dollar (“foreign currencies”). To mitigate cross-currency transaction risk, the Company analyzes significant exposures where it has receipts or payments in a currency other than the functional currency of its operations, and from time to time may strategically enter into short-term foreign currency forward contracts to lock in some or all of the cash flows associated with these transactions. The Company is also subject to currency translation risk associated with converting the foreign operations’ financial statements into U.S. dollars. The Company uses foreign currency derivative contracts in order to manage the effect of exchange fluctuations on forecasted sales and purchases that are denominated in foreign currencies. To mitigate the impact of foreign exchange rate risk, the Company entered into a series of forward contracts designated as cash flow hedges. As of June 30, 2020,2021, the notional amount of the forward contracts held to sell foreign currencies was $17,866.$7,392.
Commodity Price Risk Management
The Company is subject to changes in index pricing of platinum. To mitigate price risk of certain platinum purchase contracts, the Company has entered into a financially settled platinum swap designated as a cash flow hedge.
Credit Risk Management
The counterparties to the Company’s derivative contracts are highly-rated financial institutions. The Company regularly reviews the creditworthiness of its financial counterparties and fully expects the counterparties to perform
27


under their respective agreements. The Company is not subject to any obligations to post collateral under derivative instrument contracts. The Company records all derivative instruments on a gross basis in the Consolidated Balance Sheets. Accordingly, there are no offsetting amounts that net assets against liabilities.
Derivatives Designated as Cash Flow Hedges
The Company accounts for derivatives and hedging activities in accordance with ASC Topic No. 815, “DerivativesDerivatives and Hedging” (TopicHedging (“Topic No. 815)815”). As required by Topic No. 815, the Company records all derivatives on the balance sheet at fair value and adjusts to market on a quarterly basis. The Company’s interest rate cap isswaps are valued based on readily-observable market inputs, such as quotations on interest rates and LIBOR yield curves at the reporting date. The Company’s foreign currency forward contracts are valued based on quoted forward foreign exchange prices and spot rates at the reporting date. The Company’s platinum swap is valued using the LBMA Platinum Price PM Index at the reporting date.For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in AOCIAccumulated other comprehensive income (loss), net of tax (“AOCI”) until the hedged item affects earnings. The Company does not use derivative financial instruments for trading or speculative purposes.
The following represents the fair value recorded for derivatives designated as cash flow hedges for the periods presented:
Asset Derivatives
Balance Sheet LocationJune 30,
2021
September 30,
2020
Interest rate swapsPrepaid and other current assets$2,443 $
Foreign currency forward contractsPrepaid and other current assets48 133 
   Asset Derivatives
 Balance Sheet Location 
June 30, 2020
 September 30,
2019
Interest rate capPrepaid and other current assets $
 $19
Foreign currency forward contractsPrepaid and other current assets 278
 269

   Liability Derivative
 Balance Sheet Location 
June 30, 2020
 September 30,
2019
Interest rate swapAccrued expenses and other current liabilities $3,258
 $
Foreign currency forward contractsAccrued expenses and other current liabilities 411
 154

Liability Derivatives
Balance Sheet LocationJune 30,
2021
September 30,
2020
Interest rate swapsAccrued expenses and other current liabilities$376 $4,669 
Foreign currency forward contractsAccrued expenses and other current liabilities113 47 
Commodity swapsAccrued expenses and other current liabilities16 
The following represents the amount of (loss) gain recognized in AOCI (net of tax) during the periods presented:
 Three Months Ended
June 30,
 Nine Months Ended
June 30,
 2020 2019 2020 2019
Interest rate swap$(3,258) $
 $(3,258) $
Interest rate cap(20) (78) (19) 56
Foreign currency forward contracts10
 (173) (150) (487)

Three Months Ended
June 30,
Nine Months Ended
June 30,
2021202020212020
Interest rate swaps$(4,157)$(3,258)$5,111 $(3,258)
Interest rate cap(20)(19)
Foreign currency forward contracts67 10 (265)(150)
Commodity swaps(16)(16)
$(4,106)$(3,268)$4,830 $(3,427)
The following represents the amount of (loss) gain on foreign currency forward contracts(loss) reclassified from AOCI into earnings during the periods presented:
  Three Months Ended
June 30,
 Nine Months Ended
June 30,
Location of (Loss) Gain 2020 2019 2020 2019
Cost of product sales and services $(2) $(4) $(8) $(130)
General and administrative expense 48
 
 78
 1
Selling and marketing expense 
 
 28
 
Research and development expense 
 (86) 
 (87)
  $46
 $(90) $98
 $(216)
28


Three Months Ended
June 30,
Nine Months Ended
June 30,
Location of (Loss) Gain2021202020212020
Cost of product sales and services$$(2)$(4)$(8)
General and administrative expense48 (72)$78 
Selling and marketing expense(39)28 
Interest expense(591)(1,624)
$(582)$46 $(1,739)$98 
Based on the fair value amounts of the Company’s cash flow hedges at June 30, 2020,2021, the Company expects that approximately $187$56 of pre-tax net losses will be reclassified from AOCI into earnings during the next twelve months. The amount ultimately realized, however, will differ as exchange rates vary and the underlying contracts settle.
Derivatives Not Designated as Cash Flow Hedges
The following represents the fair value recorded for derivatives not designated as cash flow hedges for the periods presented:
   Asset Derivatives
 Balance Sheet Location 
June 30, 2020
 September 30,
2019
Foreign currency forward contractsPrepaid and other current assets $27
 $9

Asset Derivatives
Balance Sheet LocationJune 30,
2021
September 30,
2020
Foreign currency forward contractsPrepaid and other current assets$11 $
Liability Derivatives
Balance Sheet LocationJune 30,
2021
September 30,
2020
Foreign currency forward contractsAccrued expenses and other current liabilities$$
12.13. Product Warranties
The Company accrues warranty obligations associated with certain products as revenue is recognized. Provisions for the warranty obligations are based upon historical experience of costs incurred for such obligations, adjusted for site‑specific risk factors, and, as necessary, for current conditions and factors. There are significant uncertainties and judgments involved in estimating warranty obligations, including changing product designs, differences in customer installation processes and future claims experience which may vary from historical claims experience.

A reconciliation of the activity related to the accrued warranty, including both the current and long‑term portions, is as follows:
 Current Product Warranties Non-Current Product Warranties
 Nine Months Ended
June 30,
 Nine Months Ended
June 30,
 2020 2019 2020 2019
Balance at beginning of the period$4,922
 $8,907
 $2,332
 $3,360
Warranty provision for sales2,496
 4,134
 481
 1,148
Settlement of warranty claims(3,243) (4,896) (1,298) (509)
Amounts related to sale of the Memcor product line795
 
 136
 
Foreign currency translation and other276
 119
 (51) (258)
Balance at end of the period$5,246
 $8,264
 $1,600
 $3,741

Current Product WarrantiesNon-Current Product Warranties
Nine Months Ended
June 30,
Nine Months Ended
June 30,
2021202020212020
Balance at beginning of the period$6,115 $4,922 $1,724 $2,332 
Warranty provision for sales5,680 2,496 1,577 481 
Settlement of warranty claims(3,826)(3,243)(701)(1,298)
Amounts related to sale of the Memcor product line795 136 
Foreign currency translation and other94 276 29 (51)
Balance at end of the period$8,063 $5,246 $2,629 $1,600 
13.14. Restructuring and Related Charges
To better align its resources with its growth strategies and reduce theits cost structure, the Company commits to various restructuring plans as necessary.

On October 30, 2018, the Company announced a transition from a 3-segment structure to a 2-segment operating model designed to better serve the needs of customers worldwide. This new structure was effective October 1, 2018 and combined the Municipal services business with the former Industrial segment into a new segment, Integrated Solutions and Services, a group entirely focused on engaging directly with end users. The former Products segment and Municipal products businesses have been combined into a new segment, Applied Product Technologies, which is focused on developing product platforms to be sold primarily through third-party channels. The Company expects to incur up to $1,500 of expense during the final phase of this transition.
Beginning in the second quarter of fiscal 2020, the Company undertookhas undertaken various restructuring initiatives, including undertaking activities to reduce the cost structure and rationalize location footprint following the sale of the Memcor product line, transitioning from a 3-segment structure to a 2-segment operating model designed to better serve the
29


needs of customers worldwide, and various initiatives within the Integrated Solutions and Services segment to drive efficiency and effectiveness in certain divisions.
The Company currently expects to incur approximately $1,300 to $2,300 of costs through the remainder of fiscal 2021 related to restructuring charges following the sale of the Memcor product line. The Company currently expects to incur approximately $3,000$200 to $5,000$400 of additionalcash costs related to these initiatives through the remainder of fiscal 2020 and is2021 as a result of its transition to a two-segment operating model related to other non-employee related business optimizations. The Company currently evaluating additional actions that could extendexpects to incur approximately $1,000 to $1,400 of costs through the remainder of fiscal 2021 related to the following fiscal year.restructuring within certain divisions of the Integrated Solutions and Services segment.
The table below sets forth the amounts accrued for the restructuring components and related activity:
 Nine Months Ended
June 30,
 2020 2019
Balance at beginning of the period$655
 $710
Restructuring charges following the sale of the Memcor product line4,758
 
Restructuring charges related to two-segment realignment1,866
 9,274
Restructuring charges related to other initiatives1,141
 2,086
Write off charge and other non‑cash activity(62) (520)
Cash payments(7,314)
 (9,830)
Other adjustments
 (76)
Balance at end of the period$1,044
 $1,644

Nine Months Ended
June 30,
20212020
Balance at beginning of the period$970 $655 
Restructuring charges following the sale of the Memcor product line4,6494,758 
Restructuring charges related to two-segment realignment8301,866 
Restructuring charges related to other initiatives1,8561,141
Release of prior reserves(296)(62)
Write off charges(966)
Cash payments(6,349)(7,314)
Other adjustments0
Balance at end of the period$702 $1,044 
The balances for accrued restructuring liabilities at June 30, 20202021 and September 30, 2019,2020, are recorded in Accrued expenses and other liabilities on the Consolidated Balance Sheets. Restructuring charges primarily represent severance charges and other employee costs, fixed asset write-offs and certain non-cash charges and consulting fees.relocation expenses. The Company expects to pay the remaining amounts accrued as of June 30, 20202021 during the remainder of fiscal 2020.

2021.
The table below sets forth the location of amounts recorded above on the Unaudited Consolidated Statements of Operations:
 Nine Months Ended
June 30,
 2020 2019
Cost of product sales and services$5,198
 $4,912
General and administrative expense2,310
 4,929
Sales and marketing expense173
 891
Research and development expense22
 108

$7,703
 $10,840

Nine Months Ended
June 30,
20212020
Cost of product sales and services$4,341 $5,198 
General and administrative expense1,675 2,310 
Sales and marketing expense348 173 
Research and development expense(15)22 
Other operating expense, net690 
$7,039 $7,703 
The Company continues to evaluate restructuring activities that may result in additional charges in the future.
14.15. Employee Benefit Plans
The Company maintains multiple employee benefit plans.
Certain of the Company’s employees in the UK were participants in a Siemens defined benefit plan established for employees of a UK-based operation acquired by Siemens in 2004. The plan was frozen with respect to future service credits for active employees, however the benefit formula recognized future compensation increases. The Company
30


agreed to establish a replacement defined benefit plan, with the assets of the Siemens scheme transferring to the new scheme on April 1, 2015.
The Company’s employees in Germany also participate in a defined benefit plan. Assets equaling the plan’s accumulated benefit obligation were transferred to a German defined benefit plan sponsored by the Company upon the acquisition of EWT from Siemens. The German entity also sponsors a defined benefit plan for a small group of employees located in France.
The components of net periodic benefit cost for the plans were as follows:
 Three Months Ended
June 30,
 Nine Months Ended
June 30,
 2020 2019 2020 2019
Service cost$259
 $214
 $779
 $648
Interest cost67
 118
 203
 357
Expected return on plan assets(30) (30) (89) (90)
Amortization of actuarial losses235
 95
 706
 288
Pension expense for defined benefit plans$531
 $397
 $1,599
 $1,203

Three Months Ended
June 30,
Nine Months Ended
June 30,
2021202020212020
Service cost$287 $259 $858 $779 
Interest cost81 67 240 203 
Expected return on plan assets(88)(30)(262)(89)
Amortization of actuarial losses266 235 640 706 
Pension expense for defined benefit plans$546 $531 $1,476 $1,599 
The components of pension expense, other than the service cost component which is included in General and administrative expense, are included in the line item Other operating expense in the Unaudited Consolidated Statements of Operations.
15.16. Income Taxes
The income tax provision for interim periods is comprised of tax on ordinary income (loss) provided at the most recent projected annual effective tax rate (“PAETR”), adjusted for the tax effect of discrete items. Management estimates the PAETR each quarter based on the forecasted annual pretax income or (loss). The Company is required to reduce deferred tax assets by a valuation allowance if, based on all available evidence, it is considered more likely than not that some portion or all of the benefit of the deferred tax assets will not be realized in future periods. The Company also records the income tax impact of certain discrete, unusual or infrequently occurring items including changes in judgment about valuation allowances and effects of changes in tax laws or rates, in the interim period in which they occur.

When a company maintains a valuation allowance in a particular jurisdiction, no net deferred income tax expense or (benefit) will typically be provided. Jurisdictions with projected income that maintain a valuation allowance typically will form part of the PAETR calculation discussed above. However, jurisdictions with a projected loss for the year that maintain a valuation allowance are excluded from the PAETR calculation. Instead, the income tax for these jurisdictions is computed separately.
The actual year-to-date income tax expense (benefit) is the product of the most current PAETR and the actual year-to-date pretax income (loss) adjusted for any discrete tax items. The income tax expense (benefit) for a particular quarter, except for the first quarter, is the difference between the year-to-date calculation of income tax expense (benefit) and the year-to-date calculation for the prior quarter. Items unrelated to current period ordinary income or (loss) are recognized entirely in the period identified as a discrete item of tax. Discrete items generally relate to changes in tax laws, adjustments to prior period’s actual liability determined upon filing tax returns, and adjustments to previously recorded reserves for uncertain tax positions, initially recording or fully reversing valuation allowances. The inclusion of discrete items in a particular quarter can cause the actual effective rate for that quarter to vary significantly from the PAETR.
Therefore, the actual effective income tax rate for a particular quarter can vary significantly based upon the jurisdictional mix and timing of actual earnings compared to projected annual earnings, permanent items, earnings for those jurisdictions that maintain a valuation allowance, tax associated with jurisdictions excluded from the PAETR calculation and discrete items.
31


Annual Effective Tax Rate
The updated PAETR, which excludes the impact of discrete items, was 3.9%19.7% and 38.9%3.9% as of the nine months ended June 30, 20202021 and 2019,2020, respectively. For the nine months ended June 30, 2020,2021, the PAETR of 3.9% was lower than the U.SU.S. federal statutory rate of 21.0% primarily due to the gainimpact of maintaining a U.S. valuation allowance that is provided on U.S. deferred tax assets offset by changes in the mix of earnings between countries, some of which have higher statutory rates, and it is higher than the prior year’s rate which included the impact of the sale of the Memcor product line the U.S. valuation allowance provided on U.S. deferred tax assets as well asand the impact ofon deferred tax liabilities related to indefinite lived intangibles, a portion of which werewas reversed in relation to the sale of the Memcor product line.
The Company continues to maintain a full valuation allowance on U.S. federal and state net deferred tax assets (excluding the tax effects of deferred tax liabilities associated with indefinite lived intangibles) for the yearperiod ending SeptemberJune 30, 20202021 as a result of pretax losses incurred since the Company’s inception in early 2014. The Company reported positive U.S. pre-tax earnings for the first time in 2017 and again in 2020 and is projecting positive pre-tax earnings in 2020,2021, however, the Company generated pre-tax losses in all other years andyears. The Company was in a three-year cumulative loss position at September 30, 2019.2019, but was no longer in a three-year cumulative loss position at September 30, 2020. The Company believes it is prudent to retain a valuation allowance until a more consistent pattern of earnings is established and net operating loss carryforwards begin to be utilized.
PriorCurrent and CurrentPrior Period Tax Expense
For the three months ended June 30, 2021, the Company recognized income tax expense of $3,887 on pretax income of $17,086. The rate of 22.7% differed from the U.S. statutory rate of 21.0% principally due to the impact of higher earnings in non-U.S. tax jurisdictions, some with higher statutory rates, which increases overall tax expense, and lower earnings in the U.S., which does not impact tax expense due to the U.S. valuation allowance.
For the three months ended June 30, 2020, the Company recognized income tax expense of $740 on pretax income of $22,581. The rate of 3.3% differed from the U.S. statutory rate of 21%21.0% principally due to the favorable impact to the PAETR of the gain on the sale of the Memcor product line which did not generate significant tax expense due to the combination of the U.S. valuation allowance and favorable foreign tax regimes, as well as the favorable impact of the reversal of a portion of deferred tax liabilities related to indefinite lived intangibles.
For the threenine months ended June 30, 2019,2021, the Company recognized income tax expense of $7,959$7,672 on a pretax income of $12,249.$32,430. The rate of 65%23.7% differed from the U.S. statutory rate of 21%21.0% principally due to the unfavorable impact of discrete items related to an adjustment for prior periods and recording an uncertain tax position related to a tax audit in a foreign jurisdiction, as well as the impact of higher earnings in non-U.S. tax jurisdictions, which increases overall tax expense, and lower forecasted earnings in the U.S., which does not impact tax expense due to restructuring initiatives for which no tax benefit will be realized, the impact of deferred tax liabilities related to indefinite lived intangibles as well as discrete items during the period related to the adjustment process for the difference between actual tax results per tax returns filed versus those expected from the prior year tax provision.U.S. valuation allowance.
For the nine months ended June 30, 2020, the Company recognized income tax expense of $3,336 on pretax income of $86,593. The rate of 3.9% differed from the statutory rate of 21%21.0% principally due to the gain on the sale of the Memcor product line, which did not generate significant tax expense due to the combination of the U.S. valuation allowance and favorable foreign tax regimes, as well as the favorable impact of the reversal of a portion of deferred tax liabilities related to indefinite lived intangibles.


For the nine months endedAt June 30, 2019, the Company recognized an income tax benefit of $1,134 on a pretax loss of $11,559. The rate of 9.8% differed from the statutory rate of 21% principally due to the benefit on an overall year-to-date loss offset by higher forecasted earnings in certain non-U.S. jurisdictions that have a higher statutory tax rate than the U.S. as well as the impact of deferred tax liabilities related to indefinite lived intangibles.

At June 30,2021 and 2020, the Company had gross unrecognized tax benefits of $1,313.$1,805 and $1,313 respectively.
On March 27, 2020, The Coronavirus Aid, Relief, and Economic Security (CARES) Act (the “CARES Act”) was passed in response to the COVID-19 pandemic. Provisions of the CARES Act adjust elements of the Tax Cuts and Jobs Act (“TCJA”), including net operating loss (“NOL”) modifications, a relaxation of the limitation on interest deductions, and modification of the credits for prior year minimum tax liability.
The CARES Act accelerates the ability of companies to recover the alternative minimum tax (“AMT”) credits by permitting immediate refund claims.
The TCJA subjected net operating losses arising in tax years beginning after December 31, 2017 to a taxable income limitation and eliminated the ability to carry these net operating losses back to a prior tax year. The CARES Act modified these rules and provides that NOLs arising in a tax year beginning after December 31, 2017 and ending before January 1, 2021 can be carried back five years. Additionally, the taxable income limitation is temporarily suspended for tax years beginning before January 1, 2021.
The TCJA limited the business interest expense deduction to 30% of adjusted taxable income (“ATI”) starting with the 2018 tax years. The CARES Act modified the TCJA limitations for business interest expense for 2019 and 2020 by increasing the limitation to 50% of ATI. Further, for the tax year 2020, the Company may use either the 2019 or 2020 ATI for purposes of determining deductible business interest expense.
The CARES Act did not have an impact on the Company’s Unaudited Consolidated Financial Statements.
16.17. Share-Based Compensation
The Company designs equity compensation plans to attract and retain employees while also aligning employees’ interests with the interests of the Company’s shareholders. In addition, members of the Company’s Board of Directors (the “Board”) participate in equity compensation plans in connection with their service on the Company’s Board.

The Company established the Evoqua Water Technologies Corp. Stock Option Plan (the “Stock Option Plan”) shortly after the acquisition date of January 16, 2014. The plan allows certain management employees and the Board to purchase shares in Evoqua Water Technologies Corp.the Company. Under the Stock Option Plan, the number of shares available for award was 11,083.
32


As of June 30, 2020,2021, there were approximately 1,7042,177 shares available for future grants, however, the Company does not currently intend to make additional grants under the Stock Option Plan.    
In connection with the IPO, the Board adopted, and the Company’s shareholders approved, the Evoqua Water Technologies Corp. 2017 Equity Incentive Plan (or the(the “Equity Incentive Plan”), under which equity awards may be granted in the form of options, restricted stock, restricted stock units, stock appreciation rights, dividend equivalent rights, share awards and performance-based awards (including performance share units and performance-based restricted stock). Upon adoption of the Equity Incentive Plan, 5,100 shares of common stock of the Company were reserved for issuance thereunder. On February 18, 2020, the Company’s shareholders approved the amendment and restatement of the Equity Incentive Plan in order to increase the number of shares of common stock reserved for issuance thereunder by 5,000 shares and incorporate other changes.

On May 18, 2021 (the “Grant Date”), the Compensation Committee of the Board approved and the Company granted special one-time awards of 234 restricted stock units (“Special RSUs”) and 469 performance share units (“Special PSUs”) under the Equity Incentive Plan to certain executive officers of the Company. Subject to the applicable executive officer’s continued employment with the Company and the terms and conditions of the Equity Incentive Plan and the related award agreement, the Special RSUs will vest ratably over a three-year period on each annual anniversary of the Grant Date, and the Special PSUs will be earned incrementally in three tranches of 25%, 25%, and 50% after one-, two-, and three-year performance periods, respectively, and will cumulatively be paid, if earned, after the end of the three-year performance period ending on May 18, 2024, based on the Company’s total stockholder return (“TSR”) compared to peer water companies, including certain U.S.-listed companies included in the S&P Global Water Index (the “Peer Companies”). Each tranche of the Special PSUs reflects the right to receive between 50% and 100% of the shares underlying such tranche based on the Company’s TSR as compared to the Peer Companies (“Relative TSR”) for the applicable performance period. Subject to certain exceptions provided in the award agreements in the event of death, disability, or change in control, for each tranche, Special PSUs will be earned as follows: 100% if Relative TSR for the period is at the 80th percentile or above; 50% if Relative TSR for the period is at the 60th percentile; and 0% if Relative TSR is below the 60th percentile. Linear interpolation will be used to determine the percentage of each tranche earned when Relative TSR is between the 60th percentile and the 80th percentile for the applicable performance period. The payout for each tranche of the Special PSUs is capped at 100% even if Relative TSR exceeds the 80th percentile for the applicable period. If the Company’s TSR is negative for any performance period, the number of Special PSUs that may vest for the corresponding tranche will be capped at 50% of the amount that otherwise would have been earned for the period.

As of June 30, 2020,2021, there were approximately 5,9634,336 shares available for grants under the Equity Incentive Plan.

In addition to the establishment of the Equity Incentive Plan, in connection with the IPO, the Company entered into restricted stock unit (“RSU”) agreements with each of the executive officers and certain other key members of management. Pursuant to the RSU agreements, 1,197 stock-settled RSUs were granted, the aggregate value of which equals $25,000. The RSUs vested and settled in full upon the second anniversary of the IPO on November 2, 2019, resulting in the issuance of 1,159 shares, 419 of which were deposited into treasury in satisfaction of withholding tax obligations resulting from the vesting of the RSUs.


Option awards are granted at various times during the year, vest ratably at 25% per year, and are exercisable at the time of vesting. The options granted have a ten-year contractual term of ten years.term.

33


A summary of the stock option activity as of June 30, 20202021 is presented below:
(In thousands, except per share amounts)Options Weighted Average Exercise Price/Share Weighted Average Remaining Contractual Term Aggregate Intrinsic Value
Outstanding at September 30, 20198,619
 $8.15
 6.3 years $80,826
Granted800
 23.52
   

Exercised(1,711) 5.61
   

Cancelled(5) 20.50
    
Forfeited(106) 15.05
   

Outstanding at June 30, 20207,597
 $10.24
 6.2 years $69,871
Options exercisable at June 30, 20205,294
 $6.92
 5.1 years $63,047
Options vested and expected to vest at June 30, 20207,521
 $10.13
 6.2 years $69,763


(In thousands, except per share amounts)OptionsWeighted Average Exercise Price/ShareWeighted Average Remaining Contractual TermAggregate Intrinsic Value
Outstanding at September 30, 20207,430 $10.30 5.9 years$83,152 
Granted611 24.76 
Exercised(2,548)6.50 
Forfeited(42)20.70 
Outstanding at June 30, 20215,450 $13.61 6.1 years$109,936 
Options exercisable at June 30, 20213,505 $9.66 4.9 years$84,548 
Options vested and expected to vest at June 30, 20215,388 $13.50 6.1 years$109,276 
The total intrinsic value of options exercised (which is the amount by which the stock price exceeded the exercise price of the options on the date of exercise) during the nine months ended June 30, 20202021 was $26,051.$51,448.
    
A summary of the status of the Company's non-vested stock options as of and for the nine months ended June 30, 20202021 is presented below.
(In thousands, except per share amounts)Shares Weighted Average Grant Date Fair Value/Share
Nonvested at beginning of period2,379
 $4.96
Granted800
 6.06
Vested(770) 4.77
Forfeited(106) 4.97
Nonvested at end of period2,303
 $5.40

(In thousands, except per share amounts)SharesWeighted Average Grant Date Fair Value/Share
Nonvested at beginning of period2,166 $5.56 
Granted611 8.98 
Vested(790)5.53 
Forfeited(42)6.73 
Nonvested at end of period1,945 $6.62 
The total fair value of options vested during the nine months ended June 30, 2020,2021, was $3,673.$4,371.
34



Restricted Stock Units
The following is a summary of the RSU activity for the nine months ended June 30, 2020.2021.
(In thousands, except per share amounts)SharesWeighted Average Grant Date Fair Value/Share
Outstanding at September 30, 2020750 $17.86 
Granted729 25.94 
Vested(239)17.55 
Forfeited(23)20.38 
Cancelled(7)21.22 
Outstanding at June 30, 20211,210 $22.72 
Expected to vest at June 30, 20211,147 $22.57 
(In thousands, except per share amounts)Shares Weighted Average Grant Date Fair Value/Share
Outstanding at September 30, 20192,002
 $17.45
Granted386
 23.10
Vested(1,554) 18.80
Forfeited(51) 14.09
Outstanding at June 30, 2020783
 $17.77
Vested and expected to vest at June 30, 2020749
 $17.64
The following is a summary of the Special PSU activity for the nine months ended June 30, 2021.

(In thousands, except per share amounts)SharesWeighted Average Grant Date Fair Value/Share
Granted469 $16.92 
Nonvested at end of period469 $16.92 
Expected to vest422 $16.92 
Expense Measurement and Recognition
The Company recognizes share-based compensation for all currently outstanding awards and, in future periods, will recognize compensation costs for the unvested portion of awards based on grant date fair values. Total share-based compensation expense was $2,542$5,526 and $4,985$2,542 during the three months ended June 30, 20202021 and 2019,2020, respectively, of which $2,520$4,228 and $4,978$2,520 was non-cash, respectively. Total share-based compensation expense was $8,559$11,816 and $14,308$8,559 during the nine months ended June 30, 20202021 and 2019,2020, respectively, of which $8,504$10,461 and $14,248$8,504 was non-cash, respectively. The unrecognized compensation expense related to stock options, RSUs, and restricted stock unitsSpecial PSUs was $10,140$10,309, $22,934 and $11,972,$7,611, respectively at June 30, 2020,2021, and is expected to be recognized over a weighted average period of 2.3 years, 2.4 years and 2.9 years, respectively. The Company received $17,949$18,096 from the exercise of stock options during the nine months ended June 30, 2020. The remaining stock options exercised during the nine months ended June 30, 2020 were effected via a cashless net exercise.2021.

Employee Stock Purchase Plan    
Effective October 1, 2018, the Company implemented an employee stock purchase plan (“ESPP”(the “ESPP”) which allows employees to purchase shares of the Company’s stock at 85% of the lower of the fair market value on the first day of the applicable offering period or on the last business day of a six-monthsix-month purchase period within the offering period. These purchases are offered twice throughout each fiscal year, and wereare paid by employees through payroll deductions over the respective six month purchase period, at the end of which point the stock will beis transferred to the employees. On December 21, 2018, the Company registered 11,297 shares of common stock, par value $0.01 per share, of which 5,000 are available for future issuance under the ESPP. During the ninethree months ended June 30, 20202021 and 2019,2020, the Company incurred compensation expense of $227$249 and $293,$153, respectively, in salaries and wages inwith respect ofto the ESPP, representing the fair value of the discounted price of the shares. During the nine months ended June 30, 2021 and 2020, the Company incurred compensation expense of $652 and $227, respectively. These amounts are included in the total share-based compensation expense above. On October 1, 20192, 2020 and April 1, 2020, 562021, 120 and 7162 shares, respectively, were issued under the ESPP plan.ESPP.
17.18. Concentration of Credit Risk
The Company’s cash and cash equivalents and accounts receivable are potentially subject to concentration of credit risk. Cash and cash equivalents are placed with financial institutions that management believes are of high credit quality. Accounts receivable are derived from revenue earned from customers located in the U.S. and internationally and
35


generally do not require collateral. The Company’s trade receivables do not represent a significant concentration of credit risk at June 30, 20202021 and September 30, 20192020 due to the wide variety of customers and markets into which products are sold and their dispersion across geographic areas. The Company does perform ongoing credit evaluations of its customers and maintains an allowance for potential credit losses on trade receivables. As of and for the three and nine months ended June 30, 20202021 and 2019,2020, no customer accounted for more than 10% of net sales or net accounts receivable.
The Company operates predominantly in 10 countries worldwide and provides a wide range of proven product brands and advanced water and wastewater treatment technologies, mobile and emergency water supply solutions, and service contract options through its Integrated Solutions and Services and Applied Product Technologies segments. The Company is a multi-national business but its sales and operations are primarily in the U.S. Sales to unaffiliated customers are based on the Company locations that maintain the customer relationship and transactstransact the external sale.

18. Related‑Party Transactions
The Company reimbursed AEA Investors LP (“AEA”), the Company’s private equity sponsor, for normal and customary expenses incurred by AEA on behalf of the Company. The Company notes that these related-party transactions have not been significant in the three and nine months ended June 30, 2020 and 2019.
19. Leases
Lessee Accounting
As discussed in Note 2, “Summary of Significant Accounting Policies” the Company adopted ASU 2016-02 on October 1, 2019. ASU 2016-02 requires a lessee to recognize assets and liabilities on the balance sheet for all leases, with the result being the recognition of a right-of-use (“ROU”) asset and a corresponding lease liability. The lease liability is equal to the present value of the minimum lease payments for the term of the lease using the discount rate determined at lease commencement and including any optional renewal periods that were determined to be reasonably certain to be exercised. The ROU asset is equal to the initial measurement of the lease liability plus any lease payments made to the lessor at or before the commencement date and any unamortized initial indirect costs incurred by the lessee, less any unamortized lease incentives received. ROU assets are periodically reviewed for impairment whenever events or changes in circumstances arise. During the nine months ended June 30, 2020, the Company incurred no impairment charges on ROU assets.
The discount rate utilized in calculating the lease liability is the rate implicit in the lease, if known, otherwise, the incremental borrowing rate (“IBR”) for the expected lease term is used. Generally, the Company cannot determine the interest rate implicit in the lease. The Company’s IBR approximates the rate the Company would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms.
The Company occupies certain facilities and operates certain equipment and vehicles under non‑cancelable lease arrangements. Lease agreements may contain lease escalation clauses and purchase and renewal options. At the inception of a contract, the Company determines whether the arrangement is or contains a lease. A lease is determined to exist if there is an identified asset, the Company has the right to obtain substantially all of the economic benefits from the use of the identified asset and the right to direct the use of the asset. Once a lease is determined to exist, the Company determines the lease classification at lease commencement. Leases are classified as operating or finance leases based on specific criteria. Operating lease expense is recognized on a straight-line basis on the Unaudited Consolidated Statements of Operations. Finance lease expense have front-loaded expense recognition that is recognized as depreciation expense and interest expense on the Unaudited Consolidated Statements of Operations. On the Consolidated Statements of Changes in Cash Flows, payments for operating leases are included in operating activities and payments for finance leases are included in financing activity, with the interest component included in operating activities.
The Company’s real estate leases often include options to extend the lease term; however, the Company has not included the renewal options in the ROU asset and lease liability because the likelihood of renewal was not reasonably certain. In addition, the Company has leases that include variable lease payments, for items such as maintenance or other operating expenses, which are expensed as incurred as variable lease expense.
Adoption of ASU 2016-02, Leases (Topic 842)
The Company applied Topic 842 to all existing leases at October 1, 2019 using the modified retrospective approach. As a result, prior period amounts have not been adjusted and continue to be reported in accordance with the Company’s historical accounting under Topic 840. The Company has elected the following package of practical expedients which exempts the Company from having to reassess: (i) whether expired or existing contracts contain a lease, (ii) the lease classification for expired or existing leases, and (iii) initial direct costs for existing leases. In addition, the Company elected to separate lease and non-lease components for all asset classes, did not elect to use hindsight to determine the lease term and made an accounting policy election for short-term leases which does not require the capitalization of leases with terms of 12 months or less.

As a result of adoption of Topic 842 on October 1, 2019, the Company recognized $42,073 of ROU assets related to operating leases in Operating lease right-of-use assets, net and $42,904 of corresponding lease liabilities, of which $13,596 is included in Accrued expenses and other liabilities and $29,308 is included in Obligation under operating leases on the Consolidated Balance Sheets. The difference is attributable to deferred rent balance as of September 30, 2019 that reduced the ROU asset balance on October 1, 2019, of which $73 was removed from Prepaid and other current assets and the remainder was recognized in Retained deficit on the Consolidated Balance Sheets. In addition, the Company recorded an ROU asset related to finance leases in Property, plant, and equipment, net of $2,812 and $3,245 in corresponding lease liabilities included in Other non‑current liabilities on the Consolidated Balance Sheets, with the difference recognized in Retained deficit. See Note 2, “Summary of Significant Accounting Policies” for further information on the impact of adoption.
The following represents the components of lease cost for the three and nine months ended June 30, 2020 and other information for both operating and finance leases for the nine months ended June 30, 2020:
 Three Months Ended
June 30, 2020
 Nine Months Ended
June 30, 2020
Lease cost   
Finance lease cost:   
Amortization of ROU assets$3,359
 $10,190
Interest on lease liabilities490
 1,501
Operating lease cost3,944
 12,075
Short-term lease cost2,774
 4,690
Variable lease cost
 
Sublease income(14) (42)
Total lease cost$10,553
 $28,414
Other information 
(Gains)/losses on sale and leaseback transactions, net$
Cash paid for amounts included in the measurement of lease liabilities 
Operating cash flows from finance leases$1,504
Operating cash flows from operating leases12,003
Financing cash flows from finance leases9,991
ROU assets obtained in exchange for new finance lease liabilities8,411
ROU assets obtained in exchange for new operating lease liabilities5,668
ROU asset remeasurement125
Weighted average remaining lease term - finance leases3.9 years
Weighted average remaining lease term - operating leases5.0 years
Weighted average discount rate - finance leases4.7%
Weighted average discount rate - operating leases4.5%

The following table reconciles future minimum undiscounted rental commitments for operating leases to operating lease liabilities record on the Consolidated Balance Sheet as of June 30, 2020:
Fiscal Year 
Remainder of 2020$3,886
202113,455
20229,763
20237,481
20245,288
Thereafter9,938
Total undiscounted lease payments$49,811
Present value adjustment(5,810)
Operating lease liabilities44,001
Less current installments of obligations under operating leases12,993
Obligations under operating leases, excluding current installments$31,008


The gross and net carrying values of the equipment under finance leases as of June 30, 2020 and September 30, 2019 was as follows:
 June 30,
2020
 September 30,
2019
Gross carrying amount$84,151
 $69,760
Net carrying amount36,194
 36,337

The following table reconciles future minimum undiscounted rental commitments for finance leases to the finance lease liabilities recorded on the Consolidated Balance Sheet as of June 30, 2020:
Fiscal Year 
Remainder of 2020$3,582
202112,222
20229,770
20237,187
20244,874
Thereafter3,449
Total undiscounted lease payments41,084
Present value adjustment(3,776)
Finance lease liabilities37,308
Less current installments of obligations under finance leases11,456
Obligations under finance leases, excluding current installments$25,852

The current installments of obligations under finance leases are included in Accrued expenses and other liabilities. Obligations under finance leases, excluding current installments, are included in Other non-current liabilities.
Lessor Accounting
The Company is a lessor to multiple parties. In certain instances, the Company enters into a contract with a customer but must construct the underlying asset prior to its lease. At the time of contract inception, the Company determines if an arrangement is or contains a lease. These contracts generally contain both lease and non-lease components, including installation, maintenance and monitoring services of the Company owned equipment, in addition to sale of certain constructed assets. In situations where arrangements contain multiple elements, contract consideration is allocated based on relative standalone selling price. Lease components associated to underlying assets that have an alternative use are classified as

operating leases with revenue recognized over time throughout the lease term, within Revenue from services on the Unaudited Consolidated Statements of Operations. Lease components associated to underlying assets that have no alternative use are classified as sales-type leases, with point in time revenue recognition at the on-set of the lease. In order for a component to be separate, the Customer would be able to benefit from the right of use of the component separately or with other resources readily available to the Customer and the right of the use is not highly dependent or highly interrelated with the other rights to use the other underlying assets or components.
As of June 30, 2020, future minimum lease payments receivable under operating leases are as follows:
Fiscal year 
Remainder of 2020$41,173
202178,159
202248,401
202335,193
202424,133
Thereafter91,454
Future minimum lease payments$318,513

20. Commitments and Contingencies
Guarantees
From time to time, the Company is required to provide letters of credit, bank guarantees, or surety bonds in support of its commitments and as part of the terms and conditions on water treatment projects.  In addition, the Company is required to provide letters of credit or surety bonds to the Department of Environmental Protection or equivalent in some states in order to maintain its licenses to handle toxic substances at certain of its water treatment facilities.
These financial instruments typically expire after all Company commitments have been met, a period typically ranging from twelve months to ten years, or more in some circumstances.  The letters of credit, bank guarantees, or surety bonds are arranged through major banks or insurance companies. In the case of surety bonds, the Company generally indemnifies the issuer for all costs incurred if a claim is made against the bond. 
The following summarizes the Company’s outstanding letters of credit and surety bonds as of June 30, 20202021 and September 30, 2019,2020, respectively.
 June 30,
2020
 September 30,
2019
Revolving credit capacity$45,000
 $45,000
Letters of credit outstanding11,872
 12,956
Remaining revolving credit capacity$33,128
 $32,044
    
Surety capacity$230,000
 $220,000
Surety issuances148,108
 144,717
Remaining surety available$81,892
 $75,283


June 30,
2021
September 30,
2020
Revolving credit capacity$60,000 $45,000 
Letters of credit outstanding11,504 12,963 
Remaining revolving credit capacity$48,496 $32,037 
Surety capacity$250,000 $230,000 
Surety issuances141,837 152,990 
Remaining surety available$108,163 $77,010 
The longest maturity date of letters of credit and surety bonds in effect as of June 30, 20202021 was March 20, 2030.
Litigation
From time to time, the Company is subject to various claims, charges and litigation matters that arise in the ordinary course of business. The Company believes these actions areas a normal incident of the nature and kind of business in which the Company is engaged.engaged, various claims or charges are asserted and litigation is commenced against it arising from or related to: product liability; personal injury; trademarks, trade secrets, or other intellectual property; shareholder disputes; labor and employee disputes; commercial or contractual disputes; breach of warranty; or environmental matters. Claimed amounts may be substantial but may not bear any reasonable relationship to the merits of the claim or the extent of any real risk of court or arbitral awards. While it is not feasible to predict the outcome of these matters with certainty, and some lawsuits, claims or proceedings may be disposed or decided unfavorably, the Company does

not believeexpect that any asserted or unassertedun-asserted legal claims or proceedings, individually or in the aggregate, will have a material adverse effect on its business, financial condition, results of operations, or prospects.financial condition.
36


As of June 30, 2021, an accrued liability of $16,650 relating to the proposed settlement of securities litigation and a corresponding asset for the related insurance coverage of $16,650 is included in Accrued expenses and other liabilities and Prepaid and other current assets on the Consolidated Balance Sheets, respectively. See Part II, Item 1, “Legal Proceedings,” for additional information regarding legal proceedings in which the Company is engaged.
21.
20. Accrued Expenses and Other Liabilities
Accrued expenses and other liabilities consisted of the following:
June 30,
2021
September 30,
2020
Salaries, wages and other benefits$67,648 $67,766 
Provisions for litigation(1)
19,439 2,580 
Obligation under operating leases13,293 12,767 
Obligation under finance leases12,097 11,362 
Third party commissions9,415 9,270 
Taxes, other than income5,675 5,316 
Insurance liabilities3,377 3,954 
Earn-outs related to acquisitions1,056 295 
Severance payments702 970 
Fair value of liability derivatives512 4,716 
Other31,913 24,393 
$165,127 $143,389 
 June 30,
2020
 September 30,
2019
Salaries, wages and other benefits$44,735
 $35,206
Obligation under operating leases12,993
 
Obligation under finance leases11,456
 17,859
Insurance liabilities7,570
 4,895
Third party commissions9,434
 11,394
Taxes, other than income5,029
 5,215
Provisions for litigation2,718
 1,533
Severance payments1,044
 655
Option and Purchase Right506
 
Earn-outs related to acquisitions91
 611
Other28,440
 24,471
 $124,016
 $101,839

(1)
    At June 30, 2021, provisions for litigation includes an accrued liability of $16,650 relating to the proposed settlement of securities litigation. See Note 19, “Commitments and Contingencies” for further discussion.
22.21. Business Segments
The Company’s reportable operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated on a regular basis by the chief operating decision maker, or decision making group, in deciding how to allocate resources to an individual segment and in assessing performance. The key factors used to identify these reportable operating segments are the organization and alignment of the Company’s internal operations, the nature of the products and services, and customer type.
The Company has 2 reportable operating segments, Integrated Solutions and Services and Applied Product Technologies. The business segments are described as follows:
Integrated Solutions and Services is a group entirely focused on engaging directly with end users through direct sales with a market vertical focus. Integrated Solutions and Services provides tailored services and solutions in collaboration with the customers backed by life‑cycle services including on‑demand water, outsourced water, recycle / reuse, and emergency response service alternatives to improve operational reliability, performance, and environmental compliance. Key offerings within this segment also include equipment systems for industrial needs (influent water, boiler feed water, ultrahigh purity, process water, wastewater treatment, and recycle / reuse), full-scale outsourcing of operations and maintenance, and municipal services, including odor and corrosion control services.
Applied Product Technologies is focused on developing product platforms to be sold primarily through third party channels. This segment primarily engages in indirect sales through independent sales representatives, distributors, and aftermarket channels. Applied Product Technologies provides a range of highly differentiated and scalable products and technologies specified by global water treatment designers, OEMs,original equipment manufacturers (“OEMs”), engineering firms, and integrators. Key offerings within this segment include filtration and separation, disinfection, wastewater solutions, anode and electrochlorination technology, and aquatics technologies and solutions for the global recreational and commercial pool market.
The Company evaluates its business segments’ operating results based on earnings before interest, taxes, depreciation and amortization, and certain other charges that are specific to the activities of the respective segments.
37


Corporate activities include general corporate expenses, elimination of inter-segment transactions, interest income and expense, and certain other charges. Certain other charges may include restructuring and other business transformation charges that have been

undertaken to align and reposition the Company to the current reporting structure, acquisition related costs (including transaction costs and certain integration costs, and recognition of backlog intangible assets recorded in purchase accounting)) and share-based compensation charges. 
Since certain administrative and other operating expenses and other items have not been allocated to business segments, the results in the below table are not necessarily a measure computed in accordance with generally accepted accounting principles and may not be comparable to other companies.
Reportable operating segment revenue and operating profit for the three and nine months ended June 30, 2021 and 2020 were as follows:
Three Months Ended
June 30,
Nine Months Ended
June 30,
2021202020212020
Total revenue
Integrated Solutions and Services$245,414 $230,314 $690,370 $702,938 
Applied Product Technologies149,434 136,350 419,122 404,303 
Total revenue394,848 366,664 1,109,492 1,107,241 
Intersegment revenue
Integrated Solutions and Services5,727 1,603 11,832 8,204 
Applied Product Technologies19,440 17,234 59,222 53,442 
Total intersegment revenue25,167 18,837 71,054 61,646 
Revenue to external customers
Integrated Solutions and Services239,687 228,711 678,538 694,734 
Applied Product Technologies129,994 119,116 359,900 350,861 
Total revenue$369,681 $347,827 $1,038,438 $1,045,595 
Operating profit (loss)
Integrated Solutions and Services$37,793 $32,608 $94,934 $102,457 
Applied Product Technologies22,735 23,588 54,218 110,480 
Corporate(32,218)(23,130)(88,430)(89,024)
Total operating profit28,310 33,066 60,722 123,913 
Interest expense(11,224)(10,485)(28,292)(37,320)
Income before income taxes17,086 22,581 32,430 86,593 
Income tax expense(3,887)(740)(7,672)(3,336)
Net income$13,199 $21,841 $24,758 $83,257 
June 30,
2021
September 30,
2020
Assets
Integrated Solutions and Services$862,288 $835,307 
Applied Product Technologies611,785 598,701
Corporate369,085 410,450
Total assets$1,843,158 $1,844,458 
38
 Three Months Ended
June 30,
 Nine Months Ended
June 30,
 2020 2019 2020 2019
Total sales       
Integrated Solutions and Services$230,314
 $227,815
 $702,938
 $669,031
Applied Product Technologies136,350
 158,526
 404,303
 437,196
Total sales366,664
 386,341
 1,107,241
 1,106,227
Intersegment sales       
Integrated Solutions and Services1,603
 2,386
 8,204
 6,240
Applied Product Technologies17,234
 23,612
 53,442
 68,014
Total intersegment sales18,837
 25,998
 61,646
 74,254
Sales to external customers       
Integrated Solutions and Services228,711
 225,429
 694,734
 662,791
Applied Product Technologies119,116
 134,914
 350,861
 369,182
Total sales347,827
 360,343
 1,045,595
 1,031,973
Operating profit (loss)       
Integrated Solutions and Services32,608
 37,345
 102,457
 102,282
Applied Product Technologies23,588
 22,524
 110,480
 38,362
Corporate(23,130) (32,778) (89,024) (108,444)
Total operating profit33,066
 27,091
 123,913
 32,200
Interest expense(10,485) (14,842) (37,320) (43,759)
Income (loss) before income taxes22,581
 12,249
 86,593
 (11,559)
Income tax (expense) benefit(740) (7,959) (3,336) 1,134
Net income (loss)$21,841
 $4,290
 $83,257
 $(10,425)
Depreciation and amortization       
Integrated Solutions and Services$17,745
 $14,035
 $50,702
 $42,307
Applied Product Technologies3,556
 4,350
 10,673
 13,142
Corporate6,241
 5,760
 18,681
 15,948
Total depreciation and amortization$27,542
 $24,145
 $80,056
 $71,397
Capital expenditures       
Integrated Solutions and Services$23,734
 $19,646
 $56,918
 $53,303
Applied Product Technologies1,040
 1,720
 4,407
 5,988
Corporate2,391
 1,900
 4,599
 4,657
Total capital expenditures$27,165
 $23,266
 $65,924
 $63,948


 June 30,
2020
 September 30,
2019
Assets   
Integrated Solutions and Services$836,389
 $762,707
Applied Product Technologies589,721
 657,879
Corporate351,786
 317,262
Total assets$1,777,896
 $1,737,848
Goodwill   
Integrated Solutions and Services$222,669
 $222,013
Applied Product Technologies170,758
 170,877
Total goodwill$393,427
 $392,890

23.22. Earnings Per Share
The following table sets forth the computation of basic and diluted earnings (loss) from continuing operations per common share (in thousands, except per share amounts):
Three Months Ended
June 30,
Nine Months Ended
June 30,
2021202020212020
Numerator:
Numerator for basic and diluted earnings per common share—Net income attributable to Evoqua Water Technologies Corp.$13,155 $21,384 $24,624 $82,341 
Denominator:
Denominator for basic net income per common share—weighted average shares119,015116,621119,015116,621
Effect of dilutive securities:
Share‑based compensation3,245 3,595 3,312 4,432 
Denominator for diluted net income per common share—adjusted weighted average shares122,260 120,216 122,327 121,053 
Basic earnings attributable to Evoqua Water Technologies Corp. per common share$0.11 $0.18 $0.21 $0.71 
Diluted earnings attributable to Evoqua Water Technologies Corp. per common share$0.11 $0.18 $0.20 $0.68 
 Three Months Ended
June 30,
 Nine Months Ended
June 30,
 2020 2019 2020 2019
Numerator:       
Numerator for basic and diluted earnings (loss) per common share—Net income (loss) attributable to Evoqua Water Technologies Corp.$21,384
 $4,135
 $82,341
 $(11,211)
Denominator:       
Denominator for basic net income (loss) per common share—weighted average shares116,621
 114,653
 116,621
 114,653
Effect of dilutive securities:       
Share‑based compensation3,595
 4,781
 4,432
 
Denominator for diluted net income (loss) per common share—adjusted weighted average shares120,216
 119,434
 121,053
 114,653
Basic earnings (loss) attributable to Evoqua Water Technologies Corp. per common share$0.18
 $0.04
 $0.71
 $(0.10)
Diluted earnings (loss) attributable to Evoqua Water Technologies Corp. per common share$0.18
 $0.03
 $0.68
 $(0.10)
23. Subsequent Events
None.
39


Since the Company was in a net loss position for the nine months ended June 30, 2019, there was no difference between the number of shares used to calculate basic and diluted loss per share. Because of their anti-dilutive effect, 4,358 common share equivalents, comprised of employee stock options, have been excluded from the diluted EPS calculation for the nine months ended June 30, 2019.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition and results of our operations should be read in conjunction with the Unaudited Consolidated Financial Statements, including the notes, included in Part I, Item 1 of this Quarterly Report on Form 10-Q (this “Report”), and with our audited consolidated financial statements and the related notes thereto in our Annual Report on Form 10-K for the fiscal year ended September 30, 2019,2020, as filed with the SEC on November 25, 2019 and as amended on December 4, 201920, 2020 (the “2019“2020 Annual Report”). You should review the disclosures in Part I, Item 1A. “Risk Factors” in the 20192020 Annual Report, in Part II, Item 1A. “Risk Factors” of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, as filed with the SEC on May 6, 2020, as well as any cautionary language in this report,Report, for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis. Unless otherwise indicated or the context otherwise requires, all references to “the Company,” “Evoqua,” “Evoqua Water Technologies Corp.,” “EWT Holdings I Corp.,” “we,” “us,” “our” and similar terms refer to Evoqua Water Technologies Corp., together with its consolidated subsidiaries. Unless otherwise specified, all dollar amounts in this section are referred to in millions.
Overview and Background
We are a leading provider of mission criticalmission-critical water and wastewater treatment solutions, offering a broad portfolio of products, services, and expertise to support industrial, municipal, and recreational customers who value water. With over 200,000 installations worldwide, we hold leading positions in the industrial, commercial and municipal water treatment marketsmarkets. We are headquartered in North America.Pittsburgh, Pennsylvania, with locations across ten countries. We offerhave a comprehensive portfolio of differentiated, proprietary technology solutions soldtechnologies offered under a number of market‑leading and well‑established brands to our global customer base. We have worked to protectbrands. Our core technologies are primarily focused on removing impurities from water, rather than neutralizing them through the environment and our employees for over 100 years. As a result, we have earned a reputation for quality, safety and reliability and are sought out by our customers to solve the full rangeaddition of their water treatment needs, and maintaining our reputation is critical to the success of our business.chemicals.
Our solutions are designed to ensure thatprovide our customers havewith the quantity and quality of water that meetsnecessary to meet their unique specifications. We enable our customers to achieve lower costs through greater uptime, throughput and efficiency in their operations and supportwhile supporting their regulatory compliance and environmental sustainability.sustainability requirements. We deliver and maintain these mission critical solutions through the largestour extensive North American service network, in North America, assuringand we sell our customers continuous uptime with 92 branches as of June 30, 2020.products and technologies internationally through direct and indirect sales channels. We have an extensive serviceworked to protect water, the environment, and support network, and asour employees for more than 100 years. As a result, we have earned a certified Evoqua Service Technician is generally no more thanreputation for quality, safety and reliability around the world. Our employees are united by a two‑hour drive from more than 90% of our North American customers’ sites.common purpose: Transforming water. Enriching life.®
Our vision “to be the world’s first choice for water solutions” and our values of “integrity, customers, performancesustainable, and sustainable”performance” foster a corporate culture that is focused on establishing a workforce that is enabled, empowered and accountable, which createscreating a highly entrepreneurial and dynamic work environment. Our purpose is “Transforming water. Enriching life.”
We draw fromserve our customers through the following two segments:
Integrated Solutions and Services segment, which provides application-specific solutions and full lifecycle services for critical water and wastewater applications across numerous end markets, including on‑demand water, outsourced water, recycle and reuse, and emergency response service alternatives to improve operational reliability, performance and environmental compliance; and
Applied Product Technologies segment, which provides a long legacyhighly differentiated and scalable range of water treatment innovations and industry firsts, supported by more than 1,100 grantedwastewater products and technologies that can be stand-alone or pending patents, whichas components in aggregate are imperativeintegrated solutions to our business. Our core technologies are primarily focused on removing impurities from water, rather than neutralizing them througha diverse set of system specifiers, integrators, and end-users around the addition of chemicals, and we are able to achieve purification levels which are 1,000 times greater than typical drinking water.
Business Segmentsglobe.
Our business is organized by customer base and offerings into two reportable operating segments that each draw from the same reservoir of leading technologies, shared manufacturing infrastructure, common business processes, and corporate philosophies. Our reportable operating segments consist of: (i) our Integrated Solutions and Services segment and (ii) our Applied Product Technologies segment. The key factors used to identify these reportable operating segments are the organization and alignment of our internal operations, the nature of the products and services and customer type.
Within the Integrated Solutions and Services segment, we primarily provide tailored solutions We expect to drive growth in collaboration with our customers backed by life‑cycle services including on‑demand water, outsourced water, recycle and reuse and emergency response service alternatives to improve operational reliability, performance and environmental compliance.

Within the Applied Product Technologies segment, we provide a highly differentiated and scalable range of products and technologies specified by global water treatment designers, OEMs, engineering firms and integrators.
We evaluatesegments through market expansion, leveraging our business segments’ operating results based on income from operations and EBITDA or Adjusted EBITDA on a segment basis. EBITDA and Adjusted EBITDA are non-GAAP financial measures. For more information regarding EBITDA and Adjusted EBITDA, including a reconciliation to the most directly comparable GAAP financial measure, please see the section titled “How We Assess the Performance of Our Business”. Corporate activities include general corporate expenses, elimination of intersegment transactions, interest income and expense and certain other charges, which have not been allocated to business segments. As such, the segment results provided herein may not be comparable to other companies.
Organic Growth Drivers
Market Growth
We maintain a leading position among customers in growing industries that utilize water as a critical part of their operations or production processes, including pharmaceuticals and health sciences, microelectronics, food and beverage, hydrocarbon and chemical processing, power, general manufacturing, municipal drinking and wastewater, marine and aquatics. Water treatment is an essential, non‑discretionary market that is growing in importance as access to clean water has become an international priority. Underpinning this growth are a number of global, long‑term trends that have resulted in increasingly stringent effluent regulations, along with a growing demand for cleaner and sustainable waste streams for reuse. These trends include the growing global population, increasing levels of urbanization and continued global economic growth, and we have seen these trends manifest themselves within our various end markets creating multiple avenues of growth. For example, within the industrial market, water is an integral and meaningful component in the production of a wide‑range of goods spanning from consumer electronics to automobiles. We anticipate that the COVID-19 pandemic and the resulting economic downturn may cause some near-term contraction in certain end markets that we serve, and we continue to monitor macroeconomic trends closely. However, we do not expect that the pandemic will significantly alter these long-term trends.
Our Existing Customer Base
We believe our strong brands, leading position in highly fragmented markets, scalable and global offerings, leading installedexisting customer base and unique ability to provide complete treatment solutions will enable us to capturerecurring service model, innovation through new product technology development, a larger sharefocus on operational excellence, and strategic acquisitions. For a detailed discussion of our existing customers’ water treatment spend while expanding with existing and new customers into adjacent end‑markets and underpenetrated regions, including by investing ingrowth drivers, see our sales force and cross‑selling to existing customers. We believe that we are uniquely positioned to further penetrate our core markets, with over 200,000 installations across over 38,000 global customers. We maintain a customer‑intimate business model with strong brand value and provide solutions‑focused offerings capable of serving a customer’s full lifecycle water treatment needs, both in current and new geographic regions.2020 Annual Report.
Our Service Model
40
We selectively target high value projects with opportunities for recurring business through service, parts and other aftermarket opportunities over the lifecycle of the process or capital equipment. In particular, we have developed internet‑connected monitoring technologies through the deployment of our WaterOne® service platform, which enables customers to outsource their water treatment systems and focus on their core business, offering customers system optimization, predictive and proactive service, and simplified billing and pricing. Our WaterOne® platform also enables us to transition our customers to pricing models based on usage, which otherwise would not have been possible without technological advancement. Our technology solutions provide customers with increased stability and predictability in water‑related costs, while enabling us to optimize our service route network and on demand offerings through predictive analytics, which we believe will result in market share gains, improved service levels, increased barriers to entry and reduced costs.



Product and Technology Development
We develop our technologies through in‑house research, development and engineering and targeted tuck‑in, vertical market and geography‑expanding, technology-enhancing acquisitions. We have a reservoir of recently launched technologies and a strong pipeline of new offerings designed to provide customers with innovative, value‑enhancing solutions. Furthermore, since April 2016, we have successfully completed thirteen acquisitions and the acquisition of a 60% interest in Frontier Water Systems LLC (“Frontier”), each of which expands our vertical markets and geographic reach and enhance our technologies, strengthening our existing capabilities and adding new capabilities and cross selling opportunities in areas such as mobile wastewater treatment, soil and air treatment, regenerative media filtration, anodes, UV and ozone disinfection, aerobic and anaerobic biological treatment technologies and electrochemical and electrochlorination cells. We are able to rapidly scale new technologies using our leading direct and third‑party sales channels and our relationships with key influencers, including municipal representatives, engineering firms, designers and other system specifiers. We believe our continued investment in driving penetration of our recently launched technologies, robust pipeline of new capabilities and best‑in‑class channels to market will allow us to continue to address our customer needs across the water lifecycle.
Operational Excellence
We believe that continuous improvement of our operations, processes and organizational structure is a key driver of our earnings growth. We have separately identified and are pursuing a number of discrete initiatives which, if successful, we expect could result in additional cost savings over the next two years. These initiatives include our supply chain improvement program to consolidate and manage global spending, our improved logistics and transportation management program, capturing benefits of our WaterOne® platform and further optimizing our engineering cost structure, our global shared services organization and our sales, inventory and operations planning. These improvements focus on creating value for customers through reduced lead times, improved quality and superior customer support, while also creating value for shareholders through enhanced earnings growth. Furthermore, as a result of significant investments we have made and plan to continue to make in our footprint and facilities, we believe we have capacity to support our planned growth without commensurate increase in fixed costs.
Acquisitions and Divestitures
We believe that capex-like, tuck‑in acquisitions present a key opportunity within our overall growth strategy, which we will continue to evaluate strategically. These strategic acquisitions are expected to enable us to accelerate our growth by extending our critical mass in existing markets, as well as expand in new geographies and new end market verticals. Our existing customer relationships, best‑in‑class channels to market and ability to rapidly commercialize technologies provide a strong platform to drive rapid growth in the businesses we acquire. To capitalize on these opportunities, we have built an experienced team dedicated to mergers and acquisitions that has, since April 2016, successfully completed thirteen acquisitions and the acquisition of a 60% interest in Frontier, each of which expands our vertical markets and geographic reach and enhance our technologies, with purchase prices ranging from approximately $2.6 million to approximately $283.7 million, and pre‑acquisition revenues ranging from approximately $3.1 million to approximately $55.7 million.
On December 31, 2019 we completed the sale of the Memcor product line to DuPont de Nemours, Inc. (DuPont). The aggregate purchase price paid by DuPont was $110.0 million in cash, subject to certain adjustments. Following adjustments for cash and net working capital, gross proceeds paid by DuPont were $131.0 million. The Company recognized a $49.0 million net pre-tax benefit on the sale of the Memcor product line, net of $8.3 million of discretionary compensation payments to employees in connection with the transaction and $1.0 million in transaction costs incurred in the three months ended December 31, 2019. As a result of net working capital adjustments, the Company recognized an additional $9.0 million net pre-tax benefit in the three months ended March 31, 2020. The Company and DuPont have a history of collaboration, and following the sale, DuPont will continue to supply the Company with Memcor® products.
Recent Developments, Key Factors and Trends Affecting Our Business and Financial Statements
VariousOur 2020 Annual Report includes a discussion of various key factors and trends and other factors affect orthat we believe have affected or may affect our operating results, including:

results. The following discussion highlights recent developments, as well as significant changes in these key factors and trends.
Impact of the COVID-19 pandemic. In response to the challenges created by the COVID-19 pandemic, we have continued to prioritize protecting the safety of our employees and stakeholders, taking actions to ensure the resiliency of our business and managing the business for liquidity. Our business has been considered essential under federal and local standards, and we have maintained business continuity at our critical service branches and manufacturing facilities.facilities to date. We have taken measures throughout the duration of the pandemic to protect our employees, including implementation of remote working practices where possible and managingenhanced safety procedures for employees on site at our facilities and our customers’ facilities, and to manage our supply chain to ensure that necessary personal protective equipment is available to our personnel. WeThese measures have also takenresulted in additional incremental costs and reductions in service productivity over the course of the pandemic, although neither had a significant impact on our financial results in the three months ended June 30, 2021.
To date, the pandemic has negatively impacted volume across our business, due primarily to customer site access restrictions, temporary customer site closures, and temporary delays in annual maintenance activities by customers in certain end markets, although we have started to see volume rebound in certain end markets during the third quarter, as further discussed below in the discussion of our results of operations. Along with this increase in volume, in the third quarter we experienced increases in certain discretionary costs that were the subject of cost reduction actions such as reduction of marketingearlier in the pandemic, particularly employee travel expenses. We have continued to focus on collecting outstanding customer account balances, and, travel activity as well as deferment of headcount additions to preserve liquidity and reallocated existing resources to maintain productivity levels where feasible.
In general,through June 30, 2021, we have seen increased demand for servicesnot experienced any deterioration in collections from customers in pharmaceutical and laboratory industries through the period ended June 30, 2020, as the impact of the pandemic broadened. However, we also continue to see uneven demand for our products and services from customers in certain other industries, such as oil and gas, refining and aquatics. Customer site shut-downs and project delays created by the pandemic contributed to a decline in revenue from services in the quarter.customers. We continue to evaluate the impact of the pandemic on our business particularly how social distancing guidelines and government-imposed restrictions mightthe potential effects of recent spikes in COVID-19 cases in certain regions, as well as challenges created by the macro-economic conditions associated with the reopening and reacceleration of global economies. These challenges include disruptions in our supply chain, material price inflation, shortages of and delays in obtaining certain materials and component parts, labor shortages, and wage inflation. We have taken and continue to affect our accesstake measures to our customers’ sites and howmitigate the economic downturn resulting from the pandemic might affect our customers’ willingness to make capital expenditures and our ability to collect from our customers. Given the evolving natureimpact of the unprecedented pandemic, the overall impactthese challenges, but if sustained, they could have a material adverse effect on our operations over the remainderresults of the fiscal year cannot be reasonably estimated at this time.operations.

For more information regarding factors and events that may impact our business, results of operations and financial condition from the effectsas a result of the COVID-19 pandemic, see “Risk Factors-Risks Related to the COVID-19 Pandemic” included in Part II,I, Item 1A. “Risk Factors” in the 2020 Annual Report.
Acquisitions and divestitures. On December 17, 2020, we acquired the industrial water business of our Quarterly ReportUltrapure & Industrial Services, LLC (“Ultrapure”) for $8.7 million cash paid at closing. On April 1, 2021, we paid an additional $0.3 million as a result of net working capital adjustments. Ultrapure, based out of Texas, provides customers across multiple end markets with a variety of water treatment products and services, including service deionization, reverse osmosis, UV, and ozonation. Ultrapure will strengthen the Company’s service capabilities in the Houston and Dallas markets and is a part of the Integrated Solutions and Services segment. During the nine months ended June 30, 2021, the Company incurred approximately $0.2 million in acquisition costs, which are included in General and administrative expense on Form 10-Qthe Unaudited Consolidated Statements of Operations.
On March 1, 2021, we completed the divestiture of the Lange containment system, geomembrane, and geosynthetic liner product line (the “Lange Product Line”) for $0.9 million in cash at closing. The Lange Product Line was a part of the quarterIntegrated Solutions and Services segment. During the nine months ended MarchJune 30, 2021, the Company recognized a loss of $0.2 million on the divestiture.
On April 1, 2021, we acquired Water Consulting Specialists, Inc (“WCSI”) for $12.0 million cash paid at closing. In addition, we recorded a liability of $0.8 million associated with an earn-out related to the acquisition, which is included in Accrued expenses and other liabilities on the Consolidated Balance Sheets. WCSI is a leader in the design, manufacturing, and service of industrial high-purity water treatment systems. The acquisition strengthens the Company’s portfolio of high-purity water treatment systems and provides the opportunity to further expand its digitally enabled solutions and services in key industrial markets. WCSI is a part of the Integrated Solutions and Services segment. During the nine months ended June 30, 2021, the Company incurred approximately $0.1 million in acquisition costs, which are included in General and administrative expense on the Unaudited Consolidated Statements of Operations.
On December 31, 2020, as filed2019, we completed the sale of the Memcor product line to DuPont de Nemours, Inc. The Company recognized a $49.0 million net pre-tax benefit on the sale of the Memcor product line, net of $8.3 million of
41


discretionary compensation payments to employees in connection with the SEC on May 6, 2020.
Overall economic trends. The overall economic environmenttransaction and related changes$1.0 million in industrial, commercial and municipal spending impact our business. In general, positive conditionstransaction costs incurred in the broader economy promote industrial, commercialnine months ended June 30, 2020.
On October 1, 2019, we acquired a 60% investment position in San Diego-based Frontier Water Systems, LLC (“Frontier”), which included an agreement to purchase the remaining 40% interest in Frontier on or prior to March 30, 2024. This agreement gave holders of the remaining 40% interest in Frontier (the “Minority Owners”) the right to sell to Evoqua up to approximately 10% of the outstanding equity in Frontier at a predetermined price, which right was exercisable by the Minority Owners between January 1, 2021 and municipal customer spending, while economic weakness resultsFebruary 28, 2021 (the “Option”). The Minority Owners exercised the Option, and on April 8, 2021, the Company completed the purchase of an additional 8% of the outstanding equity in Frontier for approximately $1.5 million. As a reduction of new industrial, commercial and municipal project activity. Macroeconomic factors that can affect customer spending patterns, and thereby our results of operations, include population growth, total water consumption, municipal budgets, employment rates, business conditions,result, the availability of credit or capital, interest rates, tax rates, imposition of tariffs and regulatory changes. Since the businesses of our customers varyCompany’s ownership position in cyclicality, periodic downturns in any specific sector typically have modest impacts on our overall business. For example, the current weakness in global oil markets has created, and we expect willFrontier increased to 68%.
We continue to create, some weakness in demand from customersactively evaluate acquisition opportunities that we serve in the oil and gas industry. Additionally, the COVID-19 pandemic has increased economic uncertainty and has caused an economic slowdown that is likely to continue and may result inare consistent with our business strategy. We maintain a sustained global recession.
Changes in costs and availability. We have significant exposures to certain commodities, including steel, caustic, carbon, calcium nitrate and iridium, and volatility in the market price and availabilityrobust pipeline of these commodity input materials has a direct impact onpotential acquisition targets, developed by our costs and our business. For example, restrictions on international trade, including tariffs imposed by the U.S. government and other governments,management team as well as supply chain disruptions caused byvarious outside industry experts and consultants.
Debt refinancing.On April 1, 2021, we completed the COVID-19 pandemic, have increasedrefinancing of the term loan (the “2014 Term Loan”) outstanding under our First Lien Credit Agreement dated January 15, 2014 (as modified, amended or supplemented from time to time, the “2014 Credit Agreement”), among EWT Holdings III Corp. (“EWT III”), EWT Holdings II Corp. (“EWT II”), the lenders party thereto and could further increaseCredit Suisse AG as administrative agent and collateral agent. On April 1, 2021, EWT III entered into a Credit Agreement (the “2021 Credit Agreement”) among EWT III, as borrower, EWT II, as parent guarantor, the cost of certain materialslenders from time to time party thereto, JPMorgan Chase Bank, N.A., as administrative agent and have restrictedcollateral agent, and could further restrict availability of certain commodities,ING Capital, LLC, as sustainability coordinator, which may result in delays in our execution of projects. Although we have offsetprovides for (i) a portion of these cost increases through price increases, there can be no assurance that we will be able to continue to recuperate additional cost increases from our customers through product price increases. If we are unable to manage commodity fluctuations through pricing actions, cost savings projects and sourcing decisions as well as through consistent productivity improvements, it may adversely impact our gross profit and gross margin. Further, additional potential acquisitions and international expansion will place increased demands on our operational, managerial, administrative and other resources. Managing our growth effectively will require us to continue to enhance our management systems, financial and management controls and information systems. We will also be required to hire, train and retain operational and sales personnel, which affects our operating margins.
Inflation and deflation trends. Our financial results can be expected to be directly impacted by substantial increases in costs due to commodity cost increases or general inflation which could leadsenior secured term loan facility relating to a reduction in our revenues as well as greater margin pressure as increased costs may not be able to be passed on to customers. We actively monitor changes in cost and respond as we deem appropriate to attempt to mitigate the impact to our results.
Fluctuation in quarterly results. Our quarterly results have historically varied depending upon a variety of factors, including funding, readiness of projects, regulatory approvals and significant weather events. In addition, our contracts for

large capital water treatment projects, systems and solutions for industrial, commercial and municipal applications are generally fixed‑price contracts with milestone billings. As a result of these factors, our working capital requirements and demands on our distribution and delivery network may fluctuate during the year.
New products and technologies. Our ability to maintain our appeal to existing customers and attract new customers depends on our ability to originate, develop and offer a compelling array of products, services and solutions responsive to evolving customer innovations, preferences and specifications. We expect that increased use of water in industrial and commercial processes will drive increased customer demandterm loan (the “2021 Term Loan”) in the future,amount of $475.0 million maturing on April 1, 2028, and our ability(ii) a multi-currency senior secured revolving credit facility in an aggregate principal amount not to grow will depend in part on effectively responding to innovation in our customers’ processes and systems. Further, our ability to provide products that comply with evolving government regulations will also be a driver of the appeal of our products, services and solutions to industrial and commercial customers.
Government policies. Decaying water systems in the United States (“U.S.”) will require critical drinking water and wastewater repairs, often led by municipal governments. Further, as U.S. states increase regulation on existing and emerging contaminants, we expect that our customers will increasingly require sustainable solutions to their water‑related needs. In general, increased infrastructure investment and more stringent municipal, state and federal regulations promote increased spending on our products, services and solutions, while a slowdown in investment in public infrastructure or the elimination of key environmental regulations could result in lower industrial and municipal spending on water systems and products.
Availability of water. In general, we expect demand for our products and services to increase as the availability of clean water from public sources decreases. Secular trends that will drive demand for water across a multitude of industrial, commercial and municipal applications include global population growth, urbanization, industrialization and overall economic growth. In addition, the supply of clean water could be adversely impacted by factors including an aging water infrastructure within North America and increased levels of water stress from seasonal rainfall, inadequate water storage options or treatment technologies. Because water is a critical component and byproduct of many processes, including in manufacturing and product development, we expect that, as global consumption patterns evolve and water shortages persist, demand for our equipment and services will continue to increase.
Operational investment. Our historical operating results reflect the impact of our ongoing investments to support our growth. We have made significant investments in our business that we believe have laid the foundation for continued profitable growth. Activities related to operational investments include employee training and development, integrating acquired businesses, implementing enhanced information systems, research, development and engineering investments and other activities to enable us to support our operating model.
Our ability to source and distribute products effectively. Our revenues are affected by our ability to purchase our inputs in sufficient quantities at competitive prices. While we believe our suppliers have adequate capacity to meet our current and anticipated demand, our level of revenues could be adversely affected in the event of constraints in our supply chain, including the inability of our suppliers to produce sufficient quantities of raw materials in a manner that is able to match demand from our customers.
Contractual relationships with customers. Due to our large installed base and the nature of our contractual relationships with our customers, we have high visibility into a large portion of our revenue. The one‑ to twenty‑year terms of many of our service contracts and the regular delivery and replacement of many of our products help to insulate us from the negative impact of any typical economic decline.
Exchange rates. The reporting currency for our Unaudited Consolidated Financial Statements is the U.S. dollar. We operate in numerous countries around the world and therefore, certain of our assets, liabilities, revenues and expenses are denominated in functional currencies other thanexceed the U.S. dollar primarilyequivalent of $350.0 million (the “2021 Revolving Credit Facility”) maturing on April 1, 2026.
On April 1, 2021, Evoqua Finance LLC (“Evoqua Finance”) entered into an accounts receivable securitization program (the “Receivables Securitization Program”) consisting of, among other agreements, (i) a Receivables Financing Agreement (the “Receivables Financing Agreement”) among Evoqua Finance, as the borrower, the lenders from time to time party thereto (the “Receivables Financing Lenders”), PNC Bank, National Association (“PNC Bank”), as administrative agent, Evoqua Water Technologies LLC (“EWT LLC”), an indirect wholly-owned subsidiary of the Company, as initial servicer, and PNC Capital Markets LLC (“PNC Markets”), as structuring agent, pursuant to which the lenders have made available to Evoqua Finance a receivables finance facility (the “Securitization Facility”) in an amount up to $150.0 million maturing on April 1, 2024, and (ii) a Sale and Contribution Agreement (the “Sale Agreement”) among Evoqua Finance, as purchaser, EWT LLC, as initial servicer and as an originator, and Neptune Benson, Inc., an indirectly wholly-owned subsidiary of the Company, as an originator (together with EWT LLC, the “Originators”).

On April 1, 2021, we borrowed $475.0 million under the 2021 Term Loan, $105.0 million under the 2021 Revolving Credit Facility and $142.2 million under the Securitization Facility. The net proceeds of these facilities, together with cash on hand, were used to repay all outstanding indebtedness under our 2014 Credit Agreement, in an aggregate principal amount of approximately $814.5 million. The reduction in the euro, U.K. sterling, Chinese renminbi, Canadian dollar, Australian dollar and Singapore dollar. To prepare our Unaudited Consolidated Financial Statements we must translate those assets, liabilities, revenues and expenses into U.S. dollars at the applicable exchange rate. As a result, increases or decreases in the value of the U.S. dollar against these other currencies will affect theoutstanding principal amount of these items recordedour term loan of approximately $340.0 million was funded by draws on the 2021 Revolving Credit Facility, the Securitization Facility and $100.0 million of cash on hand. In addition to extending the maturities of our term loan and previous revolving credit facility, the refinancing reduced our weighted average cash borrowing cost and improved liquidity. See “Liquidity and Capital Resources” below for additional information. At June 30, 2021, the Company had $475.0 million outstanding under the 2021 Term Loan, $95.0 million outstanding on the 2021 Revolving Credit Facility, and $148.2 million outstanding under the Securitization Facility.
Legal Settlement. As of June 30, 2021, an accrued liability of $16.7 million relating to the proposed settlement of securities litigation and a corresponding asset for the related insurance coverage of $16.7 million is included in our UnauditedAccrued expenses and other liabilities and Prepaid and other current assets on the Consolidated Financial Statements, even if their value has not changedBalance Sheets, respectively. See Part II, Item 1, “Legal Proceedings,” for additional information regarding legal proceedings in the functional currency. While we believe thatwhich we are not susceptible to any material impact on our results of operations caused by fluctuations in exchange rates because our operations are primarily conducted in the U.S., if we expand our foreign operations in the future, substantial increases or decreases in the value of the U.S. dollar relative to these other currencies could have a significant impact on our results of operations.engaged.
42


How We Assess the Performance of Our Business
In assessing the performance of our business, we consider a variety of performance and financial measures. The key indicators of the financial condition and operating performance of our consolidated business are revenue, gross profit, gross margin, operating expenses,and net income (loss). Management utilizes these financial measures prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) when reviewing the Company’s performance and Adjusted EBITDA (which is amaking financial, operational, and strategic decisions, and believes they are useful metrics for investors that help with performance comparability period over period. In addition, we consider certain non-GAAP financial measure).measures such as adjusted EBITDA, as described more fully below. We evaluate our business segments’ operating results based on revenue, income from operations (“operating profit”) and adjusted EBITDA on a segment basis. We believe these financial measures are helpful in understanding and evaluating the segments’ core operating results and facilitates comparison of our performance on a consistent basis period over period.

Revenue
Our sales arerevenue is a function of sales volumes and selling prices, eachprices. We report revenue by segment and by source which includes revenue from product sales (capital projects and aftermarket) and revenue from service. Revenue is used by management to evaluate the performance of whichour business. Organic revenue is a functiondefined as revenue excluding the impact of foreign currency translation and inorganic revenue. Inorganic revenue represents the impact from acquisitions and divestitures during the first 12 months following the closing of the mix of product and service sales, and consist primarily of:
acquisition or divestiture. Divestitures include sales of tailored light industry technologies, heavy industry technologies and environmental products, services and solutions in collaboration withinsignificant portions of our industrial customers, backedbusiness that did not meet the criteria for classification as a discontinued operation. Management believes that reporting organic revenue provides useful information to investors by lifecycle services including emergency response services and outsourced water alternatives, to a broad group of industrial customershelping identify underlying growth trends in our U.S., Canadacore business and Singapore markets;
sales of products, services and solutions to engineering firms and municipalities to purify drinking water and treat wastewater globally; and
sales of a wide variety of differentiated products and technologies, to an array of OEM, distributor, end‑user, engineering firm and integrator customers in allfacilitating easier comparisons of our geographic marketsrevenue performance with prior and aftermarket channels.future periods and to our peers. We exclude the effect of foreign currency translation from organic sales because foreign currency translation is not under management’s control, is subject to volatility and can obscure underlying business trends. We exclude the effect of acquisitions and divestitures because they can obscure underlying business trends and make comparisons of long-term performance difficult between the Company and its peers due to the varying nature, size and number of transactions from period to period. See “Non-GAAP Reconciliations” in Item 2 of this Report for a reconciliation of organic revenue.
Cost of Sales,
Gross Profitprofit and Gross Margingross margin

Gross profit is determined by subtracting cost of product sales and cost of services from our product and services revenue. Gross margin measures gross profit as a percentage of our combined product and services revenue.
Cost of product sales consists of all manufacturing costs required Gross profit and gross margin provide a comparable metric to bring a product to a ready for sale condition, including directhelp investors evaluate the cost efficiency and indirect materials, direct and indirect labor costs including benefits, freight, depreciation, information technology, rental and insurance, repair and maintenance, utilities, other manufacturing costs, warranties and third party commissions.
Cost of services primarily consistsability of the cost of personnel and travel for our field service, supply chain and technicians, depreciation of equipment and field service vehicles and freight costs.
Operating Expenses
Operating expenses consist primarily of general and administrative, sales and marketing and research and development expenses.Company to convert revenue to profit.
General and Administrative.
General and administrative expenses (“G&A expense”) consist of fixed overhead personnel expenses associated with our corporate functions and our service organization (including district and branch managers, customer service, contract renewals and regeneration plant management). We expect our general and administrative expenses to increase due to the anticipated growth of our business and related infrastructure as well as due to the legal, accounting, insurance, investor relations and other costs associated with being a public company.
Sales and Marketing. Sales and marketing expenses (“S&M expense”) consist primarily of advertising and marketing promotions of our products, services and solutions and related personnel expenses (including all Evoqua sales and application employees’ base compensation and incentives), as well as sponsorship costs, consulting and contractor expenses, travel, display expenses and related amortization. We expect our sales and marketing expenses to increase as we continue to actively promote our products, services and solutions.
Research and Development. Research and development expenses (“R&D expense”) consist primarily of personnel expenses related to research and development, patents, sustaining engineering, consulting and contractor expenses, tooling and prototype materials and overhead costs allocated to such expenses. Substantially all of our research and development expenses are related to developing new products and services and improving our existing products and services. To date, research and development expenses have been expensed as incurred, because the period between achieving technological

feasibility and the release of products and services for sale has been short and development costs qualifying for capitalization have been insignificant.
R&D expense can fluctuate depending on our determination to invest in developing new products, services and solutions and enhancing our existing products, services and solutions versus adding these capabilities through a mergers and acquisitions strategy.
Net Income (Loss)income (loss)

Net income (loss) is determined by subtracting operating expenses and interest expense from, and adding other operating income (expense), equity income (loss) from our partnership interest in Treated Water Outsourcing and income tax benefit (expense) to, gross profit. For more information on how we determine gross profit, see “Gross Profit.”Net income (loss) is used by the Company to measure profitability as well as the overall health of the business.

Adjusted EBITDA
Adjusted EBITDA, which is a non-GAAP financial measure, is one of the primary metrics used by management to evaluate the strength and financial performance of our core business. Adjusted EBITDA is defined as net income (loss) before interest expense, income tax benefit (expense) and depreciation and amortization, adjusted for the impact of certain other items, including restructuring and related business transformation costs, purchase accounting adjustment costs, non-cash share-based compensation, transaction costs, and other gains, losses and expenses.expenses that we believe do not directly reflect our underlying business operations. We present Adjustedadjusted EBITDA because we believe it is frequently used by analysts, investors and other interested parties to evaluate and compare operating performance and value companies inwithin our industry. Further, we believe it is helpful in highlighting trends in our operating results and provides greater clarity and comparability period over period to management and our investors regarding the operational impact of long-term strategic decisions regarding capital structure, the tax jurisdictions in which we operate, and capital investments. In addition, adjusted EBITDA highlights true business performance by removing the impact of certain items that management believes do not directly
43


reflect our underlying operations and provides investors with greater visibility into the ongoing organic drivers of our business performance.
Management uses Adjustedadjusted EBITDA to supplement GAAP measures of performance as follows:
to assist investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance;
in our management incentive compensation, which is based in part on components of Adjustedadjusted EBITDA;
in certain calculations under our senior secured credit facilities, which use components of Adjustedadjusted EBITDA;
to evaluate the effectiveness of our business strategies;
to make budgeting decisions; and
to compare our performance against that of other peer companies using similar measures.
In addition to the above, our chief operating decision maker uses EBITDA and Adjustedadjusted EBITDA of each reportable operating segment to evaluate the operating performance of such segments. Adjusted EBITDA on a segment basis is defined as earnings before depreciation and amortization, adjusted for the impact of certain other items that have been reflected at the segment level. Adjusted EBITDA of the reportable operating segments do not include certain charges that are presented within corporate activities. These charges include certain restructuring and other business transformation charges that have been incurred to align and reposition the Company to the current reporting structure, acquisition related costs (including transaction costs and integration costs and recognition of backlog intangible assets recorded in purchase accounting)costs) and share-based compensation charges.
Adjusted EBITDA should not be considered a substitute for, or superior to, financial measures prepared in accordance with GAAP. The financial results prepared in accordance with GAAP and the reconciliations from these results should be carefully evaluated. See “Non-GAAP Reconciliations” in Item 2 of this Report for a reconciliation of adjusted EBITDA. You are encouraged to evaluate each adjustment and the reasons we consider it appropriate for supplemental analysis. In addition, in evaluating Adjustedadjusted EBITDA, you should be aware that in the future, we may incur expenses similar to the adjustments in the presentation of Adjustedadjusted EBITDA. Our presentation of Adjustedadjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non‑recurringnon-recurring items. In addition, Adjustedadjusted EBITDA may not be comparable to similarly titled measures used by other companies in our industry or across different industries.
44


Results of Operations
The following table summarizes key components of our results of operations for the periods indicated:
Three Months Ended June 30,Nine Months Ended June 30,
2021202020212020
(In millions, except per share amounts)% of Revenue% of Revenue% Variance% of Revenue% of Revenue% Variance
Revenue from product sales and services$369.7 100.0 %$347.8 100.0 %6.3 %$1,038.4 100.0 %$1,045.6 100.0 %(0.7)%
Gross profit$117.0 31.6 %$110.2 31.7 %6.2 %$318.3 30.7 %$327.2 31.3 %(2.7)%
Total operating expenses$(90.1)(24.4)%$(77.5)(22.3)%16.3 %$(259.6)(25.0)%$(264.3)(25.3)%(1.8)%
Other operating income, net$1.4 0.4 %$0.4 0.1 %250.0 %$2.0 0.2 %$61.0 5.8 %(96.7)%
Interest expense$(11.2)(3.0)%$(10.5)(3.0)%6.7 %$(28.3)(2.7)%$(37.3)(3.6)%(24.1)%
Income before income taxes$17.1 4.6 %$22.6 6.5 %(24.3)%$32.4 3.1 %$86.6 8.3 %(62.6)%
Income tax expense$(3.9)(1.1)%$(0.8)(0.2)%387.5%$(7.7)(0.7)%$(3.3)(0.3)%133.3 %
Net income$13.2 3.6 %$21.8 6.3 %(39.4)%$24.7 2.4 %$83.3 8.0 %(70.3)%
Net income attributable to non‑controlling interest$— — %$0.4 0.1 %(100.0)%$0.1 — %$1.0 0.1 %(90.0)%
Net income attributable to Evoqua Water Technologies Corp.$13.2 3.6 %$21.4 6.2 %(38.3)%$24.6 2.4 %$82.3 7.9 %(70.1)%
Weighted average shares outstanding
Basic119.0 116.6 119.0 116.6 
Diluted122.3 120.2 122.3 121.1 
Earnings per share
Basic$0.11 $0.18 $0.21 $0.71 
Diluted$0.11 $0.18 $0.20 $0.68 
Other financial data:
Adjusted EBITDA(1)$66.2 17.9 %$63.8 18.3 %3.8 %$169.0 16.3 %$164.1 15.7 %3.0 %

(1)Adjusted EBITDA is a non-GAAP financial measure. For a reconciliation to net income (loss), its most directly comparable financial measure presented in accordance with GAAP, see “Non-GAAP Reconciliations” in Item 2 of this Report.
Consolidated Results for the Three Months Ended June 30, 2021 and 2020
Revenue-Revenue increased $21.9 million, or 6.3%, to $369.7 million in the three months ended June 30, 2021, from $347.8 million in the three months ended June 30, 2020. Revenue from product sales increased $10.8 million, or 5.2%, to $218.4 million in the three months ended June 30, 2021, from $207.6 million in the three months ended June 30, 2020. Revenue from services increased $11.1 million, or 7.9%, to $151.3 million in the three months ended June 30, 2021, from $140.2 million in the three months ended June 30, 2020.
45


The following tables provide the change in revenue by offering and the change in revenue by driver during the three months ended June 30, 2021 and 2020:
Three Months Ended June 30,
20212020$ Variance% Variance
(In millions)
% of
Revenue
% of
Revenue
Revenue from product sales:
Capital$156.0 42.2 %$150.4 43.2 %$5.6 3.7 %
Aftermarket62.4 16.9 %57.2 16.4 %5.2 9.1 %
Revenue from services151.3 40.9 %140.2 40.3 %11.1 7.9 %
$369.7 100.0 %$347.8 100.0 %$21.9 6.3 %
Three Months Ended June 30,
20212020$ Variance% Variance
(In millions)
% of
Revenue
% of
Revenue
Organic$358.1 96.9 %$347.0 99.8 %$11.1 3.2 %
Inorganic4.1 1.1 %0.8 0.2 %3.3 0.9 %
Foreign currency translation7.5 2.0 %n/an/a7.5 2.1 %
$369.7 100.0 %$347.8 100.0 %$21.9 6.3 %
The increase in organic revenue was primarily driven by increased pricing across all offerings. The increase was also driven by higher service sales volume as demand improved, primarily in North America, following economic closures and delays that occurred in the prior year period due to the COVID-19 pandemic. In addition, higher sales volume from product sales across multiple product lines, primarily in the Asia Pacific and EMEA regions, partially offset a decline in capital sales volume from projects in the microelectronics end market as compared to the prior year period. Revenue also increased due to contributions from acquisitions and favorable foreign currency translation.
Cost of sales and gross margin-Total gross margin decreased slightly to 31.6% in the three months ended June 30, 2021, from 31.7% in the three months ended June 30, 2020.
The following table provides the change in cost of product sales and cost of services, respectively, along with related gross margins:
Three Months Ended June 30,
20212020
(In millions)
Gross
Margin
Gross
Margin
Cost of product sales$(152.6)30.1 %$(143.5)30.9 %
Cost of services(100.1)33.8 %(94.1)32.9 %
$(252.7)31.6 %$(237.6)31.7 %
Gross margin from product sales decreased by 80 basis points (“bps”) to 30.1% in the three months ended June 30, 2021, from 30.9% in the three months ended June 30, 2020. This decrease was primarily driven by product mix, which was influenced by delays and economic closures related to the COVID-19 pandemic, coupled with timing of large projects. This was partially offset by positive price realization.
Gross margin from services increased by 90 bps to 33.8% in the three months ended June 30, 2021, from 32.9% in the three months ended June 30, 2020. This increase was primarily driven by increased service productivity as negative impacts from the COVID-19 pandemic lessened in the current year period.
46


Operating expenses-Operating expenses increased $12.6 million, or 16.3%, to $90.1 million in the three months ended June 30, 2021, from $77.5 million in the three months ended June 30, 2020. Operating expenses are comprised of the following:
Three Months Ended June 30,
20212020
(In millions)% of Revenue% of Revenue% Variance
General and administrative expense$(50.8)(13.7)%$(44.9)(12.9)%13.1 %
Sales and marketing expense(35.9)(9.7)%(29.8)(8.6)%20.5 %
Research and development expense(3.4)(0.9)%(2.8)(0.8)%21.4 %
Total operating expenses$(90.1)(24.4)%$(77.5)(22.3)%16.3 %
The increase period over period in operating expenses was primarily due to increased employee related expenses as well as a reduction in foreign currency translation gains from the prior period, most of which is related to intercompany loans. In addition, there was an increase in amortization expense from acquisitions in the current period, increased sales and marketing expenses, and higher consulting expenses. The above increases were partially offset by reduced spending across various areas as well as favorable settlement on outstanding insurance claims in the current period.
Other operating income, net-Other operating income, net increased $1.0 million to $1.4 million in the three months ended June 30, 2021, from $0.4 million in the three months ended June 30, 2020. This increase was primarily due to COVID-19 pandemic subsidies received from the Canadian government.
Interest expense-Interest expense increased $0.7 million, or 6.7%, to $11.2 million in the three months ended June 30, 2021, from $10.5 million in the three months ended June 30, 2020. The increase in interest expense was primarily due to an additional $3.1 million of fees incurred as a result of the April 2021 refinancing of our senior credit facility, which also resulted in the write off of $1.3 million of deferred financing fees. This was partially offset by a reduction in ongoing interest expense due to the change in the interest rate spread and LIBOR year over year as well as debt reduction undertaken in the April 2021 refinancing.
Income tax expense-Income tax expense increased to $3.9 million in the three months ended June 30, 2021, as compared to income tax expense of $0.8 million in the three months ended June 30, 2020. The increase in tax expense was primarily due to higher earnings in non-U.S. tax jurisdictions, which increases tax expense, and lower earnings in the U.S., which does not impact tax expense due to the U.S. valuation allowance. Additionally, the prior period benefited from the impact of the Memcor disposal, which created a low PAETR and tax expense for the three months ended June 30, 2020.

Net income-Net income decreased $8.6 million, or 39.4%, to $13.2 million in the three months ended June 30, 2021, from $21.8 million in the three months ended June 30, 2020, as a result of the variances noted above.
Adjusted EBITDA-Adjusted EBITDA is a non-GAAP financial measure. Adjusted EBITDA for the three months ended June 30, 2021 increased by $2.4 million, or 3.8%, to $66.2 million, as compared to $63.8 million for the three months ended June 30, 2020, primarily driven by higher sales volume in the current period. See “Non-GAAP Reconciliations” in Item 2 of this Report for a reconciliation of adjusted EBITDA.
47


Segment Results
Three Months Ended June 30,
20212020
(In millions)% of Revenue% of Revenue% Variance
Revenue
Integrated Solutions and Services$239.7 64.8 %$228.7 65.8 %4.8 %
Applied Product Technologies130.0 35.2 %119.1 34.2 %9.2 %
Total Consolidated$369.7 100.0 %$347.8 100.0 %6.3 %
Operating profit (loss)
Integrated Solutions and Services$37.8 10.2 %$32.6 9.4 %16.0 %
Applied Product Technologies22.7 6.1 %23.6 6.8 %(3.8)%
Corporate(32.2)(8.7)%(23.1)(6.6)%39.4 %
Total Consolidated$28.3 7.7 %$33.1 9.5 %(14.5)%
Adjusted EBITDA (1)
Integrated Solutions and Services$56.3 15.2 %$50.6 14.5 %11.3 %
Applied Product Technologies28.4 7.7 %28.9 8.3 %(1.7)%
Corporate(18.5)(5.0)%(15.7)(4.5)%17.8 %
Total Consolidated$66.2 17.9 %$63.8 18.3 %3.8 %

(1)Adjusted EBITDA is a non-GAAP financial measure. For a reconciliation to segment operating profit (loss), its most directly comparable financial measure presented in accordance with GAAP, see “Non-GAAP Reconciliations” in Item 2 of this Report.
Integrated Solutions and Services
Revenue in the Integrated Solutions and Services segment increased $11.0 million, or 4.8%, to $239.7 million in the three months ended June 30, 2021, from $228.7 million in the three months ended June 30, 2020.
The following tables provide the change in revenue by offering and the change in revenue by driver during the three months ended June 30, 2021 and 2020 for the Integrated Solutions and Services segment:
Three Months Ended June 30,
20212020$ Variance% Variance
(In millions)
% of
Revenue
% of
Revenue
Revenue from product sales:
Capital$63.3 26.4 %$64.7 28.3 %$(1.4)(2.2)%
Aftermarket31.9 13.3 %29.1 12.7 %2.8 9.6 %
Revenue from services144.5 60.3 %134.9 59.0 %9.6 7.1 %
$239.7 100.0 %$228.7 100.0 %$11.0 4.8 %
Three Months Ended June 30,
20212020$ Variance% Variance
(In millions)
% of
Revenue
% of
Revenue
Organic$234.1 97.7 %$227.9 99.7 %$6.2 2.7 %
Inorganic4.1 1.7 %0.8 0.3 %3.3 1.4 %
Foreign currency translation1.5 0.6 %n/an/a1.5 0.7 %
$239.7 100.0 %$228.7 100.0 %$11.0 4.8 %

The increase in organic revenue was driven by higher sales volume across a variety of end markets, primarily in service and aftermarket revenue as demand improved following economic closures and delays that occurred in the prior
48


year period due to the COVID-19 pandemic. Favorable pricing also contributed to the increase. Lower capital sales volume was driven by a decline in projects in the microelectronics end market, which was mostly offset by new projects primarily in the chemical processing end market as compared to the prior year period.
Operating profit in the Integrated Solutions and Services segment increased $5.2 million, or 16.0%, to $37.8 million in the three months ended June 30, 2021, from $32.6 million in the three months ended June 30, 2020.
aqua-20210630_g1.jpg
Operating profit was favorably impacted by higher sales volume, favorable price/cost, and productivity improvements as the negative impacts from the COVID-19 pandemic lessened in the current year period. Operating profit was unfavorably impacted by higher employee-related expenses, which included increased compensation and travel spending as compared to the prior year period, partially offset by favorable settlement of insurance claims.
Adjusted EBITDA is a non-GAAP financial measure. Adjusted EBITDA in the Integrated Solutions and Services segment increased $5.7 million, or 11.3%, to $56.3 million in the three months ended June 30, 2021, compared to $50.6 million in the three months ended June 30, 2020. The increase was driven by the same factors that impacted operating profit, other than the change in depreciation and amortization, and also excludes restructuring and other non-recurring activity recognized in the period. See “Non-GAAP Reconciliations” in Item 2 of this Report for a reconciliation of adjusted EBITDA.
Applied Product Technologies
Revenue in the Applied Product Technologies segment increased $10.9 million, or 9.2%, to $130.0 million in the three months ended June 30, 2021, from $119.1 million in the three months ended June 30, 2020.
The following tables provide the change in revenue by offering and the change in revenue by driver during the three months ended June 30, 2021 and 2020 for the Applied Product Technologies segment:
Three Months Ended June 30,
20212020$ Variance% Variance
(In millions)
% of
Revenue
% of
Revenue
Revenue from product sales:
Capital$92.7 71.3 %$85.7 72.0 %$7.0 8.2 %
Aftermarket30.5 23.5 %28.1 23.6 %2.4 8.5 %
Revenue from services6.8 5.2 %5.3 4.5 %1.5 28.3 %
$130.0 100.0 %$119.1 100.0 %$10.9 9.2 %
49


Three Months Ended June 30,
20212020$ Variance% Variance
(In millions)
% of
Revenue
% of
Revenue
Organic$124.0 95.4 %$119.1 100.0 %$4.9 4.2 %
Inorganic— — %— — %— — %
Foreign currency translation6.0 4.6 %n/an/a6.0 4.9 %
$130.0 100.0 %$119.1 100.0 %$10.9 9.2 %

The increase in organic revenue as compared to the prior year period was primarily due to price realization. The increase was also due to sales volume increases in the Asia Pacific and EMEA regions, compared to the prior year period resulting from growth across multiple product lines, which was offset by sales volume declines in the Americas region due to continued customer site access challenges and delays.
Operating profit in the Applied Product Technologies segment decreased $0.9 million, or 3.8%, to $22.7 million in the three months ended June 30, 2021, from $23.6 million in the three months ended June 30, 2020.
aqua-20210630_g2.jpg
The decline in operating profit was primarily due to unfavorable operational variances, including additional warranty reserves and production variances, offsetting favorable price/cost and product mix. Higher employee related expenses also reduced segment profitability as compared to the prior year period, which was driven by increased compensation and travel spending.
Adjusted EBITDA is a non-GAAP financial measure. Adjusted EBITDA in the Applied Product Technologies segment decreased $0.5 million, or 1.7%, to $28.4 million in the three months ended June 30, 2021, compared to $28.9 million in the three months ended June 30, 2020. The decrease was driven by the same factors that impacted operating profit, other than the change in depreciation and amortization, and also excludes restructuring and other non-recurring activity. See “Non-GAAP Reconciliations” in Item 2 of this Report for a reconciliation of adjusted EBITDA.
50


Corporate
Operating loss in Corporate increased $9.1 million, or 39.4%, to $32.2 million in the three months ended June 30, 2021, from $23.1 million in the three months ended June 30, 2020. The increase period over period was primarily due to higher employee related expenses as compared to the prior year period. In addition, there were lower foreign currency translation gains compared to the prior period, most of which is related to intercompany loans. Finally, share-based compensation expenses increased compared to the prior period due primarily to special one-time restricted stock unit and performance share unit awards granted to our executive leadership team in May 2021 to promote retention, reward performance and incentivize further stockholder return.
Consolidated Results for the Nine Months Ended June 30, 2021 and 2020
Revenue-Revenue decreased $7.2 million, or 0.7%, to $1,038.4 million in the nine months ended June 30, 2021, from $1,045.6 million in the nine months ended June 30, 2020. Revenue from product sales decreased $9.2 million, or 1.5%, to $600.9 million in the nine months ended June 30, 2021, from $610.1 million in the nine months ended June 30, 2020. Revenue from services increased $2.0 million, or 0.5%, to $437.5 million in the nine months ended June 30, 2021, from $435.5 million in the nine months ended June 30, 2020.
The following tables provide the change in revenue by offering and the change in revenue by driver during the nine months ended June 30, 2021 and 2020:
Nine Months Ended June 30,
20212020$ Variance% Variance
(In millions)
% of
Revenue
% of
Revenue
Revenue from product sales:
Capital$425.9 41.0 %$421.2 40.3 %$4.7 1.1 %
Aftermarket175.0 16.9 %188.9 18.1 %(13.9)(7.4)%
Revenue from services437.5 42.1 %435.5 41.7 %2.0 0.5 %
$1,038.4 100.0 %$1,045.6 100.0 %$(7.2)(0.7)%
Nine Months Ended June 30,
20212020$ Variance% Variance
(In millions)
% of
Revenue
% of
Revenue
Organic$1,017.0 97.9 %$1,030.3 98.5 %$(13.3)(1.3)%
Inorganic6.5 0.6 %15.3 1.5 %(8.8)(0.8)%
Foreign currency translation14.9 1.4 %n/an/a14.9 1.4 %
$1,038.4 100.0 %$1,045.6 100.0 %$(7.2)(0.7)%
The decrease in organic revenue was driven by lower sales volume, primarily in product sales in the Americas and EMEA regions, due to continued customer site access challenges and delays in the first half of fiscal 2021 as a result of the COVID-19 pandemic. In addition, lower sales volume in capital revenue was related to the timing of completion of prior year projects in the microelectronics end market. These decreases were partially offset by sales volume growth from product sales in the Asia Pacific region across multiple product lines, as demand improved following prior year economic closures, and favorable price realization related to established service contracts.
Favorable foreign currency translation more than offset the reduction in revenue due to the prior year divestiture of the Memcor product line.
Cost of sales and gross margin-Total gross margin decreased to 30.7% in the nine months ended June 30, 2021, from 31.3% in the nine months ended June 30, 2020.
51


The following table provides the change in cost of product sales and cost of services, respectively, along with related gross margins:
Nine Months Ended June 30,
20212020
(In millions)
Gross
Margin
Gross
Margin
Cost of product sales$(428.2)28.7 %$(428.0)29.8 %
Cost of services(291.9)33.3 %(290.4)33.3 %
$(720.1)30.7 %$(718.4)31.3 %
Gross margin from product sales decreased by 110 bps to 28.7% in the nine months ended June 30, 2021, from 29.8% in the nine months ended June 30, 2020. The decrease in gross margin was primarily driven by product mix, which was influenced by delays and economic closures related to the COVID-19 pandemic, coupled with timing of large projects. This was partially offset by positive price realization.
Gross margin from services was 33.3% in both the nine months ended June 30, 2021 and 2020.
Operating expenses-Operating expenses decreased $4.7 million, or 1.8%, to $259.6 million in the nine months ended June 30, 2021, from $264.3 million in the nine months ended June 30, 2020. Operating expenses are comprised of the following:
Nine Months Ended June 30,
20212020
(In millions)% of Revenue% of Revenue% Variance
General and administrative expense$(146.1)(14.1)%$(152.8)(14.6)%(4.4)%
Sales and marketing expense(103.6)(10.0)%(101.8)(9.7)%1.8 %
Research and development expense(9.9)(1.0)%(9.7)(0.9)%2.1 %
Total operating expenses$(259.6)(25.0)%$(264.3)(25.3)%(1.8)%
The decrease period over period in operating expenses was primarily due to efforts taken by the Company to reduce spending across various areas in response to uncertainties related to the COVID-19 pandemic, such as reduced travel, particularly in the first half of fiscal 2021. In addition, there was improved collection experience in the current period, as well as a write off of accounts receivable that occurred in the prior year, which did not reoccur in the current year. Finally, general and administrative expenses include foreign currency translation gains of approximately $4.6 million in the nine months ended June 30, 2021 compared to foreign currency translation gains of approximately $2.4 million in the prior year period, most of which were related to intercompany loans. These decreases were partially offset by increased employee related expenses, increased amortization expense due to acquisitions in the current period, an increase in external legal fees, as well as a benefit in the prior year related to changes in the estimates of certain acquisitions achieving their earn-out targets.
Other operating income, net-Other operating income, net decreased $59.0 million to $2.0 million in the nine months ended June 30, 2021, from $61.0 million in the nine months ended June 30, 2020. The decrease is primarily due to the net pre-tax benefit on the sale of the Memcor product line of $58.0 million, which is net of $8.3 million of discretionary compensation payments to employees in connection with the transaction and $1.0 million in transaction costs incurred in the first quarter of 2020. In the nine months ended June 30, 2021, other operating income, net includes COVID-19 pandemic subsidies received from the Canadian government.
Interest expense-Interest expense decreased $9.0 million, or 24.1%, to $28.3 million in the nine months ended June 30, 2021, from $37.3 million in the nine months ended June 30, 2020. The decrease in interest expense was primarily driven by a reduction in the interest rate spread and LIBOR year over year, in addition to a $100.0 million debt prepayment that occurred in January 2020 and decreased debt as a result of the April 2021 refinancing of our senior credit facility.
52


Income tax expense-Income tax expense increased $4.4 million to $7.7 million in the nine months ended June 30, 2021, from $3.3 million in the nine months ended June 30, 2020. Income tax expense increased due to the recognition of discrete items in the current period related to an adjustment for prepaid income taxes and an uncertain tax position in connection with a tax audit in a foreign jurisdiction, Additionally, income tax expense increased due to higher earnings innon-U.S. tax jurisdictions, which increases tax expense, and lower earnings in the U.S., which does not impact tax expense due to the U.S. valuation allowance.

Net income-Net income decreased $58.6 million, or 70.3%, to $24.7 million in the nine months ended June 30, 2021, from $83.3 million in the nine months ended June 30, 2020, as a result of the variances noted above.
Adjusted EBITDA-Adjusted EBITDA is a non-GAAP financial measure. Adjusted EBITDA for the nine months ended June 30, 2021 increased by $4.9 million, or 3.0%, to $169.0 million, as compared to $164.1 million for the nine months ended June 30, 2020, primarily driven by operational efficiencies and cost savings, offset by the changes as compared to the prior year period in non-recurring expenses and benefits. See “Non-GAAP Reconciliations” in Item 2 of this Report for a reconciliation of adjusted EBITDA.
Segment Results
Nine Months Ended June 30,
20212020
(In millions)% of Revenue% of Revenue% Variance
Revenue
Integrated Solutions and Services$678.5 65.3 %$694.7 66.4 %(2.3)%
Applied Product Technologies359.9 34.7 %350.9 33.6 %2.6 %
Total Consolidated$1,038.4 100.0 %$1,045.6 100.0 %(0.7)%
Operating profit (loss)
Integrated Solutions and Services$94.9 9.1 %$102.5 9.8 %(7.4)%
Applied Product Technologies54.2 5.2 %110.5 10.6 %(51.0)%
Corporate(88.4)(8.5)%(89.1)(8.5)%(0.8)%
Total Consolidated$60.7 5.8 %$123.9 11.8 %(51.0)%
Adjusted EBITDA (1)
Integrated Solutions and Services$148.8 14.3 %$153.5 14.7 %(3.1)%
Applied Product Technologies72.6 7.0 %66.5 6.4 %9.2 %
Corporate(52.4)(5.0)%(55.9)(5.3)%(6.3)%
Total Consolidated$169.0 16.3 %$164.1 15.7 %3.0 %

(1)Adjusted EBITDA is a non-GAAP financial measure. For a reconciliation to segment operating profit (loss), its most directly comparable financial measure presented in accordance with GAAP, see “Non-GAAP Reconciliations” in Item 2 of this Report.
Integrated Solutions and Services
Revenue in the Integrated Solutions and Services segment decreased $16.2 million, or 2.3%, to $678.5 million in the nine months ended June 30, 2021, from $694.7 million in the nine months ended June 30, 2020.
53


The following tables provide the change in revenue by offering and the change in revenue by driver during the nine months ended June 30, 2021 and 2020 for the Integrated Solutions and Services segment:
Nine Months Ended June 30,
20212020$ Variance% Variance
(In millions)
% of
Revenue
% of
Revenue
Revenue from product sales:
Capital$166.0 24.5 %$185.4 26.7 %$(19.4)(10.5)%
Aftermarket91.5 13.5 %90.7 13.1 %0.8 0.9 %
Revenue from services421.0 62.0 %418.6 60.3 %2.4 0.6 %
$678.5 100.0 %$694.7 100.0 %$(16.2)(2.3)%
Nine Months Ended June 30,
20212020$ Variance% Variance
(In millions)
% of
Revenue
% of
Revenue
Organic$670.0 98.7 %$693.8 99.9 %$(23.8)(3.4)%
Inorganic6.5 1.0 %0.9 0.1 %5.6 0.8 %
Foreign currency translation2.0 0.3 %n/an/a2.0 0.3 %
$678.5 100.0 %$694.7 100.0 %$(16.2)(2.3)%

The decrease in organic revenue was driven by lower sales volume, primarily in capital revenue, related to the timing of completion of projects in the microelectronics end market and temporary customer site closures and delays in annual maintenance in the oil and gas refining end markets in the first half of fiscal 2021 due to the COVID-19 pandemic in North America. This was partially offset by growth in service and aftermarket revenue, including sales volume growth in a variety of end markets, as well as favorable price realization related to established service contracts.
Operating profit in the Integrated Solutions and Services segment decreased $7.6 million, or 7.4%, to $94.9 million in the nine months ended June 30, 2021, from $102.5 million in the nine months ended June 30, 2020.
aqua-20210630_g3.jpg
Operating profit was unfavorably impacted by sales volume and mix, lower productivity due to customer shutdowns and enhanced safety protocols as a result of the COVID-19 pandemic in the first half of fiscal 2021, as well as some challenges filling open positions. In addition, operating profit was negatively impacted by increased operating costs based on changes in allocation methodologies for corporate expenses. These declines were partially offset by favorable price/cost and reductions in travel and other discretionary spending in the current period.
Adjusted EBITDA is a non-GAAP financial measure. Adjusted EBITDA in the Integrated Solutions and Services segment decreased $4.7 million, or 3.1%, to $148.8 million in the nine months ended June 30, 2021, compared
54


to $153.5 million in the nine months ended June 30, 2020. The decline was driven by the same factors that impacted operating profit, other than the change in depreciation and amortization, and also excludes restructuring and other non-recurring activity. See “Non-GAAP Reconciliations” in Item 2 of this Report for a reconciliation of adjusted EBITDA.
Applied Product Technologies
Revenue in the Applied Product Technologies segment increased $9.0 million, or 2.6%, to $359.9 million in the nine months ended June 30, 2021, from $350.9 million in the nine months ended June 30, 2020.
The following tables provide the change in revenue by offering and the change in revenue by driver during the nine months ended June 30, 2021 and 2020 for the Applied Product Technologies segment:
Nine Months Ended June 30,
20212020$ Variance% Variance
(In millions)
% of
Revenue
% of
Revenue
Revenue from product sales:
Capital$259.9 72.2 %$235.8 67.2 %$24.1 10.2 %
Aftermarket83.5 23.2 %98.2 28.0 %(14.7)(15.0)%
Revenue from services16.5 4.6 %16.9 4.8 %(0.4)(2.4)%
$359.9 100.0 %$350.9 100.0 %$9.0 2.6 %
Nine Months Ended June 30,
20212020$ Variance% Variance
(In millions)
% of
Revenue
% of
Revenue
Organic$347.0 96.4 %$336.5 95.9 %$10.5 3.1 %
Inorganic— — %14.4 4.1 %(14.4)(4.1)%
Foreign currency translation12.9 3.6 %n/an/a12.9 3.6 %
$359.9 100.0 %$350.9 100.0 %$9.0 2.6 %
The increase in organic revenue was driven by sales volume growth from product sales in the Asia Pacific region across multiple product lines, as demand improved following economic closures that occurred in the prior year due to the COVID-19 pandemic. This growth was partially offset by declines across multiple product lines in the Americas and EMEA regions as a result of continued customer site access challenges and delays. In addition, the divestiture of the Memcor product line reduced revenue by $14.4 million as compared to the prior year period while foreign currency was favorable by $12.9 million.
55


Operating profit in the Applied Product Technologies segment decreased $56.3 million, or 51.0%, to $54.2 million in the nine months ended June 30, 2021, from $110.5 million in the nine months ended June 30, 2020.
aqua-20210630_g4.jpg
The decline in operating profit was primarily related to the net pre-tax benefit on the sale of the Memcor product line of $58.0 million recognized in the prior year, which was net of $8.3 million of discretionary compensation payments to employees in connection with the transaction and $1.0 million in transaction costs incurred. Operating profit was also impacted by the reduction in sales volume as a result of the sale of the Memcor product line. These declines were partially offset by favorable organic sales volume, product mix and price, which offset inflation, as well as improvement in operational efficiencies due to global plant consolidations and cost containment measures.
Adjusted EBITDA is a non-GAAP financial measure. Adjusted EBITDA in the Applied Product Technologies segment increased $6.1 million, or 9.2%, to $72.6 million in the nine months ended June 30, 2021, compared to $66.5 million in the nine months ended June 30, 2020. The increase was driven by the same factors that impacted operating profit, other than the change in depreciation and amortization, and also excludes other non-recurring activity, including the $58.0 million gain recognized in the prior year related to the divestiture of the Memcor product line. See “Non-GAAP Reconciliations” in Item 2 of this Report for a reconciliation of adjusted EBITDA.
Corporate
Operating loss in Corporate decreased $0.7 million, or 0.8%, to $88.4 million in the nine months ended June 30, 2021, from $89.1 million in the nine months ended June 30, 2020. The decrease period over period was primarily due to foreign currency translation gains of approximately $5.1 million in the nine months ended June 30, 2021 compared to foreign currency translation gains of approximately $2.5 million in the prior year period, most of which were related to intercompany loans. Additionally, the decrease was driven by reductions in discretionary spending compared to the prior period. This was partially offset by increases in expenses associated with share-based compensation and shareholder litigation in the current period.

Non-GAAP Reconciliations
The following is a reconciliation of total revenue to organic revenue for the three months ended June 30, 2021:

56


Total RevenueForeign Currency
Inorganic Revenue(1)
Organic Revenue
Three Months Ended June 30,% VarianceThree Months Ended June 30,% VarianceThree Months Ended June 30,% VarianceThree Months Ended June 30,% Variance
(In millions)20202021202020212020202120202021
Evoqua Water Technologies$347.8$369.76.3 %n/a$7.52.1 %$0.8$4.10.9 %$347.0$358.13.2 %
Integrated Solutions & Services$228.7$239.74.8 %n/a$1.50.7 %$0.8$4.11.4 %$227.9$234.12.7 %
Applied Product Technologies$119.1$130.09.2 %n/a$6.04.9 %$—$—— %$119.1$124.04.2 %

(1)Includes divestiture of the Lange Product Line on March 1, 2021, acquisition of Aquapure Technologies on September 3, 2020, acquisition of Ultrapure & Industrial Services on December 17, 2020 and acquisition of WCSI on April 1, 2021.

The following is a reconciliation of total revenue to organic revenue for the nine months ended June 30, 2021:

Total RevenueForeign Currency
Inorganic Revenue(1)
Organic Revenue
Nine Months Ended June 30,% VarianceNine Months Ended June 30,% VarianceNine Months Ended June 30,% VarianceNine Months Ended June 30,% Variance
(In millions)20202021202020212020202120202021
Evoqua Water Technologies$1,045.6$1,038.4(0.7)%n/a$14.91.4 %$15.3$6.5(0.8)%$1,030.3$1,017.0(1.3)%
Integrated Solutions & Services$694.7$678.5(2.3)%n/a$2.00.3 %$0.9$6.50.8 %$693.8$670.0(3.4)%
Applied Product Technologies$350.9$359.92.6 %n/a$12.93.6 %$14.4$—(4.1)%$336.5$347.03.1 %

(1)Includes divestiture of the Memcor product line on December 31, 2019, divestiture of the Lange Product Line on March 1, 2021, acquisition of Aquapure Technologies on September 3, 2020, acquisition of Ultrapure & Industrial Services on December 17, 2020 and acquisition of WCSI on April 1, 2021.
The following is a reconciliation of our Net income (loss) to Adjusted EBITDA (unaudited, amounts in millions):adjusted EBITDA. Amounts excluded relate to items that management believes do not reflect the underlying, ongoing operational performance of the business as a result of their nature or size and/or are non-recurring and would not be expected to occur as part of our normal business on a regular basis:
57


Three Months Ended
June 30,
Nine Months Ended
June 30,
Three Months Ended
June 30,
 Nine Months Ended
June 30,
2020 2019 2020 2019
Net income (loss)$21.8
 $4.3
 $83.3
 $(10.4)
Income tax expense (benefit)0.8
 7.9
 3.3
 (1.2)
(In millions)(In millions)20212020% Variance20212020% Variance
Net incomeNet income$13.2 $21.8 (39.4)%$24.8 $83.3 (70.2)%
Income tax expenseIncome tax expense3.9 0.8 387.5%7.7 3.3 133.3 %
Interest expense10.5
 14.9
 37.3
 43.8
Interest expense11.2 10.5 6.7 %28.3 37.3 (24.1)%
Operating profit33.1
 27.1
 123.9
 32.2
Operating profit$28.3 $33.1 (14.5)%$60.8 $123.9 (50.9)%
Depreciation and amortization27.6
 24.1
 80.1
 71.4
Depreciation and amortization29.1 27.6 5.4 %83.6 80.1 4.4 %
EBITDA60.7
 51.2
 204.0
 103.6
EBITDA$57.4 $60.7 (5.4)%$144.4 $204.0 (29.2)%
Restructuring and related business transformation costs (a)3.1
 4.5
 11.0
 18.5
Restructuring and related business transformation costs (a)1.8 3.1 (41.9)%9.0 11.0 (18.2)%
Share-based compensation (b)2.6
 5.0
 8.6
 14.3
Share-based compensation (b)5.5 2.6 111.5 %11.8 8.6 37.2 %
Transaction costs (c)0.3
 1.0
 1.0
 5.5
Transaction costs (c)0.3 0.3 — %1.6 1.0 60.0 %
Other (gains) losses and expenses (d)(2.9) (1.1) (60.5) 13.8
Other losses (gains) and expenses (d)Other losses (gains) and expenses (d)1.2 (2.9)(141.4)%2.2 (60.5)(103.6)%
Adjusted EBITDA$63.8
 $60.6
 $164.1
 $155.7
Adjusted EBITDA$66.2 $63.8 3.8 %$169.0 $164.1 3.0 %
(a)Restructuring and related business transformation costs
Adjusted EBITDA is calculated prior to considering certain restructuring or business transformation events. These events may occur over extended periods of time, and in some cases it is reasonably possible that they could reoccur in future periods based on reorganizations of the business, cost reduction or productivity improvement needs, or in response to economic conditions. For the periods presented such events include the following:
(i)Certain costs and expenses in connection with various restructuring initiatives, including severance costs, relocation costs, recruiting expenses, and third-party consultant costs to assist with these initiatives. This includes:
(A) amounts related to the Company’s restructuring initiatives to reduce the cost structure and rationalize location footprint following the sale of the Memcor product line;
(B) amounts related to the Company’s transition from a three-segment structure to a two-segment operating model designed to better serve the needs of customers worldwide; and
(C)amounts related to various other initiatives implemented to restructure and reorganize our business with the appropriate management team and cost structure.

(i)Certain costs and expenses in connection with various restructuring initiatives, including severance and other employee-related costs, relocation and facility consolidation costs, and third-party consultant costs to assist with these initiatives. This includes:
(A)amounts related to the Company’s restructuring initiatives to reduce the cost structure and rationalize location footprint following the sale of the Memcor product line;
(B)amounts related to the Company’s transition from a three-segment structure to a two-segment operating model designed to better serve the needs of customers worldwide; and
(C)amounts related to various other initiatives implemented to restructure and reorganize our business with the appropriate management team and cost structure.
58


Three Months Ended
June 30,
Nine Months Ended
June 30,
(In millions)(In millions)2021202020212020
Post Memcor divestiture restructuring(1)
$0.7 $1.2 $4.6 $4.9 
Cost of product sales and services (“Cost of sales”)Cost of product sales and services (“Cost of sales”)0.3 0.8 3.4 3.7 
Sales and marketing expense (“S&M expense”)Sales and marketing expense (“S&M expense”)— (0.1)0.2 — 
General and administrative expense (“G&A expense”)General and administrative expense (“G&A expense”)0.4 0.5 0.7 1.2 
Other operating (income) expenseOther operating (income) expense— — 0.3 — 
Two-segment restructuringTwo-segment restructuring$0.2 $0.6 $0.8 $1.9 
Cost of salesCost of sales0.1 0.4 0.3 1.0 
Three Months Ended
June 30,
 Nine Months Ended
June 30,
2020 2019 2020 2019
Post Memcor divestiture restructuring(1)
$1.2
 $
 $4.9
 $
Cost of product sales and services ("Cost of sales")0.8
 
 3.7
 
G&A expenseG&A expense0.1 0.2 0.5 0.9 
Other operating (income) expenseOther operating (income) expense— — — — 
Various other initiativesVarious other initiatives$0.5 $0.5 $2.0 $1.0 
Cost of salesCost of sales0.5 0.3 1.0 0.7 
S&M expense(0.1) 
 
 
S&M expense0.1 0.1 0.2 0.1 
G&A expense0.5
 
 1.2
 
G&A expense— 0.1 0.4 0.2 
Two-segment restructuring(2)
$0.6
 $2.9
 $1.9
 $9.9
Cost of sales0.4
 1.4
 1.0
 4.1
R&D expense
 
 
 0.1
S&M expense
 0.3
 
 0.9
G&A expense0.2
 1.2
 0.9
 4.8
Various other initiatives(3)
$0.5
 $0.6
 $1.0
 $1.3
Cost of sales0.3
 0.2
 0.7
 0.7
S&M expense0.1
 
 0.1
 
G&A expense0.1
 0.4
 0.2
 0.6
Total$2.3
 $3.5
 $7.8
 $11.2
Other operating (income) expenseOther operating (income) expense(0.1)— 0.4 — 
Total(1)
Total(1)
$1.4 $2.3 $7.4 $7.8 
(1)
(1)Of which $7.0 million and $7.7 million for the nine months ended June 30, 2021 and 2020, respectively, is reflected in restructuring charges in Note 14, “Restructuring and Related Charges,” in Part I, Item 1 of this Report.
(ii)Legal settlement costs and intellectual property related fees including fees and settlement costs associated with legacy matters, related to product warranty litigation on MEMCOR® products and certain discontinued products. This includes:
Three Months Ended
June 30,
Nine Months Ended
June 30,
(In millions)2021202020212020
Cost of sales$0.1 $0.3 $0.3 $0.5 
G&A expense0.3 0.1 0.5 0.3 
Total$0.4 $0.4 $0.8 $0.8 
(iii)Expenses associated with our information technology and functional infrastructure transformation, including activities to optimize information technology systems and functional infrastructure processes. This includes:
Three Months Ended
June 30,
Nine Months Ended
June 30,
(In millions)2021202020212020
Cost of sales$— $— $0.1 $0.1 
G&A expense— (0.1)0.1 0.6 
Total$— $(0.1)$0.2 $0.7 
(iv)Costs associated with the secondary public offering of common stock held by certain shareholders of the Company, as well as costs incurred by us in connection with establishment of our public company compliance structure and processes, including consultant costs. This includes:
of which $4.8 million is reflected in restructuring charges in Note 13, “Restructuring and Related Charges” in Part I, Item 1 of this Quarterly Report on Form 10-Q (the “Restructuring Footnote”) in the nine months ended June 30, 2020.
(2)
of which $1.9 million and $9.3 million is reflected in the Restructuring Footnote in the nine months ended June 30, 2020 and 2019, respectively.
(3)
all of which is reflected in the Restructuring Footnote in the nine months ended June 30, 2020 and 2019, respectively.
(ii)legal settlement costs and intellectual property related fees associated with legacy matters prior to the AEA Acquisition, including fees and settlement costs related to product warranty litigation on Memcor products and certain discontinued products. This includes:
59


 Three Months Ended
June 30,
 Nine Months Ended
June 30,
 2020 2019 2020 2019
Cost of sales$0.3
 $0.1
 $0.5
 $0.2
G&A expense0.1
 0.2
 0.3
 0.7
Total$0.4
 $0.3
 $0.8
 $0.9
(iii)expenses associated with our information technology and functional infrastructure transformation subsequent to the AEA Acquisition, including activities to optimize information technology systems and functional infrastructure processes. This includes:
Three Months Ended
June 30,
Nine Months Ended
June 30,
(In millions)2021202020212020
G&A expense$— $0.5 $0.6 $1.7 
Total$— $0.5 $0.6 $1.7 
 Three Months Ended
June 30,
 Nine Months Ended
June 30,
 2020 2019 2020 2019
Cost of sales$
 $0.3
 $0.1
 $0.4
G&A expense(0.1) 0.9
 0.6
 5.9
Total$(0.1) $1.2
 $0.7
 $6.3
(b)Share-based compensation

(iv)costs associated with the secondary public offering of common stock held by certain shareholders of the Company, as well as costs incurred by us in connection with establishment of our public company compliance structure and processes, including consultant costs. This includes:
 Three Months Ended
June 30,
 Nine Months Ended
June 30,
 2020 2019 2020 2019
G&A expense$0.5
 $(0.5) $1.7
 $0.1
Total$0.5
 $(0.5) $1.7
 $0.1
(b)Share-based compensation
Adjusted EBITDA is calculated prior to considering non‑cash share‑based compensation expenses related to equity awards. See Note 16,17, “Share-Based Compensation”Compensation,” in Part I, Item 1 of this Quarterly Report on Form 10-Q for further detail.
(c)Transaction related costs    
(c)Transaction related costs    
Adjusted EBITDA is calculated prior to considering transaction, integration and restructuring costs associated with business combinations because these costs are unique to each transaction and represent costs that were incurred as a result of the transaction decision. Such costs may include, without limitation, consulting and legal costs associated with due diligence and closing a transaction, restructuring and integration costs such as severance, facility consolidation costs, product rationalization or inventory obsolescence charges, system integration or conversion costs, fair value changes associated with contingent consideration, and costs associated with any litigation matters that arise subsequent to our acquisition of a business for which the matter in question preceded the transaction, but was not known, not probable or unresolved at the date of acquisition. We believe that viewing earnings prior to considering these charges provides investors with useful additional perspective because the significant costs incurred in connection with business combinations result primarily from the need to eliminate duplicate assets, activities or employees - a natural result of acquiring or disposing a fully integrated set of activities. Integration and restructuring costs associated with a business combination may occur over several years.years and include, but are not limited to, consulting fees, legal fees, certain employee-related costs, facility consolidation and product rationalization costs, and fair value changes associated with contingent consideration. This includes:
Three Months Ended
June 30,
Nine Months Ended
June 30,
(In millions)2021202020212020
Cost of sales$0.1 $0.1 $0.3 $(0.1)
G&A expense0.2 0.2 1.3 1.1 
Total$0.3 $0.3 $1.6 $1.0 
 Three Months Ended
June 30,
 Nine Months Ended
June 30,
 2020 2019 2020 2019
Cost of sales$0.1
 $0.1
 $(0.1) $1.4
G&A expense0.2
 0.9
 1.1
 4.1
Total$0.3
 $1.0
 $1.0
 $5.5
(d)Other losses, (gains) and expenses
(d)Other (gains), losses and expenses
Adjusted EBITDA is calculated prior to considering certain other significant losses, (gains), losses and expenses. Such significant items represent substantive and/or unusual items that are evaluated on an individual basis. Such evaluation considers both the quantitative and qualitative aspects of their nature and they may be highly variable and difficult to predict. Unusual items may represent items that are not part of our ongoing business, items that, either as a result of their nature or size, we would not expect to occur as part of our normal business on a regular basis, items that would be non-recurring, or items related to products we no longer sell. While not all-inclusive, examples of items that could be included as other (gains), losses and expenses would be amounts related to non-cash foreign currency exchange gains and losses on intercompany loans, significant warranty events, and certain disposals of businesses, products or facilities that do not qualify as discontinued operations under GAAP. For the periods presented such events include the following:
(i)impact of foreign exchange gains and losses;
(ii)foreign exchange impact related to headquarter allocations;

(i)impact of foreign exchange gains and losses;
(iii)expenses on disposal related to maintaining non‑operational business locations, net of gain on sale;
(iv)expenses incurred by the Company related to the remediation of manufacturing defects caused by a third- party vendor;
(v)charges incurred by the Company related to product rationalization in its electro-chlorination business;
(vi)net pre-tax benefit on the sale of the Memcor product line, which is net of $8.3 million of discretionary compensation payments to employees in connection with the transaction and $1.0 million in transaction costs incurred in the nine months ended June 30, 2020 and gain on the sale of property in the three and nine months ended June 30, 2019;
(vii)expenses incurred by the Company related to the write-off of inventory associated with product rationalization and facility consolidation; and

(ii)foreign exchange impact related to headquarter allocations;
(viii)expenses incurred by the Company as a result of the COVID-19 pandemic, including additional charges for personal protective equipment, increased costs for facility sanitization and one-time payments to certain employees.

(iii)net expense reduction related to the remediation of manufacturing defects caused by a third-party vendor for which partial restitution was received;
(iv)charges incurred by the Company related to product rationalization in its electro-chlorination business;
(v)amounts related to the prior year sale of the Memcor product line;
(vi)expenses incurred by the Company as a result of the COVID-19 pandemic, including additional charges for personal protective equipment, increased costs for facility sanitization and one-time payments to certain employees;
(vii)legal fees incurred in excess of amounts covered by the Company’s insurance related to the Securities Litigation and SEC investigation; and
(viii)loss on divestiture of the Lange Product Line.
Other losses, (gains), losses and expenses include the following for the periods presented below:
60


Three Months Ended June 30, 2021Three Months Ended June 30, 2021
Other Adjustments
(In millions)(In millions)(i)(ii)(iii)(iv)(v)(vi)(vii)(viii)Total
Cost of salesCost of sales$0.1 $— $— $1.5 $— $0.1 $— $— $1.7 
Three Months Ended June 30, 2020
G&A expenseG&A expense(1.3)— — — — — 0.8 — (0.5)
Other Adjustments
(i) (ii) (iii) (iv) (v) (vi) (vii) (viii) Total
Cost of sales$
 $
 $
 $
 $0.1
 $
 $
 $0.7
 $0.8
G&A expense(4.0) (0.1) 
 
 
 
 
 0.4
 (3.7)
Total$(4.0) $(0.1) $
 $
 $0.1
 $
 $
 $1.1
 $(2.9)Total$(1.2)$— $— $1.5 $— $0.1 $0.8 $— $1.2 
Three Months Ended June 30, 2020
Other Adjustments
(In millions)(i)(ii)(iii)(iv)(v)(vi)(vii)(viii)Total
Cost of sales$— $— $— $0.1 $— $0.7 $— $— $0.8 
G&A expense(4.0)(0.1)— — — 0.4 — — (3.7)
Total$(4.0)$(0.1)$— $0.1 $— $1.1 $— $— $(2.9)
Nine Months Ended June 30, 2021
Other Adjustments
(In millions)(i)(ii)(iii)(iv)(v)(vi)(vii)(viii)Total
Cost of sales$0.1 $— $— $2.4 $0.2 $0.2 $— $— $2.9 
G&A expense(5.2)— — — — 0.2 4.1 — (0.9)
Other operating (income) expense— — — — — — — 0.2 0.2 
Total$(5.1)$— $— $2.4 $0.2 $0.4 $4.1 $0.2 $2.2 
Nine Months Ended June 30, 2020
Other Adjustments
(In millions)(i)(ii)(iii)(iv)(v)(vi)(vii)(viii)Total
Cost of sales$(0.1)$— $0.1 $0.4 $0.2 $0.7 $— $— $1.3 
G&A expense(2.4)— — — 0.1 0.4 — — (1.9)
Other operating (income) expense— — (1.6)— (58.3)— — — (59.9)
Total$(2.5)$— $(1.5)$0.4 $(58.0)$1.1 $— $— $(60.5)
61


Three Months Ended June 30, 2019
 Other Adjustments
 (i) (ii) (iii) (iv) (v) (vi) (vii) (viii) Total
Cost of sales$0.2
 $
 $
 $0.4
 $0.2
 $
 $(0.1) $
 $0.7
G&A expense(1.4) 
 
 
 
 
 
 
 (1.4)
Other operating (income) expense
 
 
 
 
 (0.4) 
 
 (0.4)
Total$(1.2) $
 $
 $0.4
 $0.2
 $(0.4) $(0.1) $
 $(1.1)
Nine Months Ended June 30, 2020
 Other Adjustments
 (i) (ii) (iii) (iv) (v) (vi) (vii) (viii) Total
Cost of sales$(0.1) $
 $
 $0.1
 $0.4
 $0.2
 $
 $0.7
 $1.3
G&A expense(2.4) 
 
 
 
 0.1
 
 0.4
 (1.9)
Other operating (income) expense
 
 
 (1.6) 
 (58.3) 
 
 (59.9)
Total$(2.5) $
 $
 $(1.5) $0.4
 $(58.0) $
 $1.1
 $(60.5)

Nine Months Ended June 30, 2019
 Other Adjustments
 (i) (ii) (iii) (iv) (v) (vi) (vii) (viii) Total
Cost of sales$0.2
 $
 $0.5
 $1.7
 $3.2
 $
 $5.0
 $
 $10.6
G&A expense3.6
 
 
 
 
 
 
 
 3.6
Other operating (income) expense
 
 
 
 
 (0.4) 
 
 (0.4)
Total$3.8
 $
 $0.5
 $1.7
 $3.2
 $(0.4) $5.0
 $
 $13.8
Immaterial rounding differences may beWe do not present in the tables above.

Results of Operations
The following tables summarize key components of our results of operations for the periods indicated:
 Three Months Ended June 30, Nine Months Ended June 30,
 2020 2019   2020 2019  
(In millions, except per share amounts)  % of Revenue   % of Revenue % Variance   % of Revenue   % of Revenue % Variance
Revenue$347.8
 100.0 % $360.3
 100.0 % (3.5)% $1,045.6
 100.0 % $1,032.0
 100.0 % 1.3 %
Cost of product sales and services(237.6) (68.3)% (249.0) (69.1)% (4.6)% (718.4) (68.7)% (736.4) (71.4)% (2.4)%
Gross profit110.2
 31.7 % 111.3
 30.9 % (1.0)% 327.2
 31.3 % 295.6
 28.6 % 10.7 %
General and administrative expense(44.9) (12.9)% (49.6) (13.8)% (9.5)% (152.8) (14.6)% (152.6) (14.8)% 0.1 %
Sales and marketing expense(29.8) (8.6)% (31.9) (8.9)% (6.6)% (101.8) (9.7)% (103.5) (10.0)% (1.6)%
Research and development expense(2.8) (0.8)% (3.3) (0.9)% (15.2)% (9.7) (0.9)% (11.4) (1.1)% (14.9)%
Other operating income (expense), net0.4
 0.1 % 0.6
 0.2 % (33.3)% 61.0
 5.8 % 4.1
 0.4 % 1,387.8 %
Interest expense(10.5) (3.0)% (14.9) (4.1)% (29.5)% (37.3) (3.6)% (43.8) (4.2)% (14.8)%
Income (loss) before income taxes22.6
 6.5 % 12.2
 3.4 % (85.2)% 86.6
 8.3 % (11.6) (1.1)% 846.6 %
Income tax (expense) benefit(0.8) (0.2)% (7.9) (2.2)% 89.9 % (3.3) (0.3)% 1.2
 0.1 % (375.0)%
Net income (loss)21.8
 6.3 % 4.3
 1.2 % 407.0 % 83.3
 8.0 % (10.4) (1.0)% 901.0 %
Net income attributable to non‑controlling interest0.4
 0.1 % 0.2
 0.1 % 100.0 % 1.0
 0.1 % 0.8
 0.1 % 25.0 %
Net income (loss) attributable to Evoqua Water Technologies Corp.$21.4
 6.2 % $4.1
 1.1 % 422.0 % $82.3
 7.9 % $(11.2) (1.1)% 834.8 %
                    
Weighted average shares outstanding                   
Basic116.6
   114.7
     116.6
   114.7
    
Diluted120.2
   119.4
     121.1
   114.7
    
Earnings (loss) per share                   
Basic$0.18
   $0.04
     $0.71
   $(0.10)    
Diluted$0.18
   $0.03
     $0.68
   $(0.10)    
                    
Other financial data:                  
Adjusted EBITDA(1)$63.8
 18.3 % $60.6
 16.8 % 5.3 % $164.1
 15.7 % $155.7
 15.1 % 5.4 %

(1)For the definition of Adjusted EBITDA (a non-GAAP financial measure) and a reconciliation to net income (loss), its most directly comparable financial measure presented in accordance with GAAP, see “How We Assess the Performance of Our Business-Adjusted EBITDA.”

Consolidated Results
Revenues-Revenues decreased $12.5 million, or 3.5%, to $347.8 million in the three months ended June 30, 2020 from $360.3 million in the three months ended June 30, 2019. Revenues increased $13.6 million, or 1.3%, to $1,045.6 million in the nine months ended June 30, 2020 from $1,032.0 million in the nine months ended June 30, 2019.
The following table provides the change in revenues from product sales and revenues from services, respectively:
 Three Months Ended June 30, Nine Months Ended June 30,
 2020 2019 % Variance 2020 2019 % Variance
   
% of
Revenue
   
% of
Revenue
     
% of
Revenue
   
% of
Revenue
  
Revenue from product sales$207.6
 59.7% $210.3
 58.4% (1.3)% $610.1
 58.3% $597.3
 57.9% 2.1%
Revenue from services140.2
 40.3% 150.0
 41.6% (6.5)% 435.5
 41.7% 434.7
 42.1% 0.2%
 $347.8
 100.0% $360.3
 100.0% (3.5)% $1,045.6
 100.0% $1,032.0
 100.0% 1.3%
Revenues from product sales decreased $2.7 million, or 1.3%, to $207.6 million in the three months ended June 30, 2020 from $210.3 million in the three months ended June 30, 2019. The decrease was related to a decline in aftermarket revenues of $17.5 million, of which $15.2 million was driven by the divestiture of the Memcor product line as well as site closures and delays due to COVID-19. This decline was partially offset by increased capital revenues of $14.8 million derived primarily from activity in the microelectronics end market.
Revenues from product sales increased $12.8 million, or 2.1%, to $610.1 million in the nine months ended June 30, 2020 from $597.3 million in the nine months ended June 30, 2019. The increase was driven by additional capital revenues of $37.5 million, primarily related to projects in the microelectronics end market as well as $1.0 million related to the acquisitions of ATG UV and Frontier, partially offset by a decrease in aftermarket revenues of $24.8 million, related to the divestiture of the Memcor product line as well as site closures and delays due to COVID-19.
Revenues from services decreased $9.8 million, or 6.5%, to $140.2 million in the three months ended June 30, 2020 from $150.0 million in the three months ended June 30, 2019. This decrease was evenly driven by the timing of completion of certain large projects in the prior year as well as the impact of COVID-19 shut-downs and delays, primarily in refining and oil and gas end markets, offset somewhat by price realization related to established service contracts.
Revenues from services increased $0.8 million, or 0.2%, to $435.5 million in the nine months ended June 30, 2020 from $434.7 million in the nine months ended June 30, 2019. This increase was driven by strong organic service growth, which was augmented by price realization, offset by the decline in the three months ended June 30, 2020 due to the factors mentioned above.
Cost of Sales and Gross Margin-Total gross margin increased to 31.7% in the three months ended June 30, 2020 from 30.9% in the three months ended June 30, 2019. Total gross margin increased to 31.3% in the nine months ended June 30, 2020 from 28.6% in the nine months ended June 30, 2019.
The following table provides the change in cost of product sales and cost of services, respectively, along with related gross margins:
 Three Months Ended June 30, Nine Months Ended June 30,
 2020 2019 2020 2019
   
Gross
Margin %
   
Gross
Margin %
   
Gross
Margin %
   
Gross
Margin %
Cost of product sales$(143.5) 30.9% $(148.4) 29.4% $(428.1) 29.8% $(438.9) 26.5%
Cost of services(94.1) 32.9% (100.6) 32.9% (290.4) 33.3% (297.5) 31.6%
 $(237.6) 31.7% $(249.0) 30.9% $(718.4) 31.3% $(736.4) 28.6%

Gross margin from product sales increased by 1.5% to 30.9% in the three months ended June 30, 2020 from 29.4% in the three months ended June 30, 2019. The increase in gross margin was driven by improved plant productivity and operational execution as the Company continues to realize the benefits of restructuring efforts along with some impact from product mix and price realization.
Gross margin from product sales increased by 3.3% to 29.8% in the nine months ended June 30, 2020 from 26.5% in the nine months ended June 30, 2019. The increase in gross margin was primarily driven by costs incurred in the prior year of $10.6 million related to restructuring and product rationalization, that did not reoccur in the current year.
Gross margin from services remained flat at 32.9% in the three months ended June 30, 2020 as compared to 2019. The operational impacts of declining revenue volume and productivity challenges were neutralized by improved pricing. Gross margin from services also increased approximately 1.7% to 33.3% in the nine months ended June 30, 2020 from 31.6% in the nine months ended June 30, 2019. This increase is mainly driven by price realization recognized in revenue as well as continued focus on labor productivity even as previous increases in revenue volumes were offset in the current period.
Operating Expenses-Operating expenses decreased $7.3 million, or 8.6%, to $77.5 million in the three months ended June 30, 2020 from $84.8 million in the three months ended June 30, 2019. The change in foreign currency translation, most of which is related to intercompany loans, resulted in a net decrease in operating expenses of $3.0 million period over period. The remaining decrease is due to various efforts taken by the Company to reduce costs across various areas in response to COVID-19 uncertainties, such as reduced travel and other employee costs.
Operating expenses decreased $3.2 million, or (1.2)%, to $264.3 million in the nine months ended June 30, 2020 from $267.5 million in the nine months ended June 30, 2019. This decrease is mainly due to favorable change in foreign currency translation on the intercompany loans of $6.7 million, partially offset by increased costs of $3.8 million related to the addition of operating expenses as a result of the ATG UV and Frontier acquisitions, mainly due to amortization expense on purchased intangibles. The remaining decrease is due to various efforts taken by the Company to reduce costs across various areas in response to COVID-19 uncertainties, such as reduced travel and other employee costs.     
A discussion of operating expenses by category is as follows:
Research and Development Expense - Research and development expenses decreased $0.5 million during the three months ended June 30, 2020 as compared to June 30, 2019, and decreased $1.7 million during the nine months ended of the same periods due to the Company’s continued efforts to reduce spending, offset partially by increased expenses by the addition of the Frontier acquisition.
Sales and Marketing Expense - Sales and marketing expenses had a decrease of $2.1 million during the three months ended June 30, 2020 and a decrease of $1.7 million during the nine months ended June 30, 2020, respectively, mainly due to a reduction in certain marketing initiatives and travel related expenses, offset by increased costs by the addition of the Frontier acquisition.
General and Administrative Expense - General and administrative expenses decreased $4.7 million, or 9.5%, to $44.9 million in the three months ended June 30, 2020 from $49.6 million in the three months ended June 30, 2019. This decrease in general and administrative expenses was primarily due to the favorable change in foreign currency translation on the intercompany loans, as described above, of $2.9 million, in addition to a reduction in travel related expenses of $1.8 million.
General and administrative expenses increased $0.2 million, or 0.1%, to $152.8 million in the nine months ended June 30, 2020 from $152.6 million in the nine months ended June 30, 2019. The increase is due to:
increased employee related expenses of $3.1 million;
increased costs of $3.3 million related to the addition of the Frontier acquisition;
costs incurred related to the secondary public offering of shares of common stock held by certain shareholders of the Company of $1.6 million; and
transaction costs related to the sale of the Memcor product line of $1.0 million.

The above increases were partially offset by:
favorable change in foreign currency translation on the intercompany loans of $6.3 million;
reduction in travel expenses of $2.5 million.

Other operating income (expense)-Other operating income (expense) decreased slightly by $0.2 million, to income of $0.4 million in the three months ended June 30, 2020 from income of $0.6 million in the three months ended June 30, 2019.
Other operating income (expense) increased $56.9 million to income of $61.0 million in the nine months ended June 30, 2020 from income of $4.1 million in the nine months ended June 30, 2019. The increase is mainly due to the net pre-tax benefit on sale of the Memcor product line of $58.0 million, which is net of $8.3 million of discretionary compensation payments to employees in connection with the transaction and $1.0 million in transaction costs incurred in the first quarter of 2020.
Interest Expense-Interest expense decreased $4.4 million, or 29.5%, to $10.5 million in the three months ended June 30, 2020 from $14.9 million in the three months ended June 30, 2019. Interest expense decreased $6.5 million, or 14.8%, to $37.3 million in the nine months ended June 30, 2020 from $43.8 million in the nine months ended June 30, 2019. The decrease in interest expense was primarily driven by a reduction in LIBOR year over year in addition to a $100 million debt repayment in the three months ended June 30, 2019, partially offset by a write-off of deferred financing fees related to the debt paydown and interest expense associated with additional equipment financings.
Income tax (expense) benefit-Income tax expense of $0.8 million and income tax expense of $7.9 million were recorded for the three months ended June 30, 2020 and 2019, respectively. The decrease in tax expense from the prior year was principally due to the favorable impact to the projected annual effective tax rate of the gain on the sale of the Memcor product line which did not generate significant tax expense due to the combination of the U.S. valuation allowance and favorable foreign tax regimes, as well as the favorable impact of the reversal of a portion of deferred tax liabilities related to indefinite lived intangibles, as compared to the prior year in which the quarter reflected the year-to-date cumulative tax impact of a profitable quarter while remaining in a year-to-date loss.
Income tax expense of $3.3 million and an income tax benefit of $1.2 million was recorded for the nine months ended June 30, 2020 and 2019, respectively. The increase in tax expense from the prior year was principally due to the significant income earned in the current year, primarily from the sale of the Memcor product line, as compared to a loss in the prior year.
Net Income-Net income increased by $17.5 million, or 407.0%, to $21.8 million for the three months ended June 30, 2020, from net income of $4.3 million in the three months ended June 30, 2019. The main driver of this increase was a net decrease in income tax expense in the current year period based on the projected effective tax rate for the fiscal year of $7.1 million. Additionally, there was a reduction in interest of expense of $4.4 million and a favorable change in foreign currency translation resulting in a net gain of $3.1 million. The remaining increase in net income is due to overall contributions of revenue volume and mix, operational efficiency and cost savings.
Net income increased by $93.7 million, or 901.0%, to net income of $83.3 million for the nine months ended June 30, 2020 from a net loss of $10.4 million in the nine months ended June 30, 2019. The main driver of this increase was the sale of the Memcor product line, which resulted in a gain on sale of $67.3 million, less amounts paid for discretionary bonuses of $8.3 million and transaction costs of $1.0 million incurred in the nine months ended June 30, 2020. The resulting net pre-tax benefit was $58.0 million. In addition to the net benefit of the sale, we saw overall contributions of revenue volume and mix as well as operational efficiencies of $26.4 million and a favorable change in foreign currency translation resulting in a net gain of $7.3 million. Finally, interest expense decreased by $6.5 million. These increases were offset by an increase in income tax expense of $4.5 million.
Adjusted EBITDA-Adjusted EBITDA is a non-GAAP financial measure. Adjusted EBITDA for the three months ended June 30, 2020 was $63.8 million, as compared to $60.6 million for the three months ended June 30, 2019. Adjusted EBITDA for the quarter as compared to the prior year period was driven primarily by operational efficiencies and cost savings, offset by the changes as compared to the prior year period in non-recurring expenses and benefits.

Adjusted EBITDA increased $8.4 million, or 5.4%, to $164.1 million for the nine months ended June 30, 2020 from $155.7 million for the nine months ended June 30, 2019. The increase in Adjusted EBITDA as compared to the prior year period was primarily driven by increased revenue volume and favorable change in mix as well as operational efficiencies.
Segment Results
 Three Months Ended June 30, Nine Months Ended June 30,
 2020 2019 % Variance 2020 2019 % Variance
   % of Revenue   % of Revenue     % of Revenue   % of Revenue  
Revenues                   
Integrated Solutions and Services$228.7
 65.8 % $225.4
 62.6 % 1.5 % $694.7
 66.4 % $662.8
 64.2 % 4.8 %
Applied Product Technologies119.1
 34.2 % 134.9
 37.4 % (11.7)% 350.9
 33.6 % 369.2
 35.8 % (5.0)%
Total Consolidated347.8
 100.0 % 360.3
 100.0 % (3.5)% 1,045.6
 100.0 % 1,032.0
 100.0 % 1.3 %
Operating profit (loss)                   
Integrated Solutions and Services32.6
 9.4 % 37.4
 10.4 % (12.8)% 102.5
 9.8 % 102.3
 9.9 % 0.2 %
Applied Product Technologies23.6
 6.8 % 22.5
 6.2 % 4.9 % 110.5
 10.6 % 38.4
 3.7 % 187.8 %
Corporate(23.1) (6.6)% (32.8) (9.1)% (29.6)% (89.1) (8.5)% (108.5) (10.5)% (17.9)%
Total Consolidated33.1
 9.5 % 27.1
 7.5 % 22.1 % 123.9
 11.8 % 32.2
 3.1 % 284.8 %
EBITDA                   
Integrated Solutions and Services50.4
 14.5 % 51.4
 14.3 % (1.9)% 153.2
 14.7 % 144.6
 14.0 % 5.9 %
Applied Product Technologies27.1
 7.8 % 26.9
 7.5 % 0.7 % 121.2
 11.6 % 51.5
 5.0 % 135.3 %
Corporate and unallocated costs(16.8) (4.8)% (27.1) (7.5)% (38.0)% (70.4) (6.7)% (92.5) (9.0)% (23.9)%
Total Consolidated$60.7
 17.5 % $51.2
 14.2 % 18.6 % $204.0
 19.5 % $103.6
 10.0 % 96.9 %



Adjusted EBITDA is a non-GAAP financial measure. Adjusted EBITDA on a segment basis is defined as earnings beforebecause we do not allocate interest expense or income tax expense (benefit) and depreciation and amortization, adjusted forbenefit (expense) to our segments, making operating profit the impact of certain other items that have been reflected at the segment level.most comparable GAAP metric. The following is a reconciliation of our segment Adjustedadjusted EBITDA to operating profit, its most directly comparable financial measure presented in accordance with GAAP:
Three Months Ended June 30,Nine Months Ended June 30,
2021202020212020
(In millions)Integrated Solutions and ServicesApplied Product TechnologiesIntegrated Solutions and ServicesApplied Product TechnologiesIntegrated Solutions and ServicesApplied Product TechnologiesIntegrated Solutions and ServicesApplied Product Technologies
Operating profit$37.8 $22.7 $32.6 $23.6 $94.9 $54.2 $102.5 $110.5 
Depreciation and amortization18.2 3.5 17.8 3.5 52.3 10.6 50.7 10.7 
EBITDA$56.0 $26.2 $50.4 $27.1 $147.2 $64.8 $153.2 $121.2 
Restructuring and related business transformation costs (a)0.3 0.7 0.2 1.6 1.4 5.2 0.3 5.6 
Transaction costs (b)— — — 0.1 — — — (1.2)
Other losses (gains) and expenses (c)— 1.5 — 0.1 0.2 2.6 — (59.1)
Adjusted EBITDA$56.3 $28.4 $50.6 $28.9 $148.8 $72.6 $153.5 $66.5 
 Three Months Ended June 30, Nine Months Ended June 30,
 2020 2019 2020 2019
 Integrated Solutions and Services Applied Product Technologies Integrated Solutions and Services Applied Product Technologies Integrated Solutions and Services Applied Product Technologies Integrated Solutions and Services Applied Product Technologies
Operating Profit$32.6
 $23.6
 $37.4
 $22.5
 $102.5
 $110.5
 $102.3
 $38.4
Depreciation and amortization17.8
 3.5
 14.0
 4.4
 50.7
 10.7
 42.3
 13.1
EBITDA$50.4
 $27.1
 $51.4
 $26.9
 $153.2
 $121.2
 $144.6
 $51.5
Restructuring and related business transformation costs (a)0.2
 1.6
 
 0.2
 0.3
 5.6
 0.4
 0.7
Transaction costs (b)
 0.1
 
 
 
 (1.2) 0.5
 0.7
Other losses (gains) and expenses (c)
 0.1
 
 0.2
 
 (59.1) 0.1
 9.6
Adjusted EBITDA (d)$50.6
 $28.9
 $51.4
 $27.3
 $153.5
 $66.5
 $145.6
 $62.5
(a)Represents costs and expenses in connection with restructuring initiatives in the three and nine months ended June 30, 2021 and 2020, respectively. Such expenses are primarily composed of severance, relocation and facility consolidation costs.
(a)Represents costs and expenses in connection with restructuring initiatives distinct to our Integrated Solutions and Services and Applied Product Technologies segments in the three and nine months ended June 30, 2020 and 2019, respectively. Such expenses are primarily composed of severance and relocation costs.
(b)Represents costs associated with a change in the current estimate of certain acquisitions achieving their earn-out targets, which resulted in a (decrease) increase
(b)Represents costs associated with a change in the current estimate of certain acquisitions achieving their earn-out targets, which resulted in a decrease to the fair valued amount of the earn-out recorded upon acquisition, in the three and nine months ended June 30, 2020 and 2019, respectively, distinct to our Integrated Solutions and Services and Applied Product Technologies segments.
(c)Other losses, (gains) and expenses as discussed above in “How We Assess the Performance of Our Business-Adjusted EBITDA” distinct to our Integrated Solutions and Services (“ISS”) and Applied Product Technologies (“APT”) segments include the following:

 Three Months Ended June 30, Nine Months Ended June 30,
 2020 2019 2020 2019
(In millions)ISS APT ISS APT ISS APT ISS APT
Net pre-tax benefit on sale of the Memcor product line$
 $
 $
 $
 $
 $(58.0) $
 $
Gain on sale of property
 
 
 (0.4) 
 
 
 (0.4)
Remediation of manufacturing defects
 
 
 0.4
 
 (1.5) 
 1.7
Product rationalization in electro-chlorination business
 0.1
 
 0.3
 
 0.4
 
 3.2
Expenses related to maintaining non-operational business locations
 
 
 
 
 
 0.1
 
Write-off of inventory
 
 
 (0.1) 
 
 
 5.0
Foreign exchange impact related to headquarter allocations
 
 
 
 
 
 
 0.1
Total$
 $0.1
 $
 $0.2
 $
 $(59.1) $0.1
 $9.6

(d)For the definition of Adjusted EBITDA (a non-GAAP financial measure) and a reconciliation to net income (loss), its most directly comparable financial measure presented in accordance with GAAP, see “How We Assess the Performance of Our Business-Adjusted EBITDA.” Immaterial rounding differences may be present in the tables above.
Integrated Solutions and Services
Revenues in the Integrated Solutions and Services segment increased $3.3 million, or 1.5%, to $228.7 million in the three months ended June 30, 2020 from $225.4 million in the three months ended June 30, 2019. The increase in revenue was mainly driven by growth in capital revenue of $11.7 million, exclusive of the Frontier acquisition. These increases were primarily driven by continued strong demand for water solutions and systems in the microelectronics end market. The Frontier acquisition resulted in another increase of $1.4 million of revenue. These increases were offset by a decline in service revenue of $8.8 million. The decline was evenly driven by the timing of completion of certain large projects in the prior year, as well as the impact of COVID-19 shut down and delays, primarily in the refining and oil and gas end markets, offset somewhat by price realization related to established service contracts. Finally, aftermarket revenue saw a decline of $1.0 million.
chart-ca3b2a47275a53048b6.jpg
Revenues in the Integrated Solutions and Services segment increased $31.9 million, or 4.8%, to $694.7 million in the nine months ended June 30, 2020, from $662.8 milliondistinct to our Applied Product Technologies segment.
(c)Other losses, (gains) and expenses as discussed above in “How We Assess the nine months ended June 30, 2019. The increase in revenue was driven by stronger capital growthPerformance of $30.0 million, exclusive of acquisitions, primarily relatedOur Business-Adjusted EBITDA” distinct to projects in the microelectronics end market. In addition, service growth of $1.0 million was a combination of price realization offset by

timing of large projects completed in the prior year as well as the impact of COVID-19 shut-downs and delays, primarily in the refining and oil and gas end markets. Our recent investment in Frontier resulted in an additional increase of $3.7 million of revenue. These increases were offset by a reduction in aftermarket revenue of $2.8 million.
chart-9859da609897511c96d.jpg

Operating profit in theour Integrated Solutions and Services segment decreased $4.8 million, or 12.8%, to $32.6 million in the three months ended June 30, 2020 from $37.4 million in the three months ended June 30, 2019. Segment profitability was impacted by $2.8 million of operational variances related to lower service volumes(“ISS”) and productivity due to customer shutdowns and enhanced safety protocols as well as $2.9 million related to increased employee related expenses, offset by $2.1 million of cost containment measures implemented in response to the uncertainties of COVID-19. Additionally, higher depreciation and amortization expense resulted in another reduction of profit of $3.8 million. These decreases were partially offset by $2.6 million profit in the period driven by increased organic and acquisition related revenue volume, augmented by improved pricing.
chart-4f908b1209a25efca06.jpg
Operating profit in the Integrated Solutions and Services segment increased $0.2 million, or 0.2%, to $102.5 million in the nine months ended June 30, 2020 from $102.3 million in the nine months ended June 30, 2019. Segment profitability improved $16.7 million in the period driven by increased organic and acquisition related revenue volume, augmented by improved pricing, offset by $2.8 million of operational variances in the current quarter related to lower service volumes and productivity due to customer shutdowns and enhanced safety protocols. The current period negative impacts were somewhat mitigated by $2.1 million of cost containment measures implemented in response to the uncertainties of COVID-19. Profitability in the current year was also favorably impacted by the non-recurrence of $0.5 million of charges related to the achievement of earn-out targets associated with the Pure Water acquisition, in addition to the non-recurrence of other charges noted in the prior year of approximately $0.2 million related to restructuring and inactive sites. Negative drivers to profitability were increased employee related expenses of $8.1 million and higher depreciation and amortization expense of $8.4 million.

chart-94409ba5a4b5590f9f4.jpg
EBITDA in the Integrated Solutions and Services segment decreased $1.0 million, or 1.9%, to $50.4 million in the three months ended June 30, 2020, compared to $51.4 million in the three months ended June 30, 2019 and increased $8.6 million, or 5.9%, to $153.2 million in the nine months ended June 30, 2020, compared to $144.6 million in the nine months ended June 30, 2019.
Applied Product Technologies
Revenues in the Applied Product Technologies segment decreased $15.8 million, or 11.7%, to $119.1 million(“APT”) segments include the following:
Three Months Ended June 30,Nine Months Ended June 30,
2021202020212020
(In millions)ISSAPTISSAPTISSAPTISSAPT
Trailing costs from the sale of the Memcor product line$— $— $— $— $— $0.2 $— $— 
Net pre-tax benefit on sale of the Memcor product line— — — — — — — (58.0)
Remediation of manufacturing defects— — — — — — — (1.5)
Product rationalization in electro-chlorination business— 1.5 — 0.1 — 2.4 — 0.4 
Loss on divestiture of Lange Product Line— — — — 0.2 — — — 
Total$— $1.5 $— $0.1 $0.2 $2.6 $— $(59.1)

Immaterial rounding differences may be present in the three months ended June 30, 2020 from $134.9 million in the three months ended June 30, 2019. The impact from the divestiture of the Memcor product line and the acquisition of ATG UV resulted in a net reduction in revenue of $11.1 million. The segment also saw an unfavorable foreign currency translation impact of $1.4 million. Additionally, revenue declined across multiple product lines in both the Americas and EMEA regions by $3.6 million and $1.7 million, respectively, mainly due to COVID-19 related site closures and delays. These decreases were partially offset by organic revenue growth by an increase in Asia Pacific of $2.0 million, driven by volume in the Anodes and Aquatics product lines, as demand improved in the region as it recovers from COVID-19.tables above.
chart-ecbe36eb8d765a21a84.jpg
Revenues in the Applied Product Technologies segment decreased $18.3 million to $350.9 million in the nine months ended June 30, 2020 from $369.2 million in the nine months ended June 30, 2019. The divestiture of the Memcor product line and the acquisition of ATG UV resulted in a net reduction in revenue of $15.2 million. Additionally, organic revenues were down $3.3 million and $1.2 million in the Americas and Asia Pacific regions, respectfully, predominantly due to COVID-19 slow down and delays. The segment also saw an unfavorable foreign currency translation impact of $3.5 million. These declines were partially offset by organic revenue growth in EMEA of $4.9 million.

chart-ea474e245934526a9be.jpg
Operating profit in the Applied Product Technologies segment increased $1.1 million, or 4.9%, to $23.6 million in the three months ended June 30, 2020 from $22.5 million in the three months ended June 30, 2019. The increase is mainly driven by mix performance and price of $3.2 million, operational performance improvements of $1.0 million, employee & other cost variances of $0.7 million, in addition to lower depreciation of $0.9 million. These increases were offset by a volume impact of $2.3 million. The divestiture of the Memcor product line and the acquisition of ATG UV resulted in a net reduction of $0.8 million, and $0.2 million in unfavorable foreign currency.

Further operating profit decreases were due to one-time costs of $1.8 million related to:

An increase in restructuring charges of $1.4 million primarily due to costs incurred following the sale of the Memcor product line;
A gain on sale recorded in the prior year of $0.4 million, which did not reoccur in the current year; and
An increase of $0.1 million related to charges related to the achievement of earn-out targets on a prior acquisition.

These decreases were partially offset by:

A reduction in costs incurred by the Company in the prior year from a settlement with a third-party vendor associated with remediation of manufacturing defects caused by the vendor of $0.4 million.
Other non-recurring charges related to product rationalization that declined by $0.1 million as compared to the prior year period.


chart-451b3c48662054ada1f.jpg
Operating profit in the Applied Product Technologies segment increased $72.1 million, or 187.8%, to $110.5 million in the nine months ended June 30, 2020 from $38.4 million in the nine months ended June 30, 2019. The increase is mainly due to the net pre-tax benefit on sale of the Memcor product line of $58.0 million, which is net of $8.3 million of discretionary compensation payments to employees in connection with the transaction and $1.0 million in transaction costs incurred. Increased profit was also driven by volume and mix performance, augmented by improved pricing, of $9.0 million, in addition to a $0.3 million net benefit from the divestiture of the Memcor product line and the acquisition of ATG UV and lower depreciation of $2.4 million. Further increases were due to net reductions in nonrecurring costs of $5.3 million related to:
Reduction in costs incurred by the Company related to the write–off of inventory in the prior year of $5.0 million associated with product rationalization and facility consolidation;
A reduction in costs incurred by the Company from a settlement with a third-party vendor associated with remediation of manufacturing defects caused by the vendor of $3.2 million;
Reductions in costs related to the achievement of earn-out targets associated with certain acquisitions of $1.9 million;
Reductions in product rationalization costs related to charges incurred by the Company in its electro-chlorination business of $2.8 million;
A gain on sale recorded in the prior year of $0.4 million which did not reoccur in the current year;
Increases in restructuring charges of $4.9 million primarily due to costs incurred following the sale of the Memcor product line; and
Release of an acquisition related contingency due to the passage of time in the prior year for $2.8 million.

Operating profit was reduced by inflation and employee related costs increased $0.6 million, foreign currency of $0.5 million, and operational variances of $1.6 million.


chart-6abb37d8b23e5618aa9.jpg
EBITDA in the Applied Product Technologies segment increased $0.2 million, or 0.7%, to $27.1 million in the three months ended June 30, 2020, compared to $26.9 million in the three months ended June 30, 2019. EBITDA in the Applied Product Technologies segment increased $69.7 million, or 135.3%, to $121.2 million in the nine months ended June 30, 2020, compared to $51.5 million in the nine months ended June 30, 2019.
Liquidity and Capital Resources
Liquidity describes the ability of a company to generate sufficient cash flows to meet the cash requirements of its business operations, including working capital needs, debt service, acquisitions, other commitments and contractual
62


obligations. We consider liquidity in terms of cash flows from operations and their sufficiency to fund our operating and investing activities.
Our principal sources of liquidity are our cash generated by our operating activities, and borrowings under our Revolving Credit Facility.revolving credit facility and financing arrangements related to capital expenditures for equipment used to provide services to our customers. Historically, we have financed our operations primarily from cash generated from operations and periodic borrowings under our $125.0 million Revolving Credit Facility.these sources. Our primary cash needs are for day to day operations, to pay interest and principal on our indebtedness, to fund working capital requirements and to make capital expenditures.
Our ability to fund our capital needs depends on our ongoing ability to generate cash from operations and access to bank financing and the capital markets. Although the COVID-19 pandemic has not materially impacted our liquidity to date, we plan to continue to evaluate aspects of our spending, including capital expenditures, discretionary spending, and strategic investments, as the year progresses. We have considered the impacts of the COVID-19 pandemic on our liquidity and capital resources to date, and we do not currently expect it to impact our ability to meet future liquidity needs or continue to comply with our applicable debt covenants. We believe we are currently well-positioned to manage our business and have the ability and sufficient capacity to meet our cash requirements by using available cash, internally generated funds, and borrowing under our revolving credit facility. We are committed to maintaining a solid liquidity position.
As part of our ongoing efforts to improve our cash flow and related liquidity, we work with suppliers to optimize our terms and conditions, including occasionally extending payment terms. We also facilitate a voluntary supply chain finance program (the “program”) to provide certain of our suppliers with the opportunity to sell receivables due from us to participating financial institutions at the sole discretion of both the suppliers and the financial institutions. A third party administers the program; our responsibility is limited to making payment on the terms originally negotiated with our supplier, regardless of whether the supplier sells its receivable to a financial institution. We do not enter into agreements with any of the participating financial institutions in connection with the program. The range of payment terms we negotiate with our suppliers is consistent, irrespective of whether a supplier participates in the program. The June 30 year to date amounts settled through the program and paid to participating financial institutions were $24.1$27.4 million and $0.2$26.4 million in 2020the nine months ended June 30, 2021 and 2019,2020, respectively. A downgrade in our credit rating or changes in the financial markets could limit the financial institutions’ willingness to commit to participation in the program.
We expect to continue to finance our liquidity requirements through internally generated funds, borrowings under our Revolving Credit Facilityrevolving credit facility and equipment financing arrangements. We believe that our projected cash flows generated from operations, together with borrowings under our Revolving Credit Facilityrevolving credit facility and other financing arrangements are sufficient to fund our principal debt payments, interest expense, our working capital needs, and our expected capital expenditures for the next twelve months. Our capital expenditures for the nine months ended June 30, 2021 and 2020 and 2019 were $65.9$54.1 million and $63.9$65.9 million, respectively. However, our budgeted capital expenditures can vary from period to period based on the nature of capital intensive project awards. Our focus on customer outsourced water projects will continue to be a driver of capital expenditures. From time to time, we may enter into financing arrangements related

to capital expenditures for equipment used to provide services to our customers. During the nine months ended June 30, 2021 and 2020, we entered into equipment financing arrangements totaling $25.4 million and $12.9 million, respectively. In addition, we may draw on our Revolving Credit Facilityrevolving credit facility from time to time to fund or partially fund an acquisition.
As of June 30, 2020,2021, we had total indebtedness of $879.9$801.9 million, including $821.6$475.0 million of term loan borrowings under the First Lien Term Loan Facility, no borrowings2021 Credit Agreement, $95.0 million outstanding under ourthe 2021 Revolving Credit Facility, $56.0$148.2 million outstanding under the Securitization Facility, $83.3 million in borrowings related to equipment financing $0.7and $0.5 million of notes payable related to certain equipment related contracts and $1.6 million related to a mortgage.contracts. We also had $11.9$11.5 million of letters of credit issued under our $125.0 million2021 Revolving Credit Facility and an additional $51 thousand of letters of credit issued under a separate uncommitted facility as of June 30, 2020.2021.
OurAs of June 30, 2021 and September 30, 2020, we were in compliance with the covenants contained in the Credit Agreement, including the revolving credit facility under the Credit Agreement.
2021 Credit Agreement
On April 1, 2021, EWT III entered into the 2021 Credit Agreement among EWT III, as borrower, EWT II, as parent guarantor, the lenders from time to time party thereto, JPMorgan Chase Bank, N.A., as administrative agent and
63


collateral agent, and ING Capital, LLC, as sustainability coordinator. The 2021 Credit Agreement provides for a multi-currency senior secured revolving credit facilities containfacility in an aggregate principal amount not to exceed the U.S. dollar equivalent of $350.0 million and a numberdiscounted senior secured term loan facility relating to a term loan in the amount of covenants imposing$475.0 million (together, the “Senior Facilities”). The 2021 Credit Agreement also provides for a letter of credit sub-facility not to exceed $60.0 million. On April 1, 2021, EWT III borrowed the full amount of $475.0 million under the 2021 Term Loan and $105.0 under the 2021 Revolving Credit Facility. At June 30, 2021, the Company had $475.0 million outstanding under the 2021 Term Loan and $95.0 million outstanding on the 2021 Revolving Credit Facility.
The Senior Facilities are guaranteed by EWT II and certain restrictionsexisting and future direct or indirect wholly-owned domestic subsidiaries of EWT III (together with EWT III, collectively, the “Loan Parties”), and collateralized by a first lien on our business. These restrictions may affect our ability to operate our business and may limit our ability to take advantage of potential business opportunities as they arise. The restrictions these covenants place on our business operations, include limitations on our or our subsidiaries’ ability to:
incur or guarantee additional indebtedness;
make certain investments;
pay dividends or make distributions on our capital stock;
sell assets, including capital stock of restricted subsidiaries;
agree to payment restrictions affecting our restricted subsidiaries;
consolidate, merge, sell or otherwise dispose of all or substantially all of our assets;the assets of the Loan Parties, with certain exceptions, including: (i) any equity interest in, and any assets sold to or held by, Evoqua Finance in connection with the Receivables Securitization Program, (ii) any equity interest in, and any assets sold to or held by, any other special purpose entity that is an indirect subsidiary of the Company in connection with any other securitization facility permitted under the 2021 Credit Agreement, and (iii) any real property with a fair market value of $5.0 million or less, when considered individually, or $30.0 million or less when taken together with all other real property owned by the Loan Parties.
enter into transactionsWith respect to the 2021 Revolving Credit Facility, EWT III is required to pay a commitment fee based on the daily unused portion of the 2021 Revolving Credit Facility, as well as certain other fees to the agents and the arrangers under the Senior Facilities. Subject to the terms of the 2021 Credit Agreement, to the extent not previously paid, any amount owed under the 2021 Revolving Credit Facility will become due and payable in full on April 1, 2026.

With respect to the 2021 Term Loan, EWT III will pay quarterly installments of principal of approximately $1.2 million beginning in the fourth quarter of 2021. Subject to the terms of the 2021 Credit Agreement, to the extent not previously paid, any amount owed under the 2021 Term Loan will become due and payable in full on April 1, 2028.

Amounts outstanding under the Senior Facilities, at EWT III’s option, will bear interest at either (i) a Base Rate determined in accordance with our affiliates;
incur liens;the terms of the 2021 Credit Agreement, (ii) with respect to any amounts denominated in U.S. dollars or
designate any Sterling, a LIBO rate, or replacement thereof, as determined in accordance with the terms of ourthe 2021 Credit Agreement, or (iii) with respect to amounts denominated in Euros, the EURIBOR rate, or replacement thereof, as determined in accordance with the terms of the 2021 Credit Agreement. In the case of the 2021 Revolving Credit Facility, an applicable margin based on the consolidated total leverage of EWT III and its restricted subsidiaries, as unrestricted subsidiaries.calculated in accordance with the terms of the 2021 Credit Agreement, will be added to the interest rate elected by EWT III; provided that the interest rate may be adjusted if EWT III meets certain metrics for a sustainability price adjustment prior to December 31, 2021. In the case of the 2021 Term Loan, a fixed applicable margin, calculated in accordance with the terms of the 2021 Credit Agreement, will be added to the interest rate elected by EWT III.
WeThe net proceeds of the Senior Facilities, together with the net proceeds of the Receivables Securitization Program and cash on hand, were used to repay all outstanding indebtedness, in an aggregate principal amount of approximately $814.5 million, under the 2014 Credit Agreement. The proceeds of the 2021 Revolving Credit Facility may also be used to finance or refinance the working capital and capital expenditures needs of EWT III and certain of its subsidiaries and for general corporate purposes.
The 2021 Credit Agreement is subject to acceleration upon various events of default and contains customary representations, warranties, affirmative covenants, and negative covenants, each substantially similar to those included in the Credit Agreement, including, among other things, a springing maximum first lien leverage ratio of 5.55 to 1.00.
As a result of the refinancing, the Company wrote off approximately $1.3 million of deferred financing fees related to the 2014 Term Loan. In addition, the Company incurred approximately $5.0 million of fees as a result of the refinancing, of which $1.9 million were recorded as deferred financing fees on the Consolidated Balance Sheets and $3.1 million were expensed.
Receivables Securitization Program
On April 1, 2021, Evoqua Finance entered into the Receivables Securitization Program consisting of, among other agreements, (i) the Receivables Financing Agreement among Evoqua Finance, as the borrower, the Receivables
64


Financing Lenders, PNC Bank, as administrative agent, EWT LLC, as initial servicer, and PNC Markets, as structuring agent, pursuant to which the lenders have made available to Evoqua Finance the Securitization Facility in an amount up to $150.0 million and (ii) the Sale Agreement among Evoqua Finance, as purchaser, EWT LLC, as initial servicer and as an originator, and Neptune Benson, Inc., an indirectly wholly-owned subsidiary of the Company, as an originator. Under the Receivables Securitization Program, the Originators, pursuant to the Sale Agreement, are required to sell substantially all of their trade receivables and certain related rights to payment and obligations of the Originators with respect to such receivables (the “Receivables”) to Evoqua Finance, which, in turn, will obtain loans secured by the Receivables from the Receivables Financing Lenders pursuant to the Receivables Financing Agreement. On April 1, 2021, Evoqua Finance borrowed $142.2 million under the Securitization Facility. During the third quarter of 2021, Evoqua Finance borrowed an additional amount under the Securitization Facility and had $148.2 million outstanding at June 30, 2021.
Pursuant to the Receivables Securitization Program, the aggregate principal amount of the loans made by the Receivables Financing Lenders will not exceed $150.0 million outstanding, subject to the borrowing base restrictions, unless so increased under the Receivables Financing Agreement. The Receivables Financing Lenders under the Receivables Securitization Program receive interest at LIBOR or LMIR as selected by Evoqua Finance. The Receivables Financing Agreement contains customary LIBOR benchmark replacement language. Additionally, PNC Bank and PNC Markets will receive certain fees as agents, and EWT LLC will receive a fee as servicer of the Receivables.

The Receivables Securitization Program contains certain customary representations, warranties, affirmative covenants, and negative covenants, subject to certain cure periods in some cases, including the eligibility of the Receivables being sold by the Originators and securing the loans made by the Receivables Financing Lenders, as well as customary reserve requirements, events of default, termination events, and servicer defaults. The Receivables Securitization Program matures on April 1, 2024. As of June 30, 2021, we were in compliance with the covenants contained in the Receivables Securitization Program.

Evoqua Water Technologies Corp. is a holding company and dodoes not conduct any business operations of ourits own. As a result, our ability to pay cash dividends on our common stock, if any, is dependent upon cash dividends and distributions and other transfers from our operating subsidiaries. Under the terms of our senior secured credit facilities,the 2021 Credit Agreement, our operating subsidiaries are currently limited in their ability to pay cash dividends to us, and we expect these limitations to continue in the future under the terms of any future credit agreement or any future debt or preferred equity securities of ours or of our subsidiaries.
In addition, our Revolving Credit Facility, but not the First Lien Term Loan Facility, contains a financial covenant which requires us to comply with the maximum first lien net leverage ratio of 5.55 to 1.00 as of the last day of any quarter on which the aggregate amount of revolving loans and letters of credit outstanding under the Revolving Credit Facility (net of cash collateralized letters of credit and undrawn outstanding letters of credit in an amount of up to 50% of the Revolving Credit Facility) exceeds 25% of the total commitments thereunder.
As of June 30, 2020 and September 30, 2019, we were in compliance with the covenants contained in the senior secured credit facilities.
Our indebtedness could adversely affect our ability to raise additional capital, limit our ability to react to changes in the economy or our industry, expose us to interest rate risk and prevent us from meeting our obligations.
Cash Flows
The following table summarizes the changes to our cash flows for the periods presented:

Nine Months Ended
June 30,
Nine Months Ended
June 30,
(In millions)2020 2019(In millions)20212020
Statement of Cash Flows Data Statement of Cash Flows Data
Net cash provided by operating activities$82.5
 $54.4
Net cash provided by operating activities$102.9 $100.7 
Net cash provided by (used in) investing activities41.8
 (68.7)
Net cash (used in) provided by investing activitiesNet cash (used in) provided by investing activities(74.4)41.8 
Net cash used in financing activities(92.2) (6.6)Net cash used in financing activities(83.0)(110.4)
Effect of exchange rate changes on cash0.8
 (0.3)Effect of exchange rate changes on cash3.0 0.8 
Change in cash and cash equivalents$32.9
 $(21.2)Change in cash and cash equivalents$(51.5)$32.9 
Operating Activities
Cash flows from operating activities can fluctuate significantly from period‑to‑period as working capital needs and the timing of payments for restructuring activities and other items impact reported cash flows.
65


Net cash provided by operating activities increased to a source of $82.5totaled $102.9 million in the nine months ended June 30, 2020 from a source of $54.42021, and $100.7 million in the nine months ended June 30, 2019.2020.
aqua-20210630_g5.jpg
Operating cash flows in the nine months ended June 30, 20202021 reflect an increasea decrease in net earnings of $93.7$58.5 million as compared to the nine months ended June 30, 2019,2020, primarily driven by the gain on the sale of the Memcor product line.line in the prior year.
The add back of non‑cash items increased operating cash flows by $96.0 million in the nine months ended June 30, 2021, as compared to an increase to operating cash flows of $20.9 million in the nine months ended June 30, 2020, as compared to an increase to operating cash flows of $86.9 million in the nine months ended June 30, 2019, resulting in an overall reductionincrease of $65.9$75.1 million. This reductionincrease was primarily driven byrelated to the adjustment for gain on sale of business, offset by an increasethe Memcor product line, which was reflected as a reduction of operating cash flows in the prior year, as well as increased depreciation and amortization expense.in the current period. Non-cash changes also include the foreign currency translation gain or loss, deferred income taxes, amortization of deferred financing fees, and share-based compensation.
The aggregate of receivables, inventories, contract assets and liabilities, and accounts payable used $17.3provided $11.5 million in operating cash flows in the nine months ended June 30, 20202021, compared to a use of $6.8$17.3 million in operating cash flows in the nine months ended June 30, 2019.
Accounts receivable and payable was a source of $12.9 million2020.
Inventories had a use of $7.9 million
Contract assets and liabilities had a use of $15.5 million
The amount of cash flow generated from or used by the above mentioned accounts depends upon how effectively we manage our cash conversion cycle, which is a representation of the number of days that elapse from the date of purchase of raw materials and components to the collection of cash from customers. Our cash conversion cycle can be significantly impacted by the timing of collections and payments in a period.
Income taxes provided $1.6 million during the nine months ended June 30, 2020, as compared to using $6.8 million during the nine months ended June 30, 2019, resulting in an increase to cash flows of $8.4 million.
The aggregate of the remaining assets and liabilities used $6.0$26.9 million of operating cash flows in the nine months ended June 30, 20202021, compared to $8.4providing $12.2 million in the nine months ended June 30, 2019.2020, resulting in a decrease to cash flows of $39.1 million. This is mainlydecrease was primarily due to an increase in customer long term receivables and timing of payments.payments, including vendor prepayments.
Prepaids and other current assets and Other non‑current assets and liabilities provided $13.9 million during the nine months ended June 30, 2020, as compared to $11.1 million during the nine months ended June 30, 2019, resulting in an increase to cash flows of $2.8
Income taxes used $2.5 million during the nine months ended June 30, 2021, as compared to providing $1.6 million during the nine months ended June 30, 2020, resulting in a decrease to cash flows of $4.1 million as compared to the prior year period..

Accrued expenses and other liabilities used $19.9 million in operating cash flows in the nine months ended June 30, 2020 compared to a use of $19.6 million in the nine months ended June 30, 2019, resulting in a decrease to cash flows of $0.3 million.
chart-bb59e57c05a75472b08.jpg
Investing Activities
Net cash used in investing activities was $74.4 million in the nine months ended June 30, 2021, as compared to net cash provided by investing activities increased $110.4 million toof $41.8 million in the nine months ended June 30, 2020, fromresulting in a usenet
66


decrease of $68.7$116.2 million inas compared to the nine months ended June 30, 2019.prior year period. This increasedecrease was largely driven by proceeds from the sale of the Memcor product line during the nine months ended June 30, 2020, in addition to higher cash outflow associated with the Ultrapure and WCSI acquisitions in the current year period as compared to the Frontier acquisition that occurred in the prior period. This was decrease was partially offset by lower cash outflow associated with purchase of capital assets compared to the Frontier acquisition in the current yearprior period. Other activity related to purchase of capital or intangible assets remained relatively consistent with the prior period.
Financing Activities
Net cash used in financing activities increased $85.6was $83.0 million in the nine months ended June 30, 2021, as compared to a use of $92.2$110.4 million in the nine months ended June 30, 2020, fromresulting in a usenet decrease of $6.6$27.4 million inas compared to the nine months ended June 30, 2019. This additional amount ofprior year period. The decrease in cash used in financing activities for the nine months ended June 30, 20202021 was primarily due to the $100 million debt paymentrefinancing activities that occurred in the three months ended June 30, 2021. Additionally, cash received from the issuance of common stock in connection with the exercise of stock options increased in the current period and increasedtaxes paid related to net share settlements of share-based compensation awards and distribution of dividends to non-controlling interest offset by cash received from common stock.declined compared to the prior period.
Seasonality
Our business has historically exhibited seasonality resulting from our customers’ increasing demand for our products and services during the spring and summer months as compared to the fall and winter months. For example, our business servicing municipal customers experiences increased demand for our odor control product lines and services in the warmer months which, together with other factors, has historically resulted in improved performance in the second half of our fiscal year. Inclement weather, such as hurricanes, droughts and floods, can also drive increased demand for our products and services. As a result, our results from operations may vary from period to period.
 
Seasonal trends historically displayed by our business could behave been impacted by the COVID-19 pandemic, and past performance should not be considered indicative of future results.  For example, decreased customer demand resulting from the economic slowdown caused by the pandemic and the measures taken to control its spread could negatemitigated the seasonal factors that have historically resulted in improved performance in the second half of our fiscal year.2020 and could have a similar impact in fiscal 2021.


Off‑Balance Sheet Arrangements
As of June 30, 2020 and September 30, 2019, weWe had letters of credit totaling $11.9 million and $13.5 million, respectively, and surety bonds totaling $148.1 million and $144.7 million, respectively,the following outstanding under our credit arrangements. arrangements at June 30, 2021 and September 30, 2020:
(In millions)June 30,
2021
September 30,
2020
Letters of credit$11.5 $13.0 
Surety bonds$141.8 $153.0 
The longest maturity date of the letters of credit and surety bonds in effect as of June 30, 20202021 was March 20, 2030.
Critical Accounting Policies and Estimates
SeeThe Company’s significant accounting policies are described in Item 8., Note 2, “Summary of Significant Accounting Policies” included in the 2020 Annual Report. Any new accounting policies or updates to existing accounting policies as a result of new accounting pronouncements have been included in the Notes to the Unaudited Consolidated Financial Statements in Part I, Item 1 of this Report. The application of the Company’s accounting policies may require the use of estimates and assumptions. Management uses historical experience and all available information to make these estimates and assumptions. Estimates are revised as additional information becomes available. Actual results could differ from these estimates.
67


See Note 2, “Recent Accounting Pronouncements” in the Unaudited Consolidated Financial Statements in Item 1 of this Report for a complete discussion of our significantrecently issued accounting policies and recent accounting pronouncements.guidance.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
    We have market risk exposure arising from changes in interest rates on our senior secured credit facilities, which bear interest at rates that are benchmarked against LIBOR. In the third quarter of 2020, the Company entered into an interest rate swap to mitigate risks associated with variable rate debt. The interest rate swap has a five-year term to hedge the variability of interest payments on the first $500.0 million of the Company’s senior secured debt and fixes the variable LIBOR rate to 0.5455%.
Based on our overall interest rate exposure to variable rate debt outstanding of $821.6 million as of June 30, 2020, a 1% increase or decrease in interest rates would decrease or increase income (loss) before income taxes by approximately $8.3 million. By comparison, based on our overall interest rate exposure to variable rate debt outstanding of $931.1 million as of June 30, 2019, a 1% increase or decrease in interest rates would have decreased or increased income (loss) before income taxes by approximately $9.4 million.
For a discussion of the Company’s exposure to market risk related to inflation, tariffs and foreign currency exchange rates, please refer to Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk,” of our Annual Report on Form 10-K for the fiscal year ended September 30, 2019, as filed with the SEC on November 25, 2019. There have been no material changes to the Company’sinformation concerning exposure to these market risks duringas stated in Part I, Item 7A of the first nine months of fiscal 2020.2020 Annual Report.
Item 4.    Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Our disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) under the Securities Exchange Act of 1934, as amended)amended (the “Exchange Act”)) are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the Securities and Exchange CommissionSEC and to ensure that information required to be disclosed is accumulated and communicated to management, including our principal executive and financial officers, to allow timely decisions regarding disclosure. Our management has evaluated, under the supervision and with the participation of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), the effectiveness of our disclosure controls and procedures as of the end of the period covered by this ReportReport. Based on that evaluation, the CEO and based on their evaluation, haveCFO concluded that the Company’s disclosure controls and procedures were effective as of such date.

While our disclosure controls and procedures are designed to provide reasonable assurance of their effectiveness, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected.
Changes toin Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the quarterly period ended June 30, 20202021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.





68


Part II - Other Information

Item 1. Legal Proceedings
From time to time, we are subject to various claims, charges and litigation matters that arise in the ordinary course of business. We believe these actions are a normal incident of the nature and kind of business in which we are engaged. While it is not feasible to predict the outcome of these matters with certainty, we do not believe that any asserted or unasserted legal claims or proceedings, individually or in the aggregate, will have a material adverse effect on our business, financial condition, results of operations or prospects.

On or aroundIn November 6, 2018, a purported shareholder of the Company filed a class action lawsuit, captioned McWilliams v. Evoqua Water Technologies Corp., Case No. 1:18-CV-10320, in the U.S.United States District Court for the Southern District of New York captioned McWilliams v. Evoqua Water Technologies Corp., et al., Case No. 1:18-CV-10320, alleging that the Company and senior management violated federal securities laws.  Onlaws by issuing false, misleading, and/or omissive disclosures in the period leading up to the Company’s October 30, 2018 announcement of, among other things, (a) preliminary results for the full-year fiscal 2018 that were below previous expectations and (b) a transition from a three-segment structure to a two-segment operating model.  In January 31, 2019, the court appointed lead plaintiffs and lead counsel in connection withand re-captioned the action and captioned the action “as In re Evoqua Water Technologies Corp. Securities Litigation” Master File No. 1:18-CV-10320. On(the “Securities Litigation”). In March 28, 2019, lead plaintiffs filed an amended complaint, which assertsasserted claims pursuant to the Securities Exchange Act of 1934 (the “Exchange Act”) and the Securities Act of 1933 (the “Securities Act”) against the Company, members of the Company’s Boardboard of Directors,directors, senior management, other executives and/or employees,a former executive, AEA, Investors LP and a number of its affiliated entities, and the underwriters of the Company’s initial public offeringIPO and secondary public offering. The amended complaint allegesalleged that the defendants violated federal securities laws by issuing false, misleading, and/or omissive disclosures concerning the Company’s integration of acquired companies, the Company’s reduction-in-force, and the Company’s accounting practices.financial results of operations. The lawsuit seekssought compensatory damages in an unspecified amount to be proved at trial,and an award of reasonable costs and expenses to the plaintiff and class counsel, and such other relief as the court may deem just and proper.  On June 26, 2019, the defendants filed motions to dismiss the amended complaint. Briefing in connection with the motions to dismiss was completed on October 4, 2019. Oncounsel.  In March 30, 2020, the Court granted the motionsdefendants’ motion to dismiss a portion of the claims, dismissing all claims predicated on supposedly intentional misstatements or omissions, which were brought under the Securities Exchange Act of 1934. The claims that remained were those brought under the Securities Act of 1933. The Company filed an answer denying the material allegations of the complaint, the parties engaged in discovery, and deniedlead plaintiffs filed a motion for class certification in December 2020.

On June 1, 2021, following mediation, the motionsparties filed a stipulation agreeing to settle the Securities Litigation (subject to Court approval) for $16.65 million, all of which will be covered by insurance.On July 8, 2021, the Court entered an order preliminarily approving the settlement and scheduling a hearing for November 1, 2021 to determine whether to grant final approval to the settlement and dismiss the Securities Act claims. The Company believes that this lawsuit is without merit and intends to vigorously defend itself against the allegations.Litigation.

On or aroundIn April 10, 2019, aanother purported shareholder of the Company filed a shareholder derivative lawsuit ostensibly on behalf of the Company in the U.S.United States District Court for the Western District of Pennsylvania, captioned Dallas Torgersen derivatively on behalf of Evoqua Water Technologies Corp. v. Ronald C. Keating et al., Case No. 2:19-CV-410. The complaint names as defendants the Company’s CEO the Company’sand CFO, andas well as members of the Company’s Boardboard of Directors,directors, and it names the Company as a nominal defendant. The complaint alleges, among other things, that the individual defendants violated federal securities laws by issuing false, misleading, and/or omissive disclosures in the period leading up to the Company’s October 30, 2018 disclosuredisclosures, and that they breached their fiduciary duties to the Company. The lawsuit seeks compensatory damages in an unspecified amount, to be proved at trial, an award of reasonable costs and expenses, restitution from the individual defendants, and an order directing the Company and the individual defendants to take all necessaryunspecified actions to reform and improve the Company’s corporate governance and internal procedures to comply with the law and to prevent the events alleged from reoccurring, including by putting forth for shareholder vote certain resolutions for amendments to the Company’s charter or bylaws, and such other relief as the court may deem just and proper. On June 14, 2019, the Court entered an order staying the lawsuit pending resolution of the procedures.

In re Evoqua Water Technologies Corp. Securities Litigation lawsuit described above. The Company believes that this lawsuit is without merit and intends to vigorously defend itself against the allegations.

On or around July 27, 2020, a different purported shareholder of the Company filed a second shareholder derivative lawsuit ostensibly on behalf of the Company in the U.S. District Court for the Western District of Pennsylvania,same court, captioned Robert Hyams derivatively on behalf of Evoqua Water Technologies Corp. v. Ronald C. Keating et al.,, Case No. 2:20-CV-1112. The complaint is similar to the one in Torgersen but also names as defendants the Company’s CEO, the Company’s CFO, members of the Company’s Board of Directors, and AEA Investors LP and a number of its affiliated entities,entities. In September 2020, the court consolidated the Torgersen and it namesHyams cases under the caption In re Evoqua Water Technologies Corp. Derivative Litigation (the “Derivative Litigation”). The Derivative Litigation has been stayed since June 2019 pending resolution of the Securities Litigation.

In February 2020, yet another purported shareholder of the Company assent a nominal defendant. The complaint alleges, among other things,letter to the board of directors demanding that it investigate and bring claims against various directors and officers for the same matters that were already the subject of the Securities Litigation and the Derivative Litigation. Although no lawsuit has yet been filed by
69


this purported shareholder, the shareholder agreed to stay matters on terms similar to what was agreed in the Derivative Litigation.

On July 28, 2021, following mediation, the parties signed an agreement, subject to Court approval, to settle the Derivative Litigation and the stockholder demand for non-cash consideration, including certain enhancements to corporate governance practices and internal procedures.

In October 2020, the Company learned that the defendants violated federal securities laws by issuing false, misleading, and/or omissive disclosuresSEC and the United States Attorney’s Office for the District of Massachusetts are investigating whether financial misstatements were made in the period leading upCompany’s public filings and earnings announcements prior to October 2018, similar to what is alleged in the Company’s October 30, 2018 disclosure and that they breached their fiduciary duties to the Company.Securities Litigation. The lawsuit seeks compensatory damages in an unspecified amount to be proved at trial, an award of reasonable costs and expenses, restitution from the individual defendants, an order directingCompany is cooperating with those investigations. Although the Company andis unable to predict the individual defendants to take all necessary actions to reform and improve the Company’s corporate governance and internal procedures to comply with the law and to prevent the events alleged from reoccurring, including by putting forth

for shareholder vote certain resolutions for amendments to the Company’s charteroutcome or bylaws, and such other relief as the court may deem just and proper. The Company believesreasonably estimate any potential loss, we currently believe that this lawsuit is without merit and intends to vigorously defend itself against the allegations.matter will not have a material adverse effect on our business, financial condition, results of operations or prospects.

Item 1A. Risk Factors
There have been no material changes to the information concerning risk factors as stated in our 2020 Annual Report on Form 10-K for the fiscal year ended September 30, 2019, as filed with the SEC on November 25, 2019, as amended on December 4, 2019, and our Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, as filed with the SEC on May 6, 2020.Report.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
None.

Item 3.    Defaults Upon Senior Securities
None.

Item 4.    Mine Safety Disclosures
None.

Item 5.    Other Information
None.

70


Item 6.    Exhibits
The following exhibits are filed or furnished as a part of this report:

Exhibit
No.
Exhibit Description
31.1*10.1
10.2
10.3
10.4
10.5
31.1*
31.2*
32.1**
32.2**
101.INS*Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH*Inline XBRL Taxonomy Extension Schema Document.
101.CAL*Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the(formatted as Inline XBRL document (includedand contained in Exhibit 101).
†     Indicates a management contract or compensatory plan or arrangement.
*Filed herewith.

* Filed herewith

** Furnished herewith



71




SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
EVOQUA WATER TECHNOLOGIES CORP.
August 4, 20203, 2021/s/ RONALD C. KEATING
By:Ronald C. Keating
Chief Executive Officer (Principal Executive Officer)
August 4, 20203, 2021/s/ BENEDICT J. STAS
By:Benedict J. Stas
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)







77
72